SONOCO PRODUCTS CO, 10-K filed on 2/26/2026
Annual Report
v3.25.4
Cover - USD ($)
12 Months Ended
Dec. 31, 2025
Feb. 13, 2026
Jun. 29, 2025
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2025    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 001-11261    
Entity Registrant Name SONOCO PRODUCTS COMPANY    
Entity Incorporation, State or Country Code SC    
Entity Tax Identification Number 57-0248420    
Entity Address, Address Line One 1 N. Second St.    
Entity Address, City or Town Hartsville    
Entity Address, State or Province SC    
Entity Address, Postal Zip Code 29550    
City Area Code 843    
Local Phone Number 383-7000    
Title of 12(b) Security No par value common stock    
Trading Symbol SON    
Security Exchange Name NYSE    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction false    
Entity Shell Company false    
Entity Public Float     $ 4,289,986,457
Entity Common Stock, Shares Outstanding   98,644,015  
Documents Incorporated by Reference
Portions of the Proxy Statement for the annual meeting of shareholders to be held on April 15, 2026, which statement shall be filed with the Securities and Exchange Commission within 120 days after the end of the fiscal year to which this Report relates, are incorporated by reference in Part III.
   
Entity Central Index Key 0000091767    
Document Fiscal Year Focus 2025    
Document Fiscal Period Focus FY    
Amendment Flag false    
v3.25.4
Audit Information
12 Months Ended
Dec. 31, 2025
Audit Information [Abstract]  
Auditor Firm ID 238
Auditor Name PricewaterhouseCoopers LLP
Auditor Location Charlotte, North Carolina
v3.25.4
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Current Assets    
Cash and cash equivalents $ 378,398 $ 431,010
Trade accounts receivable, net of allowances of $12,512 in 2025 and $10,989 in 2024 842,810 907,526
Other receivables 178,755 175,877
Inventories 1,121,009 1,016,139
Prepaid expenses 125,352 197,134
Current assets of discontinued operations 0 450,874
Total Current Assets 2,646,324 3,178,560
Property, Plant and Equipment, Net 2,797,800 2,718,747
Goodwill 2,511,611 2,525,657
Other Intangible Assets, Net 2,683,474 2,586,698
Deferred Income Taxes 54,449 17,371
Right of Use Asset-Operating Leases 307,450 307,688
Other Assets 161,226 208,759
Noncurrent Assets of Discontinued Operations 0 964,310
Total Assets 11,162,334 12,507,790
Current Liabilities    
Payable to suppliers 1,084,152 1,130,500
Accrued expenses and other payables 638,770 463,543
Accrued wages and other compensation 138,982 140,912
Notes payable and current portion of long-term debt 537,952 2,054,525
Accrued taxes 128,821 6,755
Current liabilities of discontinued operations 0 242,056
Total Current Liabilities 2,528,677 4,038,291
Long-term Debt 3,788,973 4,985,496
Noncurrent Operating Lease Liabilities 263,192 258,735
Pension and Other Postretirement Benefits 177,976 180,827
Deferred Income Taxes 557,034 583,470
Other Liabilities 214,650 60,847
Noncurrent Liabilities of Discontinued Operations 0 113,911
Total Liabilities 7,530,502 10,221,577
Commitments and Contingencies (Note 18)
Sonoco Shareholders’ Equity    
Serial preferred stock, no par value Authorized 30,000 shares 0 shares issued and outstanding as of December 31, 2025 and 2024
Common shares, no par value Authorized 300,000 shares 98,631 and 98,260 shares issued and outstanding as of December 31, 2025 and 2024, respectively 7,175 7,175
Capital in excess of stated value 191,855 183,250
Accumulated other comprehensive income/(loss) 37,204 (502,734)
Retained earnings 3,377,647 2,583,923
Total Sonoco Shareholders’ Equity 3,613,881 2,271,614
Noncontrolling Interests 17,951 14,599
Total Equity 3,631,832 2,286,213
Total Liabilities and Equity $ 11,162,334 $ 12,507,790
v3.25.4
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
shares in Thousands, $ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Statement of Financial Position [Abstract]    
Allowances for trade accounts receivable $ 12,512 $ 10,989
Preferred stock, shares authorized (in shares) 30,000 30,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, shares authorized (in shares) 300,000 300,000
Common stock, shares issued (in shares) 98,634 98,260
Common stock, shares outstanding (in shares) 98,634 98,260
v3.25.4
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]      
Net sales $ 7,518,753 $ 5,305,365 $ 5,441,426
Cost of sales 5,944,340 4,166,132 4,238,857
Gross profit 1,574,413 1,139,233 1,202,569
Selling, general and administrative expenses 862,180 723,833 644,540
Restructuring/Asset impairment charges, net 66,215 65,370 47,909
Gain/(Loss) on divestiture of business and other assets 371,717 (23,452) 78,929
Operating profit 1,017,735 326,578 589,049
Non-operating pension costs 12,215 13,842 14,312
Interest expense 233,485 172,620 135,393
Interest income 20,547 27,570 10,026
Other (expense)/income, net (27,481) (104,200) 39,657
Income from continuing operations before income taxes 765,101 63,486 489,027
Provision for income taxes 183,586 5,509 119,730
Income before equity in earnings of affiliates 581,515 57,977 369,297
Equity in earnings of affiliates, net of tax 9,523 9,588 10,347
Net income from continuing operations 591,038 67,565 379,644
Net income from discontinued operations 412,348 96,375 96,257
Net income 1,003,386 163,940 475,901
Net (income)/loss from continuing operations attributable to noncontrolling interests (375) 180 (768)
Net income from discontinued operations attributable to noncontrolling interests 0 (171) (174)
Net income attributable to Sonoco $ 1,003,011 $ 163,949 $ 474,959
Weighted average common shares outstanding:      
Basic (in shares) 99,124 98,637 98,294
Assuming exercise of awards (in shares) 447 653 596
Diluted (in shares) 99,571 99,290 98,890
Basic earnings per common share:      
Continuing operations (usd per share) $ 5.96 $ 0.69 $ 3.85
Discontinued operations (usd per share) 4.16 0.97 0.98
Basic earnings per share attributable to Sonoco (usd per share) 10.12 1.66 4.83
Diluted earnings per common share:      
Continuing operations (usd per share) 5.93 0.68 3.83
Discontinued operations (usd per share) 4.14 0.97 0.97
Diluted earnings per share attributable to Sonoco (usd per share) $ 10.07 $ 1.65 $ 4.80
v3.25.4
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Statement of Comprehensive Income [Abstract]      
Net income $ 1,003,386 $ 163,940 $ 475,901
Other comprehensive income/(loss):      
Foreign currency translation adjustments 536,942 (143,730) 70,308
Changes in defined benefit plans, net of tax [1] 2,655 9,014 (8,654)
Changes in derivative financial instruments, net of tax [1] 2,125 (2,133) 1,737
Other comprehensive income/(loss) 541,722 (136,849) 63,391
Comprehensive income 1,545,108 27,091 539,292
Net (income)/loss attributable to noncontrolling interests-continuing operations (375) 180 (768)
Net income attributable to noncontrolling interests-discontinued operations 0 (171) (174)
Other comprehensive (income)/loss attributable to noncontrolling interests (1,784) 377 430
Comprehensive income attributable to Sonoco $ 1,542,949 $ 27,477 $ 538,780
[1] net of tax
v3.25.4
CONSOLIDATED STATEMENTS OF CHANGES IN TOTAL EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Shares
Capital in Excess of Stated Value
Accumulated Other Comprehensive Income/(Loss)
Retained Earnings
Non- controlling Interests
Beginning balance at Dec. 31, 2022 $ 2,072,797 $ 7,175 $ 140,539 $ (430,083) $ 2,348,183 $ 6,983
Beginning Balance (in shares) at Dec. 31, 2022   97,645        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 475,901       474,959 942
Other comprehensive income/(loss):            
Translation gain/(loss) 70,308     70,738   (430)
Defined benefit plan adjustment [1] (8,654)     (8,654)    
Derivative financial instruments [1] 1,737     1,737    
Other comprehensive income/(loss) 63,391     63,821   (430)
Dividends (198,762)       (198,762)  
Issuance of stock awards 1,345   1,345      
Issuance of stock awards (in shares)   488        
Shares repurchased (10,617)   (10,617)      
Shares repurchased (in shares)   (176)        
Share-based compensation 27,780   27,780      
Ending balance at Dec. 31, 2023 2,431,835 $ 7,175 159,047 (366,262) 2,624,380 7,495
Ending Balance (in shares) at Dec. 31, 2023   97,957        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 163,940       163,949 (9)
Other comprehensive income/(loss):            
Translation gain/(loss) (143,730)     (143,353)   (377)
Defined benefit plan adjustment [1] 9,014     9,014    
Derivative financial instruments [1] (2,133)     (2,133)    
Other comprehensive income/(loss) (136,849)     (136,472)   (377)
Divestiture of non-controlling interest (2,043)         (2,043)
Non-controlling interest from acquisition 9,533         9,533
Dividends (204,406)       (204,406)  
Issuance of stock awards 915   915      
Issuance of stock awards (in shares)   467        
Shares repurchased (9,246)   (9,246)      
Shares repurchased (in shares)   (164)        
Share-based compensation 29,659   29,659      
Other 2,875   2,875      
Ending balance at Dec. 31, 2024 $ 2,286,213 $ 7,175 183,250 (502,734) 2,583,923 14,599
Ending Balance (in shares) at Dec. 31, 2024 98,260 98,260        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income $ 1,003,386       1,003,011 375
Other comprehensive income/(loss):            
Translation gain/(loss) 536,942     535,158   1,784
Defined benefit plan adjustment [1] 2,655     2,655    
Derivative financial instruments [1] 2,125     2,125    
Other comprehensive income/(loss) 541,722     539,938   1,784
Divestiture of non-controlling interest (910)         (910)
Non-controlling interest from acquisition 2,346         2,346
Dividends (209,287)       (209,287)  
Dividends paid to noncontrolling interest (243)         (243)
Issuance of stock awards 1,244   1,244      
Issuance of stock awards (in shares)   602        
Shares repurchased (10,930)   (10,930)      
Shares repurchased (in shares)   (228)        
Share-based compensation 18,044   18,044      
Other 247   247      
Ending balance at Dec. 31, 2025 $ 3,631,832 $ 7,175 $ 191,855 $ 37,204 $ 3,377,647 $ 17,951
Ending Balance (in shares) at Dec. 31, 2025 98,634 98,634        
[1] net of tax
v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash Flows from Operating Activities      
Net income $ 1,003,386 $ 163,940 $ 475,901
Adjustments to reconcile net income to net cash provided by operating activities:      
Asset impairments 12,532 17,027 26,445
Depreciation and amortization 519,356 374,859 340,988
Share-based compensation expense 18,044 29,659 27,780
Net loss on foreign currency remeasurement 0 113,697 0
Equity in earnings of affiliates, net of tax (9,523) (9,588) (10,347)
Cash dividends from affiliated companies 24,822 11,926 9,389
Net gain on disposition of assets (22,631) (55) (65,947)
Net (gain)/loss on divestiture of business (978,350) 23,452 (57,104)
Gain on remeasurement of investment in affiliated companies 0 (6,012) 0
Pension and postretirement plan expense 17,846 17,477 17,460
Pension and postretirement plan contributions (22,284) (19,633) (14,662)
Net decrease in deferred taxes (22,758) (55,715) (12,209)
Change in assets and liabilities, net of effects from acquisitions, divestitures and foreign currency adjustments:      
Trade accounts receivable 97,885 17,763 24,935
Inventories (80,901) (13,269) 342,713
Payable to suppliers (87,547) 123,615 (148,841)
Prepaid expenses 42,440 (19,144) 1,394
Income taxes payable and other income tax items 125,984 (11,269) (28,286)
Accrued expenses and other assets and liabilities 51,481 75,115 (46,691)
Net cash provided by operating activities 689,782 833,845 882,918
Cash Flows from Investing Activities      
Purchases of property, plant and equipment (344,023) (393,235) (363,077)
Cash received in final net working capital settlement of acquisition [1] 16,528    
Cost of acquisitions, net of cash acquired1 [1]   (3,793,569) (372,616)
Proceeds from the sale of business, net 2,470,145 80,996 33,237
Proceeds from the sale of assets, net 46,968 15,649 80,339
Proceeds from settlement of net investment hedge 0 9,068
Cash settlement of forward contract 0 (34,414) 0
Investments in affiliated companies and other net investing proceeds 6,469 9,978 2,781
Net cash provided/(used) by investing activities 2,196,087 (4,105,527) (619,336)
Cash Flows from Financing Activities      
Proceeds from issuance of debt 66,712 4,061,319 962,557
Principal repayment of debt (2,830,688) (151,534) (1,112,917)
Net (decrease)/increase in book cash overdrafts (3,705) (8,676) 6,408
Payment of loan financing costs 0 (19,000) 0
Payment of contingent consideration 0 (948) 0
Dividends paid to noncontrolling interests (243) 0 0
Cash dividends (208,106) (203,492) (197,416)
Payments for share repurchases (10,930) (9,246) (10,617)
Net cash (used)/provided by financing activities (2,986,960) 3,668,423 (351,985)
Effects of Exchange Rate Changes on Cash 36,429 (105,618) 12,902
(Decrease)/Increase in Cash and Cash Equivalents (64,662) 291,123 (75,501)
Cash and cash equivalents at beginning of year 443,060 151,937 227,438
Cash and cash equivalents at end of year 378,398 443,060 151,937
Supplemental Schedule of Non-Cash Investing Activities:      
Non-cash additions to property, plant and equipment 26,368 29,561 23,168
Supplemental Disclosures:      
Interest paid, net of amounts capitalized 260,526 151,182 135,910
Income taxes paid, net of refunds $ 264,901 $ 92,427 $ 189,773
[1]
1The Company received a final net working capital settlement of $16,528 during 2025 related to the acquisition of Titan Holdings I B.V. (“Eviosys”).
v3.25.4
Summary of significant accounting policies
12 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
Summary of significant accounting policies Summary of significant accounting policies
Basis of presentation
The Consolidated Financial Statements include the accounts of Sonoco Products Company and its majority-owned subsidiaries (the “Company” or “Sonoco”) after elimination of intercompany accounts and transactions.
On December 18, 2024, the Company announced that it had entered into an agreement to sell its Thermoformed and Flexibles Packaging business and its global Trident business (collectively, “TFP”) to TOPPAN Holdings Inc. (“Toppan”). The sale, which reflects the completion of the Company’s previously announced strategic review of TFP, closed on April 1, 2025. In accordance with applicable accounting guidance, the results of TFP, previously part of the Company’s Consumer Packaging segment, are presented as discontinued operations in the Consolidated Statements of Income and, as such, have been excluded from both continuing operations and segment results for all periods presented in this Annual Report on Form 10-K. Further, the Company reclassified the assets and liabilities of TFP as assets and liabilities of discontinued operations in the Consolidated Balance Sheet as of December 31, 2024. The Consolidated Statements of Comprehensive Income, Changes in Total Equity, and Cash Flows are presented on a consolidated basis for both continuing operations and discontinued operations. All amounts, percentages and disclosures for all periods presented in this Annual Report on Form 10-K reflect only the continuing operations of Sonoco unless otherwise noted. See Note 2 for additional information. Certain prior period financial information has been reclassified to conform with the current period presentation.
Investment in affiliates
Investments in affiliated companies in which the Company does not control the investee or in which the Company is not the primary beneficiary but has the ability to exercise significant influence over the investee’s financial and operating decisions, are accounted for by the equity method of accounting. Income applicable to these equity investments is reported in “Equity in earnings of affiliates, net of tax” in the Consolidated Statements of Income.
Affiliated companies over which the Company exercised a significant influence at December 31, 2025, included:
Entity
Ownership Interest
Cascades Conversion, Inc.50.0 %
Cascades Sonoco, Inc.50.0 %
ISI Robotics, LLC32.3 %
Showa Products Company Ltd.22.2 %
Papertech Energía, S.L.25.0 %
Weidenhammer New Packaging, LLC40.0 %
The Company has certain other equity investments in which it is not able to exercise significant influence that are accounted for under the measurement alternative (i.e., cost less impairment, adjusted for any qualifying observable price changes). These include a 19.5% ownership in a small tubes and cores business in Chile and a 39.9% ownership interest in a small South Carolina-based designer and manufacturer of sustainable protective packaging solutions, increased from 20.5% during the second quarter of 2024. See Note 4 for additional information.
The Company’s 2.7% equity interest in Northstar Recycling Company, LLC (“Northstar”), previously accounted for under the measurement alternative, was sold on December 23, 2024. This investment was acquired on January 26, 2023, as part of the sale of its Sonoco Sustainability Solutions (“S3”) business to Northstar. See Note 4 for additional information.
In the fourth quarter of 2025, the Company received cash dividends from Cascades Conversion, Inc. and Cascades Sonoco, Inc.(collectively, “Cascades”) totaling $26,266. The Company determined that a total of $19,811 of the Cascades dividends represented a return on investment and included these in net cash provided by operating activities under the caption “Cash dividends from affiliated companies” in the Company’s Consolidated Statements of Cash Flows for the year ended December 31, 2025. The remaining Cascades dividends of $6,455 were determined to represent a return of investment and were included in net cash provided/(used) by investing activities under the caption “Investments in affiliated companies and other net investing proceeds” in the Company’s Consolidated Statements of Cash Flows for the year ended December 31, 2025.
The aggregate carrying value of equity investments is reported in “Other Assets” in the Company’s Consolidated Balance Sheets and totaled $49,644 and $67,801 at December 31, 2025 and 2024, respectively.
Estimates and assumptions
The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Revenue recognition
The Company records revenue generally at a point in time when control transfers to the customer either upon shipment or delivery, depending on the terms of sale. Additionally, in certain cases, control transfers over time in conjunction with production where the Company is entitled to payment with margin for products produced that are customer specific and without alternative use. For products that meet these two criteria, the Company recognizes over time revenue under the input method as goods are produced. The Company commonly enters into Master Supply Arrangements with customers to provide goods and/or services over specific time periods. Customers submit purchase orders with quantities and prices to create a contract for accounting purposes. Shipping and handling expenses are considered a fulfillment cost, and are included in “Cost of sales,” and freight charged to customers is included in “Net sales” in the Company’s Consolidated Statements of Income.
The Company has rebate agreements with certain customers. These rebates are recorded as reductions of sales and are accrued using sales data and rebate percentages specific to each customer agreement. Accrued customer rebates are included in “Accrued expenses and other payables” in the Company’s Consolidated Balance Sheets.
Payment terms under the Company’s arrangements are typically short term in nature. The Company provides prompt payment discounts to certain customers if invoices are paid within a predetermined period. Prompt payment discounts are determinable within a short period after the originating sale and like sales returns, are treated as a reduction of revenue.
Accounts receivable and allowance for doubtful accounts
The Company’s trade accounts receivable are non-interest bearing and are recorded at the invoiced amounts. The allowance for doubtful accounts represents the Company’s best estimate of the amount of expected credit losses in existing accounts receivable. The Company performs an evaluation of lifetime expected credit losses inherent in its accounts receivable at each balance sheet date. Such an evaluation includes consideration of historical loss experience, trends in customer payment frequency, present economic conditions, and judgment about the future financial health of its customers and industry sector. The allowance for doubtful accounts is monitored on a regular basis and adjustments are made as needed to ensure that the account properly reflects the Company’s best estimate of uncollectible trade accounts receivable. Account balances are charged off against the allowance for doubtful accounts when the Company determines that the receivable will not be recovered.
No single customer comprised 10% or more of the Company’s consolidated net sales in 2025, 2024 or 2023, nor did the receivables balance from any single customer comprise 10% or more of the Company’s total trade accounts receivable at December 31, 2025 or December 31, 2024.
The Company engages with third-party financial institutions to sell certain trade accounts receivables from customers in order to accelerate its cash collection cycle. In addition, the Company also participates in supply chain finance arrangements promoted by certain of its customers. Receivables transferred under both these arrangements generally meet the requirements to be accounted for as a true sale in accordance with guidance under Accounting Standards Codification (“ASC”) 860, “Transfers and Servicing,” resulting in derecognition of such receivables from the Company’s consolidated balance sheets. The sales under these arrangements are made without recourse and the Company’s only continuing involvement with the sold receivables is providing collection services related to the transferred assets. The servicing fees for these arrangements are immaterial to the financial statements given the short-term nature of our arrangements. In total, approximately 10% and 12% of the Company’s consolidated net sales were subject to settlement under these arrangements in 2025 and 2024, respectively.
The acquisition of Eviosys on December 4, 2024, included arrangements under which certain trade receivables sold to third-party financial institutions are made with recourse and therefore do not meet the requirements under ASC 860 to be accounted for as a true sale with derecognition of such receivables from the Company’s consolidated balance sheets. Accordingly, receivables sold under such arrangements totaling $73,487 were included in “Notes payable and current portion of long-term debt” in the Company’s Consolidated Balance Sheets at December 31, 2024. All of these obligations had been settled as of December 31, 2025.
Accounts payable and supply chain financing
The Company facilitates voluntary supply chain financing programs (the “SCF Programs”) to provide certain of its suppliers with the opportunity to sell receivables due from the Company to the participating financial institutions in the programs. Such sales are conducted at the sole discretion of both the suppliers and the financial institutions on a nonrecourse basis at a rate that leverages the Company’s credit rating and thus might be more beneficial to the supplier. No guarantees are provided by the Company or any of our subsidiaries under the SCF Programs. The Company’s responsibility under the agreements is limited to making payment to the financial institutions for confirmed invoices based on the terms originally negotiated with its suppliers. Both the Company and the financial institutions have the right to terminate the SCF Programs by providing 30 days prior written notice to the other party. The Company does not enter into any agreements with suppliers regarding their participation in the SCF Programs.
Research and development
Research and development costs are charged to expense as incurred and include salaries and other directly related expenses. Research and development costs totaling approximately $21,500 in 2025, $23,000 in 2024 and $23,900 in 2023 are included in “Selling, general and administrative expenses” in the Company’s Consolidated Statements of Income.
Restructuring and asset impairment
Costs associated with exit or disposal activities are recognized when the liability is incurred. Identifying and calculating the cost to exit operations requires certain assumptions to be made about anticipated future liabilities, including severance costs, contractual obligations, and disposition of property, plant and equipment and leased assets. If assets become impaired as a result of a restructuring action, they are written down to fair value, less estimated costs to sell, if applicable. A number of significant estimates and assumptions are involved in the determination of fair value. The Company considers historical experience and all available information at the time the estimates are made; however, the amounts that are ultimately realized upon the sale of divested assets may differ from the estimated fair values reflected in the Company’s Consolidated Financial Statements. For facility closures, the Company also generally expects to record costs for equipment relocation and facility carrying costs as incurred and to accrue costs to terminate a lease or other contracts before the end of their term.
Cash and cash equivalents
Cash equivalents are composed of highly liquid investments with an original maturity to the Company of three months or less when purchased. Cash equivalents are recorded at cost, which approximates fair market value. The Company’s cash and cash equivalents are primarily placed with large sophisticated creditworthy financial institutions thereby limiting the Company’s credit exposure.
Inventories
The majority of the Company’s inventories are accounted for using the first-in, first-out (FIFO) method or average cost methods and are stated at the lower of cost or net realizable value.
The last in, first out (“LIFO”) method is used for the valuation of certain of the Company’s domestic inventories, primarily metal, internally manufactured paper and paper purchased from third parties, and approximated 9% of total inventories at both December 31, 2025 and December 31, 2024. Inventories accounted for using the LIFO method are stated at the lower of cost or market. If the FIFO method of accounting had been used for all inventories, total inventory would have been higher by $33,323 and $33,265 at December 31, 2025 and 2024, respectively.
Details of the Company’s inventory balances at December 31, 2025 and 2024 are as follows:
20252024
Inventories:
Finished goods$370,303 $359,086 
Work in process161,313 135,004 
Materials and supplies589,393 522,049 
Inventories$1,121,009 $1,016,139 
Property, plant and equipment
Property, plant and equipment assets represent the original cost of land, buildings and equipment, less depreciation, computed under the straight-line method over the estimated useful lives of the assets, and are reviewed for impairment whenever events indicate the carrying value may not be recoverable. Equipment lives generally range from 3 to 11 years, and buildings range from 15 to 40 years.
Expenditures for repairs and maintenance are charged to expense as incurred. When properties are retired or otherwise disposed of, the cost and accumulated depreciation are eliminated from the asset and related allowance accounts, respectively. Gains or losses upon disposal are credited or charged to income as incurred.
The Company sold its timberland properties in March 2023. Prior to the sale, these timber resources were stated at cost and depletion expense was recognized based on the estimated number of units of timber cut during the period.
Leases
At the inception of a contract, the Company assesses whether the contract is, or contains, a lease. The assessment is based on (1) whether the contract involves the use of a distinct identified asset, (2) whether the Company obtains the right to substantially all the economic benefit from the use of the asset throughout the period, and (3) whether the Company has the right to direct the use of the asset. When the Company determines a lease exists, a leased asset and corresponding lease liability are recorded on its consolidated balance sheet. Lease contracts with a term of 12 months or less are not recorded in the consolidated balance sheet in conjunction with the Company’s practical expedient election under ASC 842, “Leases.” Leased assets represent the Company’s right to use an underlying asset during the lease term and are reviewed for impairment whenever events indicate the carrying value may not be recoverable. Lease liabilities represent the Company’s obligation arising from the lease. The Company’s leased assets and liabilities may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise those options. The Company has lease agreements with non-lease components that relate to lease components (e.g., common area maintenance such as cleaning or landscaping, etc.). The Company accounts for each lease and any non-lease components associated with that lease as a single lease component for all underlying asset classes in accordance with the scope of the lease accounting standard.
Leased assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. When the implicit rate in the Company’s leases is not readily determinable, the Company calculates its lease liabilities using discount rates based upon the Company’s incremental secured borrowing rate, which contemplates and reflects a particular geographical region’s interest rate for the leases active within that region of the Company’s global operations. The Company further utilizes a portfolio approach by assigning a “short” rate to contracts with lease terms of 10 years or less and a “long” rate for contracts greater than 10 years. Lease payments may be fixed or variable, however, only fixed payments or in-substance fixed payments are included in determining the lease liability. Variable lease payments are recognized in operating expenses in the period in which the expense is paid during the lease term.
The Company recognizes fixed lease expense for operating leases on a straight-line basis over the lease term. For finance leases, the Company recognizes interest expense on the lease liability using the effective interest method over the lease term and the finance lease asset balance is amortized on a straight-line basis.
Goodwill
Goodwill is not amortized. The Company assesses its goodwill for impairment annually during the third quarter, or from time to time when warranted by the facts and circumstances surrounding individual reporting units or the Company as a whole. In performing the impairment test, the Company compares the fair value of the reporting unit with its carrying amount, and if the carrying value of the reporting unit exceeds the fair value of that reporting unit, an impairment charge is recognized for the excess.
In determining the fair value of the reporting units, management considers both the income approach and the market approach. Fair value is estimated using a discounted cash flow model (income valuation approach) based on projections of future years’ operating results and associated cash flows combined with comparable trading and transaction multiples based on guideline public companies. The calculated estimated fair value of the reporting unit reflects a number of significant management assumptions and estimates including the forecast of sales growth during the discrete period, EBITDA, and discount rates. Changes in these assumptions could materially impact the estimated fair value.
The Company’s projections incorporate management’s best estimates of the expected future results, which include expectations related to new and retained business and future operating margins. Projected future cash flows are then discounted to present value using a discount rate management believes is commensurate with the risks inherent in the cash flows.
Impairment of long-lived, intangible and other assets
Other intangible assets are amortized using the straight-line method when management has determined that the straight-line method approximates the pattern of consumption of the respective intangible assets, or in relation to the specific pattern of consumption of the assets if the straight-line method does not provide a fair approximation of the consumption of benefits. The useful lives of the Company’s intangible assets generally range from 3 to 20 years. The Company has no intangibles with indefinite lives. The Company evaluates its intangible assets for impairment whenever indicators of impairment exist.
Assumptions and estimates used in the evaluation of potential impairment can result in adjustments affecting the carrying values of long-lived, intangible and other assets and the recognition of impairment expense in the Company’s Consolidated Financial Statements. The Company evaluates its long-lived assets (property, plant and equipment), definite-lived intangible assets and other assets (including right of use lease assets, notes receivable and equity and other investments) for impairment whenever indicators of impairment exist, or when it commits to sell the asset. If the sum of the undiscounted expected future cash flows from a long-lived asset, definite-lived intangible, or other asset group is less
than the carrying value of that asset group, an asset impairment charge is recognized. Key assumptions and estimates used in the projection of expected future cash flows generally include price levels, sales growth, profit margins and asset life. The amount of an impairment charge, if any, is calculated as the excess of the asset’s carrying value over its fair value, generally represented by the discounted future cash flows from that asset or, in the case of assets the Company evaluates for sale, estimated sale proceeds less costs to sell. The Company takes into consideration historical data and experience together with all other relevant information available when estimating the fair values of its assets. However, fair values that could be realized in actual transactions may differ from the estimates used to evaluate impairment. In addition, changes in the assumptions and estimates may result in a different conclusion regarding impairment.
Income taxes
The Company provides for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are determined based on differences between financial reporting requirements and tax laws. Assets and liabilities are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.
The Company recognizes liabilities for uncertain income tax positions based on its estimate of whether it is more likely than not that additional taxes will be required and the Company reports related interest and penalties within the “Provision for income taxes” line item in the Consolidated Statements of Income.
Derivatives
The Company uses derivatives to mitigate the effect of fluctuations in some of its raw material and energy costs, foreign currencies, and, from time to time, interest rates. The Company purchases commodities such as metal and energy, generally at market or at fixed prices that are established with the vendor as part of the purchase process for quantities expected to be consumed in the ordinary course of business. The Company may enter into commodity futures or swaps to manage the effect of price fluctuations. The Company may use foreign currency forward contracts and other risk management instruments to manage exposure to changes in foreign currency cash flows and the translation of monetary assets and liabilities on the Company’s consolidated financial statements. The Company is exposed to interest-rate fluctuations as a result of using debt as a source of financing for its operations. The Company may from time to time use traditional, unleveraged interest rate swaps to manage its exposure to interest rate movements. Additionally, the Company elected the normal purchase, normal sale scope exception for physical commodity contracts that meet the definition of a derivative. Derivative instruments, to the extent in an asset position, expose the Company to credit loss in the event of nonperformance by the counterparties to the derivative agreements. The Company manages its exposure to counterparty credit risk through minimum credit standards, diversification of counterparties and procedures to monitor concentrations of credit risk. The Company may enter into financial derivative contracts that may contain credit-risk-related contingent features, which could result in a counterparty requesting immediate payment or demanding immediate and ongoing full overnight collateralization on derivative instruments in net liability positions.
The Company records its derivatives as assets or liabilities on the balance sheet at fair value using published market prices or estimated values based on current price and/or rate quotes and discounted estimated cash flows. Changes in the fair value of derivatives designated as accounting hedges are recognized in net income, and otherwise are recognized in other comprehensive income. Amounts in accumulated other comprehensive income/(loss) are reclassified into earnings in the same period or periods during which the hedged forecasted transaction affects earnings. It is the Company’s policy not to speculate in derivative instruments.
Share-Based Compensation Plans
The Company utilizes share-based compensation in the form of restricted stock units (“RSUs”), performance contingent restricted stock units (“PCSUs”), and other share-based awards. The fair value of the Company’s RSUs is equal to the closing price of the Company’s stock on the date of grant discounted for any projected dividends that are not eligible to be received during the vesting period. The amount of share-based compensation expense associated with PCSUs is based on estimates of future performance using measures defined in the stock plan descriptions for each award granted. As of December 31, 2025, these performance measures include the following:
Adjusted earnings per share — three-year sum of forecasted future and historical annual adjusted earnings per share for the three-year measurement period associated with each award; and
Return on invested capital — three-year simple average of annual returns calculated by dividing 1) adjusted operating profit after tax (derived from historical or projected earnings) by 2) the average of total historical or projected debt plus equity for the respective annual periods.
For the awards granted in 2025 and 2024, the performance payout will be subject to adjustment by a total stock return modifier as determined by the Company’s relative performance within its targeted peer group for each grant. Changes in estimates regarding the future achievement of these performance measures may result in significant fluctuations from period to period in the amount of share-based compensation expense recognized in the Company’s Consolidated Financial Statements.
Pension and Postretirement Benefit Plans
The Company provides non-contributory defined benefit pension plans for certain of its employees in the United States, Mexico, Belgium, Germany, Greece, France, and Turkey. The Company also sponsors contributory defined benefit pension plans covering certain of its employees in the United Kingdom, Canada and the Netherlands, and provides postretirement healthcare and life insurance benefits to a limited number of its retirees and their dependents in the United States and Canada, based on certain age and/or service eligibility requirements. The actuarial valuations used to evaluate the plans employ key assumptions that can have a significant effect on the calculated amounts.
The Company adjusts its discount rates at the end of each fiscal year based on yield curves of high-quality debt instruments over durations that match the expected benefit payouts of each plan. The expected rate of return assumption is derived by taking into consideration the targeted plan asset allocation, projected future returns by asset class and active investment management. A third-party asset return model is used to develop an expected range of returns on plan investments over a 12- to 30-year period, with the expected rate of return selected from a best estimate range within the total range of projected results. The Company periodically re-balances its plan asset portfolio in order to maintain the targeted allocation levels. The rate of compensation increase assumption is generally based on salary and incentive compensation increases.
Other assumptions and estimates impacting the projected liabilities of these plans include inflation, participant withdrawal and mortality rates, medical cost trends, and retirement ages. The Company evaluates the assumptions used in projecting the pension and postretirement liabilities and associated expenses annually. These judgments, assumptions and estimates may affect the carrying value of pension and postretirement plan net assets and liabilities and pension and postretirement plan expenses in the Company’s Consolidated Financial Statements.
Business combinations
The Company’s acquisitions of businesses are accounted for in accordance with ASC 805, “Business Combinations.” The Company recognizes the identifiable assets acquired, the liabilities assumed, and any noncontrolling interests in an acquired business at their fair values as of the date of acquisition. Goodwill is measured as the excess of consideration transferred, also measured at fair value, over the net of the acquisition date fair values of the identifiable assets acquired and liabilities assumed. The acquisition method of accounting requires the Company to make significant estimates and assumptions regarding the fair values of the elements of a business combination as of the date of acquisition, including the fair values of identifiable intangible assets; property, plant and equipment; deferred tax asset valuation allowances; liabilities including those related to debt, pensions and other postretirement plans; uncertain tax positions; contingent consideration and contingencies. This method also requires the Company to refine these estimates over a measurement period not to exceed one year to reflect new information obtained about facts and circumstances that existed as of the acquisition date that, if known, would have affected the measurement of the amounts recognized as of that date. If the Company is required to adjust provisional amounts that were recorded for the fair values of assets and liabilities in connection with acquisitions, these adjustments could have a material impact on its financial condition and results of operations.
Significant estimates and assumptions in estimating the fair value of acquired patents, customer lists, trademarks, proprietary technology, and other identifiable intangible assets include future cash flows that the Company expects to generate from the acquired assets, discount rate, customer attrition rate, and long-term revenue growth projections. Projecting discounted future cash flows requires the Company to make significant estimates regarding projected revenues, projected earnings before interest, taxes, depreciation, and amortization margins, discount rates and customer attrition rates. If the subsequent actual results and updated projections of the underlying business activity change compared with the assumptions and projections used to develop these values, the Company could record impairment charges. In addition, the Company has estimated the economic lives of certain acquired assets, and these lives are used to calculate depreciation on property, plant and equipment and amortization expense on definite-lived intangible assets. If the estimates of the economic lives change, depreciation or amortization expenses could be increased or decreased, or the acquired assets could be impaired.
For leases acquired in a business combination, the Company measures the lease liability at the present value of the remaining lease payments, as if the acquired lease were a new lease of the Company at the acquisition date. The Company measures the right-of-use asset at the same amount as the lease liability as adjusted to reflect favorable or unfavorable terms of the lease when compared with market terms.
Reportable segments
The Company identifies its reportable segments by evaluating the level of detail reviewed by the chief operating decision maker and the similarities among operating segments related to gross profit margins, nature of products sold, nature of the production processes, type and class of customer, methods used to distribute products, and nature of the regulatory environment. Of these factors, the Company believes that the most significant in determining the aggregation of operating segments are the nature of the products and the type of customers served. The Company’s operating and reporting structure consists of two reportable segments, Consumer Packaging and Industrial Paper Packaging, with all remaining businesses reported as All Other. Effective January 1, 2026, the All Other business will be reported within the Industrial Paper Packaging segment and the use of All Other will be discontinued.
Contingencies
Pursuant to GAAP for accounting for contingencies, accruals for estimated losses are recorded at the time information becomes available indicating that losses are probable and that the amounts are reasonably estimable. Amounts so accrued are not discounted. Changes in estimates and assumptions could impact the carrying value of the accruals from one period to another as additional information becomes known.
Foreign currency translation
The Company’s foreign operations are exposed to political, geopolitical, and cultural risks, but the risks are mitigated by diversification and the relative stability of the countries in which the Company has significant operations. Because the economy in Turkey is considered highly inflationary under GAAP, the Company considers the U.S. dollar to be the functional currency for these operations and uses the official exchange rate when remeasuring the financial assets and liabilities of these operations. The remeasurement adjustments are recorded against earnings within the Company’s Consolidated Statements of Income.
v3.25.4
Discontinued operations
12 Months Ended
Dec. 31, 2025
Discontinued Operations and Disposal Groups [Abstract]  
Discontinued operations Discontinued operations
As disclosed in Note 1, as a result of the Company entering into an agreement to sell TFP on December 18, 2024, the assets and liabilities of TFP were classified as discontinued operations in the Consolidated Balance Sheet as of December 31, 2024 as presented below:
  
2024
Cash and cash equivalents$12,050 
Trade accounts receivable, net of allowances of $2,582
209,379 
Other receivables46,001 
Inventories
Finished and in process80,573 
Materials and supplies94,083 
Prepaid expenses8,788 
Current assets of discontinued operations$450,874 
Property, plant and equipment, net of accumulated depreciation of $465,923
262,662 
Goodwill502,621 
Other intangible assets, net of accumulated amortization of $206,437
103,593 
Deferred income taxes262 
Right of use asset-operating leases75,855 
Other assets19,317 
Noncurrent Assets of Discontinued Operations$964,310 
Payable to suppliers172,720 
Accrued expenses and other payables62,562 
Notes payable and current portion of long-term debt6,774 
Current liabilities of discontinued operations$242,056 
Long-term debt29,850 
Noncurrent operating lease liabilities67,789 
Deferred income taxes15,928 
Other liabilities344 
Noncurrent Liabilities of Discontinued Operations$113,911 
The following table presents key components of “Net income from discontinued operations” for the years ended December 31, 2025, 2024, and 2023:
 Year Ended December 31,
  
202520242023
Net sales$320,678 $1,291,461 $1,339,866 
Cost of sales250,854 1,037,196 1,106,970 
Gross profit69,824 254,265 232,896 
Selling, general and administrative expenses31,607 122,488 97,131 
Restructuring/Asset impairment charges, net426 3,740 9,024 
Gain on divestiture of business
606,633 — — 
Operating profit644,424 128,037 126,741 
Other (expense)/income, net
(182)— — 
Interest expense1
24,911 13,396 1,293 
Interest income281 1,668 357 
Income from discontinued operations before income taxes619,612 116,309 125,805 
Provision for income taxes207,264 19,934 29,548 
Net income from discontinued operations412,348 96,375 96,257 
Net income from discontinued operations attributable to noncontrolling interests— (171)(174)
Net income attributable to discontinued operations$412,348 $96,204 $96,083 
Weighted average common shares outstanding:
Basic99,124 98,637 98,294 
Diluted99,571 99,290 98,890 
Per common share:
Net income attributable to discontinued operations:
Basic$4.16 $0.97 $0.98 
Diluted$4.14 $0.97 $0.97 
1 Includes $24,060 and $9,528 of interest expense in 2025 and 2024, respectively, relating to certain debt contractually required to be repaid by the Company upon completion of the TFP divestiture. No such interest expense is reflected in 2023 as the debt was drawn on December 2, 2024 and repaid on April 3, 2025. See Note 11 for additional information.
The following table presents significant cash flow items from discontinued operations for the years ended December 31, 2025, 2024, and 2023:
 Year Ended December 31,
  
202520242023
Depreciation and amortization (a)
$(311)$58,798 $58,959 
Purchases of property, plant and equipment$(5,572)$(65,321)$(55,624)
(a) Subsequent to entering the agreement to sell TFP on December 8, 2024, depreciation was no longer recognized on TFP’s property, plant and equipment, and amortization was no longer recognized on TFP’s other intangible assets or right of use assets-operating leases, in accordance with ASC 360, “Property, Plant, and Equipment.”
v3.25.4
New accounting pronouncements
12 Months Ended
Dec. 31, 2025
Accounting Changes and Error Corrections [Abstract]  
New accounting pronouncements New accounting pronouncements
In November 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses,” which requires companies to disclose disaggregated amounts relating to (a) inventory purchases; (b) employee compensation; (c) depreciation; (d) intangible asset amortization; and (e) depreciation, depletion, and amortization. Further, this guidance will require companies to include certain amounts that are already required to be disclosed under current U.S. GAAP in the same disclosure as the other disaggregation requirements, disclose a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively and disclose the total amount of selling expenses and, in annual reporting periods, an entity’s definition of selling expenses. The standard is intended to benefit investors by providing more detailed expense disclosures that would be useful in making capital allocation decisions. This guidance is effective for public business entities for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027 but early adoption is permitted. ASU 2024-03 should be applied on a prospective basis, but retrospective application is permitted. The Company is currently evaluating the potential impact of adopting this new guidance on its consolidated financial statements and related disclosures.
In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” which modifies the rules on income tax disclosures to require disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid. The standard is intended to benefit investors by providing more detailed income tax disclosures that would be useful in making capital allocation decisions. The Company adopted this standard on a prospective basis as of January 1, 2025 and included the expanded annual disclosures in this Annual Report on Form 10-K.
Other than the pronouncements discussed above, there have been no other newly issued nor newly applicable accounting pronouncements that have had, or are expected to have, a material impact on the Company’s financial statements.
v3.25.4
Acquisitions and divestitures
12 Months Ended
Dec. 31, 2025
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
Acquisitions and divestitures Acquisitions and divestitures
Eviosys Acquisition
On December 4, 2024, the Company completed the acquisition of all issued and outstanding equity interests in Eviosys from an affiliate of KPS Capital Partners, LP for net cash consideration of $3,789,826, partially reduced by a final working capital settlement for which the Company received $16,528 during the second quarter of 2025. Eviosys, now operated as Sonoco Metal Packaging EMEA in the Company’s Consumer Packaging segment, is a global supplier of metal packaging that produces food cans and ends, aerosol cans, metal closures and promotional packaging with a large metal food can manufacturing footprint in the EMEA region. The Company funded the Eviosys acquisition, including related fees and expenses, with the net proceeds from the registered public offering of senior unsecured notes, borrowings from two term loan facilities, and cash on hand. See Note 11 for more information.
In order to fund the Eviosys acquisition in euros, the Company entered into foreign currency forward contracts during the month of October 2024 with varying settlement dates to sell USD and buy euro. Upon settlement of these trades, the Company, a USD functional currency entity, held euro denominated cash balances between the date of settlement and the December 4, 2024 closing date of the acquisition. Such euro cash balances, being monetary assets, were subject to remeasurement in the intervening period between settlement and December 4, 2024, resulting in the recognition of a $113,697 remeasurement loss. This loss is reflected in “Other (expense)/income, net” in the Company’s Consolidated Statement of Income for the year ended December 31, 2024. The majority of the remeasurement loss was non-cash in nature; however, included in the remeasurement loss are cash payments to counterparties totaling $34,414 reflecting the settlement of a tranche of the foreign currency forward contracts. The Company no longer holds significant euro-denominated cash on its USD functional currency entity that would be subject to future remeasurement gain/loss.
During 2025, the Company finalized its valuation of the assets acquired and liabilities assumed in the Eviosys acquisition. The final fair values, reflecting adjustments made during the measurement period, are as follows:
Initial Preliminary AllocationMeasurement Period AdjustmentsFinal Allocation
Trade accounts receivable$300,385 $(5,151)$295,234 
Other receivables114,634 2,009 116,643 
Inventories445,945 (12,938)433,007 
Prepaid expenses47,509 (2,976)44,533 
Property, plant and equipment1,057,779 (55,127)1,002,652 
Right of use asset - operating leases43,566 43,571 
Other intangible assets1,967,678 42,379 2,010,057 
Goodwill1,285,518 (27,399)1,258,119 
Long-term deferred income taxes39,023 14,853 53,876 
Other assets3,330 23 3,353 
Payable to suppliers(518,766)1,673 (517,093)
Accrued expenses and other payables(168,529)(3,167)(171,696)
Accrued wages and other compensation(41,749)(57)(41,806)
Notes payable and current portion of long-term debt(76,438)(5)(76,443)
Noncurrent operating lease liabilities(32,022)— (32,022)
Pension and other postretirement benefits(51,849)(69)(51,918)
Long-term debt— (34)(34)
Deferred income taxes(599,941)31,772 (568,169)
Other long-term liabilities(16,714)27 (16,687)
Noncontrolling Interests
(9,533)(2,346)(11,879)
Net assets acquired$3,789,826 $(16,528)$3,773,298 

Goodwill for Eviosys, $485,000 of which is expected to be deductible for income tax purposes, consists of increased access to certain markets and the value of the assembled workforce.
The following table presents the financial results for Eviosys from December 4, 2024, the date of acquisition, through December 31, 2024:
Supplemental Information
December 4 to
Eviosys
December 31, 2024
Net sales$115,031 
Net loss
$15,086 
The following table presents the Company’s pro forma consolidated results for the years ended December 31, 2024 and December 31, 2023, assuming the acquisition of Eviosys had occurred on January 1, 2023. This pro forma information is presented for informational purposes only and does not purport to represent the results of operations that would have been achieved if the acquisition had been completed at the beginning of 2023, nor is it necessarily indicative of future consolidated results.
Pro Forma Supplemental Information Years Ended
ConsolidatedDecember 31, 2024
December 31, 2023
Net sales$7,546,920 $8,032,135 
Net income from continuing operations
$157,389 $105,116 
Net income attributable to Sonoco1
$253,593 $200,589 
1 Includes results of discontinued operations
The pro forma information above does not project the Company’s expected results for any future period and gives no effect to any future synergistic benefits that may result from the combination or the costs of integrating the acquired operations with those of the Company. Pro forma information for the years ended December 31, 2024 and 2023 includes adjustments to depreciation, amortization, and income taxes based upon the final fair value allocation of the purchase price to Eviosys’ tangible and intangible assets acquired and liabilities assumed as though the acquisition had occurred on January 1, 2023. Interest expense on the additional debt issued by the Company to fund the acquisition and retention bonuses incurred related to the acquisition are also included in the pro forma information as if the acquisition had occurred on January 1, 2023. Transaction-related costs of $267,886, including the $113,697 remeasurement loss discussed above and charges related to fair value adjustments to acquisition-date inventory, incurred in 2024 are excluded from 2024 pro forma net income and are instead reflected in 2023 pro forma net income as though the acquisition had occurred on January 1, 2023.
Other Acquisitions
On June 1, 2024, the Company completed the purchase of a small tube and paper cone manufacturer in Brazil for $2,660. The financial results of this business are included in the Company’s Industrial Paper Packaging segment.
The Company completed two acquisitions during 2023 at a net cash cost of $372,616. On December 1, 2023, the Company completed the acquisition of Inapel Embalagens Ltda. (“Inapel”), a manufacturer of single-layer and multilayer materials for flexible packaging in Brazil, for net consideration of $64,390, including $59,228 of cash paid at closing. During the second quarter of 2024, the Company paid additional consideration in the amount of $2,340 and a final net working capital settlement in the amount of $489. As Inapel was one of the operations included in the April 1, 2025 divestiture of TFP, the acquired assets and liabilities are reflected as assets and liabilities of discontinued operations on the Company’s Consolidated Balance Sheet as of December 31, 2024. The remaining obligations to the seller as of December 31, 2024 totaled $2,333 and are reflected in “Current liabilities of discontinued operations.” These obligations were subsequently assumed by the buyers of TFP.
On September 8, 2023, the Company completed the acquisitions of the remaining 65% ownership interest in RTS Packaging, LLC (“RTS Packaging”) from joint venture partner WestRock Company (“WestRock”) and a paper mill in Chattanooga, Tennessee (the “Chattanooga Mill”) from WestRock for net cash consideration of $313,388. In December 2023, the Company agreed to a final working capital settlement of $452, which was paid to WestRock in January 2024. Prior to completing the acquisitions, the Company held a 35% ownership interest in the RTS Packaging joint venture, which was formed in 1997, and combined the former protective packaging operations of WestRock and Sonoco to market recycled paperboard to glass container manufacturers and producers of wine, liquor, food, and pharmaceuticals. Prior to the acquisitions, the Company reported its 35% interest in the RTS Packaging joint venture using the equity method of accounting. Subsequent to the acquisitions, the financial results of RTS Packaging and the Chattanooga Mill are accounted for under the acquisition method and their results of operations are included in the Company’s Industrial Paper Packaging segment.
On September 8, 2023, the fair value of the Company’s 35% ownership interest in RTS Packaging was determined to be $59,472 based on the cash consideration exchanged for acquiring the remaining 65% ownership interest in RTS Packaging adjusted for the deemed payment of a control premium, and the carrying value of the 35% ownership interest in RTS Packaging was $8,654. The Company recognized a net gain of $44,029 resulting from this remeasurement to fair value and the reclassification of certain amounts related to the Company’s 35% ownership interest in RTS Packaging out of “Accumulated other comprehensive income/(loss),” including foreign currency translation losses of $2,033 and losses related to defined benefit pension plans of $4,756. The net gain from such remeasurement and reclassification was recorded in “Other (expense)/income, net” in the Company’s Consolidated Statements of Income for the year ended December 31, 2023.
The Company also recognized a loss of $7,086 on the settlement of a contract associated with the Chattanooga Mill. The contract was determined to have unfavorable terms given market conditions at the time of the acquisition. This loss is reflected in “Other (expense)/income, net” in the Company’s Consolidated Statements of Income for the year ended December 31, 2023. This loss, along with the settlement of a note receivable from RTS Packaging held by the Company on the acquisition date, are reflected as components of purchase consideration transferred in connection with these acquisitions.
The following table provides a summary of the purchase consideration (as defined under ASC 805) transferred for the acquisition of the remaining interest in RTS Packaging and the acquisition of the Chattanooga Mill:
Purchase Consideration
Cash consideration, net of cash acquired $313,388 
Fair value of previously held interest in RTS Packaging59,472 
Final working capital settlement
452 
Settlement of preexisting relationships1,235 
Purchase consideration transferred$374,547 
Goodwill for RTS Packaging and the Chattanooga Mill, of which $83,000 is expected to be deductible for income tax purposes, consists of increased manufacturing capacity, access to certain markets, and the capability to support marquee customers in growing markets.
The Company has accounted for these acquisitions as business combinations under the acquisition method and has included the results of operations of the acquired businesses in the Company’s Consolidated Statements of Income from their respective dates of acquisition.
TFP Divestiture
On April 1, 2025, the Company completed the sale of TFP, part of the Consumer Packaging segment, to Toppan for net cash consideration of $1,807,493 paid at closing on a cash-free and debt-free basis. A final working capital settlement was reached in January 2026 that will require a payment of $15,211 to be made to the buyers during the first quarter of 2026. The Company has recorded a liability in this amount in “Accrued expenses and other payables” on its consolidated balance sheet as of December 31, 2025. This sale was the result of the Company’s continuing evaluation of its business portfolio and was consistent with the Company’s strategic and investment priorities. In connection with the TFP divestiture, the Company wrote off net assets totaling $1,112,489, reclassified $47,955 of cumulative translation adjustment losses from accumulated other comprehensive income/(loss) and incurred transaction fees of $25,205, resulting in a net pretax gain, including the final working capital settlement, of $606,633. The Company recognized a related tax provision of $199,457, for an after-tax gain of $407,176. The after tax gain is included in “Net income from discontinued operations” in the Company’s Consolidated Statements of Income for the year ended December 31, 2025. See Notes 1 and 2 for additional information. The majority of cash proceeds generated from this transaction were used to repay debt, as further described in Note 11.
ThermoSafe and Other Divestitures
On November 3, 2025, the Company completed the sale of ThermoSafe, part of the All Other group of businesses, to Arsenal for net cash consideration of $655,827 paid at closing on a cash-free and debt-free basis and subject to customary adjustments. The sale also allowed for additional consideration of up to $75,000 if certain performance measures for calendar year 2025 were met. However, as these performance measures were not met, no additional cash consideration is anticipated. In connection with the ThermoSafe divestiture, the Company wrote off net assets totaling $265,777, including $173,250 of goodwill, reclassified $1,197 of cumulative translation adjustment gains from accumulated other comprehensive income/(loss) and incurred transaction fees of $13,233, resulting in a net pretax gain of $378,014, which is included in “Gain/(Loss) on divestiture of business and other assets” in the Company’s Consolidated Statements of Income. The Company used the majority of the cash proceeds from the sale to pay down debt, as further described in Note 11.
On April 30, 2025, the Company completed the sale of a recycling facility in Asheville, North Carolina, part of the Industrial Paper Packaging segment, for cash proceeds of $3,924. The sale resulted in a loss of $2,114, which is included in “Gain/(Loss) on divestiture of business and other assets” in the Company’s Consolidated Statements of Income.
On March 2, 2025, the Company completed the sale of its tube and core operations in Venezuela, part of the Industrial Paper Packaging segment, in exchange for a receivable in the amount of $145. The sale resulted in a loss of $5,390, including $3,792 of cumulative translation losses that were reclassified from accumulated other comprehensive income/(loss). This loss is included in “Gain/(Loss) on divestiture of business and other assets” in the Company’s Consolidated Statements of Income.
On January 17, 2025, the Company completed the sale of a small construction tube operation in France, part of the Industrial Paper Packaging segment, for cash proceeds of $1,513 and recognized a gain of $1,207, which is included in “Gain/(Loss) on divestiture of business and other assets” in the Company’s Consolidated Statements of Income.
In November 2024, the Company completed the sale of two production facilities in China, both of which were part of the Company’s Industrial Paper Packaging segment, for $302. As a result of the sale, the Company reclassified $590 of cumulative translation losses from accumulated other comprehensive income/(loss) and recognized a loss of $25,607, which is included in “Gain/(Loss) on divestiture of business and other assets” in the Company’s Consolidated Statements of Income.
On April 1, 2024, the Company completed the sale of its Protective Solutions business (“Protexic”), part of the All Other group of businesses, to Black Diamond Capital Management, LLC (“Black Diamond”) for cash proceeds of $80,267 at closing. Upon final settlement of working capital in the third quarter of 2024, the Company paid Black Diamond $1,805. This business provided foam components and integrated material solutions for various industrial end markets. This sale was the result of the Company’s continuing evaluation of its business portfolio and is consistent with the Company’s strategic and investment priorities. In connection with the Protexic divestiture, the Company wrote off net assets totaling $74,644, including $16,559 of allocated goodwill and reclassified $2,913 of cumulative translation adjustment losses from accumulated other comprehensive loss, resulting in a net pretax gain of $905, which is included in “Gain/(Loss) on divestiture of business and other assets” in the Company’s Consolidated Statements of Income.
On July 1, 2023, the Company completed the sale of its U.S. BulkSak business, which consisted of the manufacturing and distribution of flexible intermediate bulk containers, plastic and fiber pallets, and custom fit liners and was a part of the Company’s Industrial Paper Packaging segment, to U.S. BulkSak Holdings, LLC. The cash selling price, as adjusted for the final working capital settlement, was $20,271 with net cash proceeds totaling $18,271 received in 2023 and the remaining $2,000 released to the Company from escrow in February 2025. As a result of the U.S. BulkSak divestiture, the Company wrote off net assets totaling $13,437, including $3,333 of allocated goodwill, and resulting in a net pretax gain of $6,834, which is included in “Gain/(Loss) on divestiture of business and other assets” in the Company’s Consolidated Statements of Income.
Also on July 1, 2023, the Company agreed to the sale of its Mexico BulkSak business. The sale closed in December 2023 for a cash selling price, as adjusted for working capital, of $1,096. As a result of the Mexico BulkSak sale, the Company recognized a pretax gain of $85 which is included in “Gain/(Loss) on divestiture of business and other assets” in the Company’s Consolidated Statements of Income.
On January 26, 2023, the Company completed the sale of its S3 business, a provider of customized waste and recycling management programs and part of the Company’s Industrial Paper Packaging segment, to Northstar. The Company received cash proceeds of $13,839 at closing. An additional $1,500 of cash proceeds were released to the Company from escrow in September 2024. The Company wrote off net assets totaling $4,274 as part of the divestiture of the business, including $3,042 of allocated goodwill, and recognized a pretax gain of $11,065 during the first quarter of 2023. In the second quarter of 2024, upon resolution of certain contingencies, the Company received cash proceeds and recognized an additional pretax gain of $1,250 on the sale. These gains are included in “Gain/(Loss) on divestiture of business and other assets” in the Company’s Consolidated Statements of Income for their respective periods.
On January 26, 2023, in connection with the sale of the S3 business, the Company acquired a 2.7% equity interest in Northstar valued at $5,000. This Company sold its equity interest in Northstar on December 23, 2024 for cash proceeds of $8,630. The resulting pretax gain of $3,630 is included in “Other (expense)/income, net” in the Company’s Consolidated Statements of Income for the year ended December 31, 2024.
The ThermoSafe and other divestitures did not represent a strategic shift for the Company or have a major effect on its operations or financial results. Consequently, these divestitures did not meet the criteria for reporting as discontinued operations. Cash proceeds from these sales were used to pay down debt and for general corporate purposes.
The Company continually assesses its operational footprint as well as its overall portfolio of businesses and may consider the divestiture of plants and/or business units it considers to be suboptimal or nonstrategic.
Sale of Assets
With the completion of Project Horizon, the Company’s project to convert the corrugated medium machine in Hartsville, South Carolina, to produce uncoated recycled paperboard was realized. The Company now produces paper exclusively from recycled fibers and no longer requires natural tree fiber for production. Accordingly, on March 29, 2023, the Company sold its timberland properties, consisting of approximately 55,000 acres, to Manulife Investment Management for net cash proceeds of $70,802. The Company disposed of assets with a net book value of $9,857 as part of the sale and recognized a pretax gain from the sale of these assets of $60,945 during the year ended December 31, 2023, which is included in “Gain/(Loss) on divestiture of business and other assets” in the Company’s Consolidated Statements of Income.
Additional Ownership Investment
During the second quarter of 2024, the Company increased its ownership investment in a small South Carolina-based designer and manufacturer of sustainable protective packaging solutions from 20.5% to 39.9%. The Company acquired its initial ownership interest in June 2022. The preferred stock investment increased by $18,512 during the second quarter of 2024, which included a $10,000 cash payment, a $5,400 remeasurement of the fair value of the existing investment, and a $2,500 conversion of the carrying value of the outstanding convertible notes into a preferred series stock investment, which yielded a $467 fair value increase and a $145 increase for interest income earned. The outstanding investment of $21,212 as of December 31, 2025 is included within “Other assets” in the Company’s Consolidated Balance Sheet. The remeasurement of the carrying value of the existing investment to fair value during the second quarter of 2024 resulted in a gain of $5,867 and interest income of $145, which are included in “Other (expense)/income, net” and “Interest income,” respectively, in the Company’s Consolidated Statements of Income.
Acquisition, Integration, and Divestiture-Related Costs
Acquisition, integration, and divestiture-related costs from continuing operations incurred in 2025, 2024 and 2023, were as follows:
 Year Ended December 31,
202520242023
Cost of sales$17,053 $5,806 $5,227 
Selling, general and administrative expenses37,078 85,794 19,397 
Interest expense— 33,569 — 
Total acquisition, integration, and divestiture-related costs$54,131 $125,169 $24,624 
Acquisition, integration, and divestiture-related costs included in “Cost of sales” in the Company’s Consolidated Statements of Income consist primarily of amortization of the fair value step-up of finished goods inventory, while such costs included in “Selling, general and administrative expenses” consist primarily of legal and professional fees, investment banking fees, representation and warranty insurance premiums, as well as employee-related costs, and other integration activity costs. Acquisition, integration, and divestiture-related costs included in “Interest expense” include losses on treasury lock derivative instruments and amortization of financing fees related to debt instruments associated with the financing of the Eviosys acquisition.
v3.25.4
Restructuring and asset impairment
12 Months Ended
Dec. 31, 2025
Restructuring and Related Activities [Abstract]  
Restructuring and asset impairment Restructuring and asset impairment
Due to its geographic footprint and the cost-competitive nature of its businesses, the Company is continually seeking more cost-effective means and structures to serve its customers and to respond to fundamental changes in its markets. As such, plant closures in connection with footprint rationalization and headcount reductions are an important component of the Company’s cost control initiatives. The amount of these costs can vary significantly from quarter to quarter and from year to year depending upon the scope, nature, and location of the restructuring activities.
Following are the total restructuring and asset impairment charges, net of adjustments, recognized during the periods presented:
 Year Ended December 31,
  
202520242023
Restructuring and restructuring-related asset impairment charges, net
$66,215 $65,370 $47,909 
Other asset impairments— — — 
Restructuring/Asset impairment charges, net
$66,215 $65,370 $47,909 
The table below sets forth restructuring and restructuring-related asset impairment charges by type incurred:
 Year Ended December 31,
202520242023
Severance and Termination Benefits$68,795 $37,307 $15,543 
Asset Impairment/Disposal of Assets(15,333)15,719 24,415 
Other Costs12,753 12,344 7,951 
Restructuring and restructuring-related asset impairment charges, net
$66,215 $65,370 $47,909 
The table below sets forth restructuring and restructuring-related asset impairment charges by reportable segment:
 Year Ended December 31,
202520242023
Consumer Packaging$54,200 $19,259 $4,111 
Industrial Paper Packaging8,307 33,923 38,754 
All Other1,434 2,547 
Corporate3,703 10,754 2,497 
Restructuring and restructuring-related asset impairment charges, net
$66,215 $65,370 $47,909 
“Restructuring and restructuring-related asset impairment charges” and “Other asset impairments” are included in “Restructuring/Asset impairment charges, net” in the Consolidated Statements of Income.
The following table sets forth the activity in the restructuring accrual included in “Accrued expenses and other payables” in the Company’s Consolidated Balance Sheets:
Accrual ActivitySeverance
and Termination
Benefits
Asset
Impairment/ Disposal
of Assets
Other
Costs
Total
Liability at December 31, 2023$8,864 $— $272 $9,136 
2024 charges37,307 15,719 12,344 65,370 
Cash (payments)/receipts(21,653)9,680 (11,610)(23,583)
Asset write downs/disposals— (25,399)— (25,399)
Foreign currency translation(484)— (97)(581)
Liability at December 31, 2024$24,034 $— $909 $24,943 
2025 charges/(gains)68,795 (15,333)12,753 66,215 
Cash (payments)/receipts(38,367)45,675 (10,779)(3,471)
Asset write downs/disposals— (30,342)— (30,342)
Foreign currency translation1,166 — 644 1,810 
Liability at December 31, 2025$55,628 $— $3,527 $59,155 

Severance and Termination Benefits” in 2025 include the cost of severance for approximately 450 employees whose positions were eliminated in conjunction with the Company’s ongoing organizational effectiveness efforts, as well as severance costs related to the closures of metal can facilities in France and Spain, part of the Consumer Packaging segment, and the closures of a paper mill in Mexico, cone facilities in Taiwan and Mexico, and partitions facilities in Maine and California, all part of the Industrial Paper Packaging segment.
“Severance and Termination Benefits” in 2024 include the cost of severance for approximately 300 employees whose positions were eliminated in conjunction with the Company’s ongoing organizational effectiveness efforts, including the relocation of certain facilities in Greece and Germany, and severance related to the closures of paper mills in Sumner, Washington (the “Sumner Mill”) and Kilkis, Greece (the “Kilkis Mill”), the closures of two small industrial converted products facilities in China, and the closure of an industrial converted products facility in Mississauga, Canada, all part of the Industrial Paper Packaging segment.
“Asset Impairment/Disposal of Assets” in 2025 consist primarily of asset impairment charges related to the closures of the paper mill in Mexico, the cone facilities in China and Mexico, and the partitions facilities in Maine and California, all part of the Industrial Paper Packaging segment, and the closure of the metal packaging facility in France, part of the Consumer Packaging segment. These charges were offset by gains from the sales of the land and buildings associated with previously closed facilities, primarily the cone facility in Taiwan and the partitions facility in Maine. Also offsetting the impairment charges was a gain from the sale of water rights at our former paper mill in Hutchinson, Kansas, which was closed in 2023.
“Asset Impairment/Disposal of Assets” in 2024 consist primarily of asset impairment charges related to the closures of the Sumner Mill and the Kilkis Mill, both part of the Industrial Paper Packaging segment, and the exit of a small metal canning lid business within Metal Packaging, part of the Consumer Packaging segment. These charges were partially offset by gains from the sales of previously closed facilities that were part of the Industrial Paper Packaging and Consumer Packaging segments.
“Other Costs” in 2025 consist primarily of equipment removal, utilities, plant security, property taxes, insurance and environmental remediation costs related to the prior year’s closure of the Company’s paper mill in Washington, costs related to the current year’s closures of the metal can facilities in France and Spain, the paper mill in Mexico, the cone facility in Taiwan, and ongoing facility carrying costs of previously announced plant closures.
Other Costs” in 2024 consist primarily of equipment removal, utilities, plant security, property taxes, insurance and environmental remediation costs related to the closure of the Sumner Mill, and ongoing facility carrying costs of previously announced plant closures.
The Company expects to pay the majority of the remaining restructuring reserves by the end of 2026 using cash generated from operations. The Company also expects to recognize future additional charges totaling approximately $11,000 in connection with previously announced restructuring actions and believes that the majority of these charges will be incurred and paid by the end of 2026. The Company continually evaluates its cost structure, including its manufacturing capacity, and additional restructuring actions are likely to be undertaken.
v3.25.4
Book cash overdrafts and cash pooling
12 Months Ended
Dec. 31, 2025
Cash and Cash Equivalents [Abstract]  
Book cash overdrafts and cash pooling Book cash overdrafts and cash pooling
As part of its cash management system, the Company uses “zero balance” accounts to fund disbursements. Under this system, the bank balance is zero at the end of each day, while the book balance is usually a negative amount due to reconciling items such as outstanding checks. At December 31, 2025 and 2024, outstanding checks totaling $11,996 and $15,799, respectively, were included in “Payable to suppliers” in the Company’s Consolidated Balance Sheets. In addition, outstanding payroll checks of $260 and $162 as of December 31, 2025 and 2024, respectively, were included in “Accrued wages and other compensation” in the Company’s Consolidated Balance Sheets. Changes in these book cash overdrafts are reported as cash flows from financing activities.
The Company uses a notional pooling arrangement with an international bank to help manage global liquidity requirements. Under this pooling arrangement, the Company and its participating subsidiaries may maintain either cash deposit or borrowing positions through local currency accounts with the bank, so long as the aggregate position of the global pool is a notionally calculated net cash deposit. Because it maintains a security interest in the cash deposits, and has the right to offset the cash deposits against the borrowings, the bank provides the Company and its participating subsidiaries favorable interest terms on both. The Company’s Consolidated Balance Sheets reflect a net cash deposit under this pooling arrangement of $2,170 and $12,915 as of December 31, 2025 and 2024, respectively.
v3.25.4
Property, plant and equipment
12 Months Ended
Dec. 31, 2025
Property, Plant and Equipment [Abstract]  
Property, plant and equipment Property, plant and equipment
Details of the Company’s property, plant and equipment at December 31 are as follows:
20252024
Land$324,635 $314,278 
Buildings1,046,723 967,237 
Machinery and equipment4,020,202 3,726,377 
Construction in progress282,948 337,796 
5,674,508 5,345,688 
Accumulated depreciation(2,876,708)(2,626,941)
Property, plant and equipment, net$2,797,800 $2,718,747 
Depreciation expense amounted to $324,185 in 2025, $224,595 in 2024 and $202,917 in 2023.
v3.25.4
Leases
12 Months Ended
Dec. 31, 2025
Leases [Abstract]  
Leases Leases
The Company routinely enters into leasing arrangements for real estate (including manufacturing facilities, office space, and warehouses), transportation equipment (automobiles, forklifts, and trailers), and office equipment (copiers and postage machines). The assessment of the certainty associated with the exercise of various lease renewal, termination, and purchase options included in the Company’s lease contracts is performed after contemplating all the relevant facts and circumstances in accordance with guidance under ASC 842, “Leases.” Most real estate leases, in particular, include one or more options to renew, with renewal terms that typically extend the lease term in increments from one to five years. The Company’s leases do not have any significant residual value guarantees or restrictive covenants.
On November 3, 2025, the Company completed the sale of ThermoSafe, part of the All Other group of businesses. The divestiture included operating lease assets of $20,825 and operating lease liabilities of $21,082 as well as finance lease assets of $2,743 with finance lease liabilities of $2,920.
The Company completed the Eviosys acquisition on December 4, 2024. The acquisition included operating lease liabilities of $42,468 with a weighted-average remaining lease maturity term of 8.1 years and weighted-average discount rate of 4.5%.
The Company completed the divestiture of Protexic on April 1, 2024. The divestiture included operating lease assets of $21,989 and operating lease liabilities of $22,396.
For additional information about the Company’s acquisitions and divestitures, see Note 4.
The following table sets forth the balance sheet location and values of the Company’s lease assets and lease liabilities at December 31, 2025 and December 31, 2024:
ClassificationBalance Sheet LocationDecember 31, 2025December 31, 2024
Lease Assets
Operating lease assetsRight of Use Asset-Operating Leases$307,450 $307,688 
Finance lease assetsOther Assets49,059 76,831 
Total lease assets$356,509 $384,519 
Lease Liabilities
Current operating lease liabilitiesAccrued expenses and other payables$53,978 $52,648 
Current finance lease liabilitiesNotes payable and current portion of long-term debt11,617 22,284 
Total current lease liabilities$65,595 $74,932 
Noncurrent operating lease liabilitiesNoncurrent Operating Lease Liabilities$263,192 $258,735 
Noncurrent finance lease liabilitiesLong-term Debt41,925 45,344 
Total noncurrent lease liabilities$305,117 $304,079 
Total lease liabilities$370,712 $379,011 
Certain of the Company’s leases include variable costs. Variable costs include lease payments that were volume or usage-driven in accordance with the use of the underlying asset, and also non-lease components that were incurred based upon actual terms rather than contractually fixed amounts. In addition, variable costs are incurred for lease payments that are indexed to a change in rate or index. Because the right of use asset recorded on the balance sheet was determined based upon factors considered at the commencement date, subsequent changes in the rate or index that were not contemplated in the right of use asset balances recorded on the balance sheet result in variable expenses being incurred when paid during the lease term.
The following table sets forth the components of the Company’s total lease cost for the years ended December 31, 2025, 2024, and 2023:
Lease Cost202520242023
Operating lease cost(a)$62,687 $49,327 $43,524 
Finance lease cost:
     Amortization of lease asset(a) (b)13,051 12,871 11,789 
     Interest on lease liabilities(c)3,100 3,711 3,912 
Variable lease cost(a) (d)48,807 31,404 32,016 
Impairment charges(e)2,526 — — 
Total lease cost$130,171 $97,313 $91,241 
(a) Production-related costs are included in “Cost of sales” and administrative costs are included in “Selling, general and administrative expenses” in the Consolidated Statements of Income.
(b) Included in depreciation and amortization.
(c) Included in interest expense.
(d) Also includes short term lease costs, which are deemed immaterial.
(e) Impairment charges are included in “Restructuring/Asset impairment charges, net” in the Company’s Consolidated Statements of Income. See Note 5 for additional information.

The following table sets forth the five-year maturity schedule of the Company’s lease liabilities as of December 31, 2025:
Maturity of Lease LiabilitiesOperating LeasesFinance LeasesTotal
2026$54,712 $11,841 $66,553 
202747,158 10,382 57,540 
202842,551 8,750 51,301 
202939,459 6,512 45,971 
203035,978 4,845 40,823 
Beyond 2030177,821 20,207 198,028 
Total lease payments$397,679 $62,537 $460,216 
Less: Interest(80,509)(8,995)(89,504)
Lease Liabilities$317,170 $53,542 $370,712 
The following tables set forth the Company’s weighted average remaining lease term and discount rates used in the calculation of its outstanding lease liabilities at December 31, 2025, 2024, and 2023, along with other lease-related information for those years:
Lease Term and Discount Rate202520242023
Weighted-average remaining lease term (years):
Operating leases 9.610.110.0
Finance leases8.26.77.1
Weighted-average discount rate:
Operating leases5.09%4.97%5.07%
Finance leases4.65%5.16%5.27%
Other Information202520242023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows used by operating leases$59,172 $48,380 $43,638 
Operating cash flows used by finance leases$3,100 $3,711 $3,912 
Financing cash flows used by finance leases$14,997 $15,433 $14,617 
Noncash investing and financing activities:
Leased assets obtained in exchange for new operating lease liabilities$42,646 $66,585 $18,225 
Leased assets obtained in exchange for new finance lease liabilities$20,579 $11,925 $7,755 
Modification to leased assets for increase in operating lease liabilities$17,621 $37,731 $4,431 
Modification to leased assets for increase/(decrease) in finance lease liabilities$(31,502)$53 $18 
Termination reclasses to decrease operating lease assets$8,440 $5,765 $5,702 
Termination reclasses to decrease operating lease liabilities$8,544 $5,768 $6,063 
Termination reclasses to decrease finance lease assets$303 $270 $1,429 
Termination reclasses to decrease finance lease liabilities$305 $271 $482 
Leases Leases
The Company routinely enters into leasing arrangements for real estate (including manufacturing facilities, office space, and warehouses), transportation equipment (automobiles, forklifts, and trailers), and office equipment (copiers and postage machines). The assessment of the certainty associated with the exercise of various lease renewal, termination, and purchase options included in the Company’s lease contracts is performed after contemplating all the relevant facts and circumstances in accordance with guidance under ASC 842, “Leases.” Most real estate leases, in particular, include one or more options to renew, with renewal terms that typically extend the lease term in increments from one to five years. The Company’s leases do not have any significant residual value guarantees or restrictive covenants.
On November 3, 2025, the Company completed the sale of ThermoSafe, part of the All Other group of businesses. The divestiture included operating lease assets of $20,825 and operating lease liabilities of $21,082 as well as finance lease assets of $2,743 with finance lease liabilities of $2,920.
The Company completed the Eviosys acquisition on December 4, 2024. The acquisition included operating lease liabilities of $42,468 with a weighted-average remaining lease maturity term of 8.1 years and weighted-average discount rate of 4.5%.
The Company completed the divestiture of Protexic on April 1, 2024. The divestiture included operating lease assets of $21,989 and operating lease liabilities of $22,396.
For additional information about the Company’s acquisitions and divestitures, see Note 4.
The following table sets forth the balance sheet location and values of the Company’s lease assets and lease liabilities at December 31, 2025 and December 31, 2024:
ClassificationBalance Sheet LocationDecember 31, 2025December 31, 2024
Lease Assets
Operating lease assetsRight of Use Asset-Operating Leases$307,450 $307,688 
Finance lease assetsOther Assets49,059 76,831 
Total lease assets$356,509 $384,519 
Lease Liabilities
Current operating lease liabilitiesAccrued expenses and other payables$53,978 $52,648 
Current finance lease liabilitiesNotes payable and current portion of long-term debt11,617 22,284 
Total current lease liabilities$65,595 $74,932 
Noncurrent operating lease liabilitiesNoncurrent Operating Lease Liabilities$263,192 $258,735 
Noncurrent finance lease liabilitiesLong-term Debt41,925 45,344 
Total noncurrent lease liabilities$305,117 $304,079 
Total lease liabilities$370,712 $379,011 
Certain of the Company’s leases include variable costs. Variable costs include lease payments that were volume or usage-driven in accordance with the use of the underlying asset, and also non-lease components that were incurred based upon actual terms rather than contractually fixed amounts. In addition, variable costs are incurred for lease payments that are indexed to a change in rate or index. Because the right of use asset recorded on the balance sheet was determined based upon factors considered at the commencement date, subsequent changes in the rate or index that were not contemplated in the right of use asset balances recorded on the balance sheet result in variable expenses being incurred when paid during the lease term.
The following table sets forth the components of the Company’s total lease cost for the years ended December 31, 2025, 2024, and 2023:
Lease Cost202520242023
Operating lease cost(a)$62,687 $49,327 $43,524 
Finance lease cost:
     Amortization of lease asset(a) (b)13,051 12,871 11,789 
     Interest on lease liabilities(c)3,100 3,711 3,912 
Variable lease cost(a) (d)48,807 31,404 32,016 
Impairment charges(e)2,526 — — 
Total lease cost$130,171 $97,313 $91,241 
(a) Production-related costs are included in “Cost of sales” and administrative costs are included in “Selling, general and administrative expenses” in the Consolidated Statements of Income.
(b) Included in depreciation and amortization.
(c) Included in interest expense.
(d) Also includes short term lease costs, which are deemed immaterial.
(e) Impairment charges are included in “Restructuring/Asset impairment charges, net” in the Company’s Consolidated Statements of Income. See Note 5 for additional information.

The following table sets forth the five-year maturity schedule of the Company’s lease liabilities as of December 31, 2025:
Maturity of Lease LiabilitiesOperating LeasesFinance LeasesTotal
2026$54,712 $11,841 $66,553 
202747,158 10,382 57,540 
202842,551 8,750 51,301 
202939,459 6,512 45,971 
203035,978 4,845 40,823 
Beyond 2030177,821 20,207 198,028 
Total lease payments$397,679 $62,537 $460,216 
Less: Interest(80,509)(8,995)(89,504)
Lease Liabilities$317,170 $53,542 $370,712 
The following tables set forth the Company’s weighted average remaining lease term and discount rates used in the calculation of its outstanding lease liabilities at December 31, 2025, 2024, and 2023, along with other lease-related information for those years:
Lease Term and Discount Rate202520242023
Weighted-average remaining lease term (years):
Operating leases 9.610.110.0
Finance leases8.26.77.1
Weighted-average discount rate:
Operating leases5.09%4.97%5.07%
Finance leases4.65%5.16%5.27%
Other Information202520242023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows used by operating leases$59,172 $48,380 $43,638 
Operating cash flows used by finance leases$3,100 $3,711 $3,912 
Financing cash flows used by finance leases$14,997 $15,433 $14,617 
Noncash investing and financing activities:
Leased assets obtained in exchange for new operating lease liabilities$42,646 $66,585 $18,225 
Leased assets obtained in exchange for new finance lease liabilities$20,579 $11,925 $7,755 
Modification to leased assets for increase in operating lease liabilities$17,621 $37,731 $4,431 
Modification to leased assets for increase/(decrease) in finance lease liabilities$(31,502)$53 $18 
Termination reclasses to decrease operating lease assets$8,440 $5,765 $5,702 
Termination reclasses to decrease operating lease liabilities$8,544 $5,768 $6,063 
Termination reclasses to decrease finance lease assets$303 $270 $1,429 
Termination reclasses to decrease finance lease liabilities$305 $271 $482 
v3.25.4
Goodwill and other intangible assets
12 Months Ended
Dec. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and other intangible assets Goodwill and other intangible assets
Goodwill
Changes in the carrying amount of goodwill by segment for the year ended December 31, 2025, are as follows:
Consumer
Packaging
Industrial Paper PackagingAll OtherTotal
Balance as of January 1, 2025
$1,807,971 $486,636 $231,050 $2,525,657 
Divestitures— (2,043)(173,250)(175,293)
Measurement period adjustments(27,399)— — (27,399)
Foreign currency translation167,419 23,783 (2,556)188,646 
Balance as of December 31, 2025
$1,947,991 $508,376 $55,244 $2,511,611 

Goodwill activity reflected under the caption “Measurement period adjustments” relates to the December 2024 acquisition of Eviosys. Goodwill activity reflected under the caption “Divestitures” relates to the November 2025 sale of the ThermoSafe business, part of the All Other group of businesses, and the April 2025 sale of a small recycling business in Asheville, North Carolina, part of the Industrial Paper Packaging segment. See Note 4 for additional information.
The Company assesses goodwill for impairment annually during the third quarter, or from time to time when warranted by the facts and circumstances surrounding individual reporting units or the Company as a whole. The Company completed its most recent annual goodwill impairment testing during the third quarter of 2025 and analyzed certain qualitative and quantitative factors in determining whether a goodwill impairment existed. The Company’s assessments reflected a number of significant management assumptions and estimates including the Company’s forecast of sales growth during the discrete period, EBITDA, and discount rates. Changes in these assumptions could materially impact the Company’s conclusions. Based on its assessments, the Company concluded that there was no impairment of goodwill for any of its reporting units.
Although no reporting units failed the annual impairment test, in management’s opinion, the goodwill balances of the Metal Packaging EMEA and Global Paper Products Asia Pacific (“APAC”) reporting units are at risk of impairment in the near term if the reporting unit’s operations do not perform in line with management’s expectations, or if there is a negative change in the long-term financial outlook for the reporting unit or in other factors such as the discount rate. In the case of Metal Packaging EMEA, the lower differential between the fair value and carrying value of the reporting unit is due to the acquisition of Eviosys in December 2024, at which time the majority of assets and liabilities acquired were recorded at fair value.
In the annual goodwill impairment analysis completed during the third quarter of 2025, projected future cash flows for the Metal Packaging EMEA and Global Paper Products APAC reporting units were discounted at 12.0% and 13.0%, respectively, and their estimated fair values were determined to exceed their individual carrying values by approximately 3.1% and 9.0%, respectively.
Based on equal weighting of the income and market approaches and holding other valuation assumptions constant, the discount rates for the Metal Packaging EMEA and Global Paper Products APAC reporting units would have to increase to 12.7% and 15.4%, respectively, or projected EBITDA across all future periods would have to be reduced by approximately 3.0% and 8.4%, respectively, in order for the estimated fair values of the reporting units to fall below carrying values. At December 31, 2025, the total goodwill associated with the Metal Packaging EMEA and Global Paper Products APAC reporting unit was $1,397,039 and $26,867, respectively.
During the time subsequent to the annual evaluation, and at December 31, 2025, the Company considered whether any events and/or changes in circumstances had resulted in the likelihood that the goodwill of any of its reporting units may have been impaired. It is management’s opinion that no such events and/or changes in circumstances have occurred.
Other intangible assets
Details at December 31 are as follows:
20252024
Other Intangible Assets, Gross:
Patents$29,403 $28,941 
Customer lists2,895,345 2,679,372 
Trade names28,417 38,623 
Proprietary technology234,336 226,936 
Other2,054 2,339 
Total Other Intangible Assets, Gross$3,189,555 $2,976,211 
Accumulated Amortization:
Patents$(18,706)$(15,955)
Customer lists(431,704)(332,680)
Trade names(12,488)(13,239)
Proprietary technology
(41,990)(26,203)
Other (1,193)(1,436)
Total Accumulated Amortization$(506,081)$(389,513)
Other Intangible Assets, Net$2,683,474 $2,586,698 

During 2025, the Company recorded measurement period adjustments related to the December 2024 acquisition of Eviosys that increased the previously reported fair value of customer lists by $42,379. The effect on amortization expense in the prior period was immaterial. In addition, the Company wrote off other intangible assets, primarily customer lists, with a net book value of $1,455 as a result of the divestiture of a small recycling business in Asheville, North Carolina. See Note 4 for additional information.
In conjunction with the sale of ThermoSafe on November 3, 2025, the Company disposed of intangible assets with a net book value of $9,405. The gross value of these intangible assets, which consisted primarily of customer lists and trade names, was $89,607 and the accumulated amortization was $80,202 at the time of the sale.
Other intangible assets are amortized using the straight-line method over their respective useful lives when management determines that the straight-line method approximates the pattern of consumption of the respective intangible assets or in relation to the asset’s specific pattern of consumption if management determines that the straight-line method does not provide a fair approximation of the consumption of benefits. These lives generally range from three to twenty years. The Company has no intangible assets with indefinite lives.
Aggregate amortization expense on intangible assets was $182,431, $78,595, and $67,323 for the years ended December 31, 2025, 2024, and 2023, respectively. Amortization expense on other intangible assets is expected to approximate $182,100 in 2026, $181,900 in 2027, $181,800 in 2028, $180,800 in 2029 and $178,500 in 2030 based on intangible assets as of December 31, 2025.
v3.25.4
Supply chain financing
12 Months Ended
Dec. 31, 2025
Investments, Debt and Equity Securities [Abstract]  
Supply chain financing Supply chain financing
The following table sets forth the balance sheet location and rollforward of the Company’s outstanding obligations confirmed under its SCF Programs for the years ended December 31, 2025 and 2024:
Balance Sheet Location20252024
Confirmed obligations outstanding at the beginning of the yearPayable to suppliers$28,496 $24,779 
Invoices confirmed during the year (a) (b)
187,392 96,785 
Confirmed invoices paid during the year (b) (c)
(162,766)(93,068)
Confirmed obligations outstanding at the end of the yearPayable to suppliers$53,122 $28,496 

(a) Invoices confirmed in 2025 exclude $7,763 of obligations under SCF Programs divested upon the sale of ThermoSafe on November 3, 2025 and invoices confirmed in 2024 include $7,547 of obligations assumed upon the acquisition of Eviosys on December 4, 2024.
(b) The net payment of these obligations, exclusive of the $7,547 of obligations acquired in the acquisition of Eviosys in 2024, is included in “Net cash provided by operating activities” in the Company’s Consolidated Statements of Cash Flows.
(c) Excludes $6,342 of obligations under SCF Programs divested upon the sale of ThermoSafe on November 3, 2025.
v3.25.4
Debt
12 Months Ended
Dec. 31, 2025
Debt Disclosure [Abstract]  
Debt Debt
Details of the Company’s debt at December 31 were as follows:
20252024
364-Day term loan due December 2025$— $1,493,568 
Term loan due December 2026— 698,167 
Syndicated term loan due August 2028498,320 497,674 
1.80% notes due February 2025
— 399,933 
4.45% notes due September 2026
498,749 496,869 
2.25% notes due February 2027
299,443 298,930 
4.60% notes due September 2029
595,694 594,519 
3.125% notes due May 2030
597,528 596,958 
2.85% notes due February 2032
496,824 496,302 
5.00% notes due September 2034
690,857 689,802 
5.75% notes due November 2040
536,314 536,282 
Other foreign denominated debt, average rate of 5.5% in 2025 and 6.0% in 2024
40,016 155,048 
Finance lease obligations53,542 67,628 
Other debt19,638 18,341 
Total debt$4,326,925 $7,040,021 
Less: Notes payable and current portion of long-term debt(537,952)(2,054,525)
Long-term debt$3,788,973 $4,985,496 
On February 3, 2025, the Company repaid the $400,000 aggregate principal amount of its 1.80% notes upon their maturity using proceeds from the issuance of commercial paper.
On September 16, 2024, the Company entered into a credit agreement with the lenders party thereto and JPMorgan Chase Bank, N.A., as Administrative Agent which provides the Company with the ability to borrow up to $1,500,000 on an unsecured basis (the “364-Day Term Loan Facility”) to finance a portion of the cash consideration for the Company’s acquisition of Eviosys. The Company drew down the entire 364-Day Term Loan Facility on December 2, 2024 in connection with the consummation of the Eviosys acquisition on December 4, 2024. Borrowings under the 364-Day Term Loan Facility, became payable upon completion of the TFP divestiture. Accordingly, on April 3, 2025, the Company repaid the outstanding $1,500,000 principal amount of borrowings using a portion of the cash proceeds from the sale of TFP.
On July 12, 2024, the Company entered into a credit agreement with the lenders party thereto and JPMorgan Chase Bank, N.A., as Administrative Agent which provided the Company with the ability to borrow up to $700,000 on an unsecured basis (the “Term Loan Facility”) to finance a portion of the cash consideration for the Company’s acquisition of Eviosys. The Company drew down the entire Term Loan Facility on December 2, 2024 in connection with the consummation of the Eviosys acquisition on December 4, 2024. Borrowings under the Term Loan Facility became payable upon completion of the ThermoSafe divestiture. Accordingly, on November 5, 2025, the Company repaid the outstanding $700,000 principal amount of borrowings using cash proceeds from the sale of ThermoSafe and the issuance of commercial paper.
On September 19, 2024, the Company completed a registered public offering of senior unsecured notes (the “Notes”) in a combined aggregate principal amount of $1,800,000. The Notes consisted of the following:
Principal AmountIssuance Costs and DiscountsNet ProceedsInterest RateMaturity
2026 Notes$500,000 (3,697)$496,303 4.45 %September 1, 2026
2029 Notes600,000 (5,851)594,149 4.60 %September 1, 2029
2034 Notes700,000 (10,542)689,458 5.00 %September 1, 2034
Total$1,800,000 $(20,090)$1,779,910 
The Company used the net proceeds from the Notes, together with the borrowings under the Term Loan Facility and 364-Day Term Loan Facility and cash on hand to fund the cash consideration payable by the Company in connection with the Eviosys acquisition and to pay related fees and expenses. See Note 4 for more information.
Included in “Other foreign denominated debt” at December 31, 2024 are $73,487 of transfers of certain trade receivables of Eviosys to third-party financial institutions for which the requirements to be accounted for as true sale in accordance with the guidance under ASC 860 “Transfers and Servicing,” were not met. Additions to and settlements of these obligations during the year ended December 31, 2025 are reflected as “Proceeds from issuance of debt” and “Principal repayment of debt,” respectively, in “Net cash (used)/provided by financing activities” in the Company’s Consolidated Statements of Cash Flows. All of these obligations had been settled as of December 31, 2025.
In conjunction with the announcement of the acquisition of Eviosys, the Company entered into a commitment letter with certain financial institutions that provided for a 364-day senior unsecured bridge term loan facility (the “Bridge Loan Facility”) on June 22, 2024 in an aggregate amount of up to $4,000,000 to secure funding of the acquisition. As a result of obtaining financing for the Eviosys acquisition through the Term Loan Facility, the 364-Day Term Loan Facility, and the Notes, the Company terminated the commitments under the Bridge Loan Facility and the related commitment letter effective September 19, 2024. Fees related to the Bridge Loan Facility of $19,000 were amortized to interest expense during the year ended December 31, 2024.
On August 7, 2023, the Company entered into a credit agreement with a consortium of Farm Credit System institutions and CoBank, ACB, as Administrative Agent (the “Syndicated Term Loan Agreement”). The Syndicated Term Loan Agreement provides the Company with the ability to borrow up to $900,000 on an unsecured basis (the “Syndicated Term Loan Facility”). A total of $600,000 was drawn from the Syndicated Term Loan Facility on August 7, 2023 and used to repay the syndicated term loans that were due in December 2023 and January 2025, and to make certain capital expenditures and reimburse the Company for certain capital expenditures it had made in its operation of waste disposal facilities in rural areas. An additional $270,000 was drawn from the Syndicated Term Loan Facility on September 8, 2023 and used to partially fund the acquisition of the remaining interest in RTS Packaging and the acquisition of the Chattanooga Mill (see Note 4 for more information). Borrowings under the Syndicated Term Loan Facility, net of any prepayments, will become payable in full on August 7, 2028. During the years ended December 31, 2024 and 2023, the Company repaid $75,000 and $295,000, respectively, of the amounts drawn under the Syndicated Term Loan Facility. Borrowings under the Syndicated Term Loan Facility bear interest at a fluctuating rate per annum equal to, at the Company’s option, (i) the forward-looking SOFR term rate (“Term SOFR” and such borrowings, “Syndicated Term SOFR Loans”), (ii) a base rate set forth in the Syndicated Term Loan Agreement, or (iii) a combination thereof, plus, in each case, an applicable margin calculated based on the Company’s credit ratings and, in the of case of Syndicated Term SOFR Loans, a SOFR Adjustment (as defined in the Syndicated Term Loan Agreement) of 0.1%. The Company has designated its borrowings under the Syndicated Term Loan Facility as Syndicated Term SOFR Loans. The margin currently applicable to Syndicated Term SOFR Loans based on the Company’s credit ratings, together with the SOFR Adjustment, is 1.90%. If Term SOFR ceases to be available, the benchmark rate shall switch to Daily Simple SOFR (as defined in the Syndicated Term Loan Agreement). There is no required amortization under the Syndicated Term Loan Facility, and voluntary prepayments are permissible without penalty, subject to certain conditions pertaining to minimum notice and minimum prepayment and reduction amounts as described in the Syndicated Term Loan Agreement.
The Syndicated Term Loan Agreement contains various customary representations and warranties and affirmative and negative covenants, as more fully described in the Syndicated Term Loan Agreement. The Syndicated Term Loan Agreement also contains various customary events of default (subject to grace periods, as applicable) including, among others: nonpayment of principal, interest or fees; breach of covenant; payment default on, or acceleration under, certain other material indebtedness; inaccuracy of the representations or warranties in any material respect; bankruptcy or insolvency; inability to pay debts; certain unsatisfied judgments; certain ERISA-related events; the invalidity or unenforceability of the Syndicated Term Loan Agreement or certain other documents executed in connection therewith; and the occurrence of a change of control.
On May 3, 2024, the Company entered into an Amended and Restated Credit Agreement (the “Agreement”) to extend the maturity and make certain other changes to the terms under the Company’s existing five-year credit agreement dated June 21, 2021. The Agreement increases the commitments under the Company’s revolving credit facility by $350,000 to $1,250,000 and extends the maturity date to May 3, 2029. The Company also increased its $500,000 commercial paper program by $750,000 to $1,250,000. The revolving credit facility continues to support the commercial paper program. At December 31, 2025, the Company had no commercial paper balances outstanding; accordingly, the committed capacity available for drawdown under its revolving credit facility at December 31, 2025 was $1,250,000. Based on the pricing grid, the credit agreement for the revolving credit facility and Sonoco’s current credit ratings, any drawings are subject to the Term SOFR plus the 137.5 basis points margin.
The principal requirements of debt maturing in the next five years are:
  
20262027202820292030
Debt maturities by year$537,952 $316,438 $513,555 $600,802 $602,236 
As of December 31, 2025, the Company has scheduled debt maturities through the next twelve months of $537,952. At December 31, 2025, the Company had $378,398 in cash and cash equivalents on hand, and $1,250,000 in committed capacity available for drawdown under its revolving credit facility. The Company believes that these amounts, combined with expected net cash flows from operating activities, provide ample liquidity to cover debt maturities and other cash flow needs of the Company over the course of the next year.
In addition, the Company had approximately $287,325 available under unused short-term lines of credit at December 31, 2025. These short-term lines of credit are available for general corporate purposes of our subsidiaries, including working capital and hedging requirements.
Certain of the Company’s debt agreements impose restrictions with respect to the maintenance of financial ratios and the disposition of assets. The most restrictive covenants currently require the Company to maintain a minimum level of interest coverage and a minimum level of net worth, as defined in the agreements. As of December 31, 2025, the Company’s interest coverage and net worth were substantially above the minimum levels required under these covenants.
v3.25.4
Financial instruments and derivatives
12 Months Ended
Dec. 31, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Financial instruments and derivatives Financial instruments and derivatives
The following table sets forth the carrying amounts and fair values of the Company’s significant financial instruments for which the carrying amount differs from the fair value.
 December 31, 2025December 31, 2024
  
Carrying
Amount
Fair
Value
Carrying
Amount
Fair
Value
Long-term debt, net of current portion$3,788,973 $3,728,480 $4,985,496 $4,800,455 
The carrying value of cash and cash equivalents and short-term debt approximates fair value. The fair value of long-term debt is determined based on recent trade information in the financial markets of the Company’s public debt or is determined by discounting future cash flows using interest rates available to the Company for issues with similar terms and maturities, which is considered a Level 2 fair value measurement.
Cash Flow Hedges
At December 31, 2025 and 2024, the Company had derivative financial instruments outstanding to hedge anticipated transactions and certain asset and liability related cash flows. These contracts, which have maturities ranging through December 2026, qualify as cash flow hedges under GAAP. For derivative instruments that are designated and qualify as a cash flow hedge, the gain or loss on the derivative instrument is reported as a component of other comprehensive income/(loss) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings and is presented in the same income statement line item as the earnings effect of the hedged item. Cash flows from derivative financial instruments designated as cash flow hedges are classified as cash flows from operating activities in the Company’s Consolidated Statements of Cash Flows.
Commodity Cash Flow Hedges
Certain derivative contracts entered into to manage the cost of anticipated purchases of natural gas and aluminum have been designated by the Company as cash flow hedges. At December 31, 2025, there were no natural gas swaps covering anticipated natural gas usage in 2026 and aluminum swaps covering 6,133 metric tons of aluminum represented approximately 27% of anticipated aluminum usage for 2026. The fair values of the Company’s commodity cash flow hedges netted to a gain position of $1,683 and $652 at December 31, 2025 and December 31, 2024, respectively. The amount of the gain included in accumulated other comprehensive income/(loss) at December 31, 2025, expected to be reclassified to the income statement during the next twelve months is $1,508. The Company also has certain natural gas hedges that are not designated as cash flow hedges. See “Non-Designated Derivatives” below for a discussion of these hedges.
Foreign Currency Cash Flow Hedges
The Company has entered into forward contracts to hedge certain anticipated foreign currency denominated sales and purchases expected to occur in 2026. The net positions of these contracts at December 31, 2025, were as follows (in thousands):
CurrencyActionQuantity
USD Contracts
Colombian pesopurchase9,732,940 
Mexican pesopurchase163,250 
Polish zlotypurchase87,110 
Danish kronepurchase105,120 
Swedish kronasell(1,902)
Canadian dollarpurchase15,274 
Europurchase3,326 
Turkish lirapurchase79,562 
British poundsell(6,985)
USDpurchase9,639 
Euro Contracts
Europurchase4,741 
Polish zlotypurchase3,650 
British poundpurchase2,850 
USDpurchase8,720 
Hungarian forintpurchase9,026,735 
Swiss francpurchase2,274 
The fair value of foreign currency cash flow hedges related to forecasted sales and purchases netted to a gain position of $49 at December 31, 2025, and a loss position of $(1,841) at December 31, 2024. The amount of the loss expected to be reclassified from accumulated other comprehensive income/(loss) to the income statement during the next twelve months is $103.
Net Investment Hedge
In 2023, the Company became a party to cross-currency swap agreements with a total notional amount of $500,000 to effectively convert a portion of the Company’s fixed-rate U.S. dollar denominated debt, including the semi-annual interest payments, to fixed-rate euro-denominated debt. The swap agreements, which had a maturity of December 18, 2026, provided for the Company to receive semi-annual interest payments in U.S. dollars at a fixed rate and to make semi-annual interest payments in euros at a fixed rate. On April 15, 2024, as a result of the strengthening of the U.S. dollar against the euro, as well as a reduction in the differential between U.S. and European interest rates, the Company terminated its swap agreements and received a net cash settlement of $9,068. The foreign currency translation gain of approximately $3,143, net of tax, is included as a component of “Accumulated other comprehensive income/(loss).”
Following the unwind of the swaps, in April 2024 the Company entered into new cross-currency swap agreements with a total notional amount of $500,000, maturing on May 1, 2027, to effectively convert a portion of the Company’s fixed-rate U.S. dollar-denominated debt, including the semi-annual interest payments, to fixed-rate euro-denominated debt.
In December 2024, the Company entered into additional cross-currency swap agreements with a total notional amount of $1,500,000, including $500,000 maturing on September 1, 2026, $500,000 maturing on September 1, 2029, and $500,000 maturing on May 1, 2030. The swaps effectively convert a portion of the Company’s fixed-rate U.S. dollar-denominated debt, including the semi-annual interest payments, to fixed-rate euro-denominated debt at the prevailing market rate at execution.
On June 30, 2025, the Company entered into additional cross-currency swap agreements with a total notional amount of $285,000, maturing on February 1, 2027. The swaps effectively convert a portion of the Company’s fixed-rate U.S. dollar-denominated debt, including the semi-annual interest payments, to fixed-rate euro-denominated debt at the prevailing market rate at execution.
All of the Company’s cross-currency swap agreements are designated as net investment hedges for accounting purposes and have the risk management objective of managing foreign currency risk relating to net investments in certain European subsidiaries denominated in euros.
The gain or loss on the net investment hedge derivative instruments is included in the “Foreign currency translation” component of “Accumulated other comprehensive loss” until the net investment is sold, diluted, or liquidated. Net interest income on the cross-currency swaps totaling $36,480 for the year ended December 31, 2025 is excluded from the net investment hedge effectiveness assessment and is recorded in “Interest expense” in the Company’s Consolidated Statements of Income. The assumptions used in measuring fair value of the cross-currency swaps are considered level 2 inputs, which are based upon the Euro-to-U.S. dollar exchange rate market.
The fair value of the Company’s net investment hedges was a loss position of $(207,203) and a gain position of $11,919 at December 31, 2025 and December 31, 2024, respectively. A foreign currency translation loss of $(154,366) (net of income taxes of $52,837) and gain of $8,880 (net of income taxes of $3,039) were reported as components of “Accumulated other comprehensive income/(loss)” within “Foreign currency items” at December 31, 2025 and December 31, 2024, respectively.
Non-Designated Derivatives
The Company routinely enters into other derivative contracts which are not designated for hedge accounting treatment under ASC 815, “Derivatives and Hedging.” As such, changes in fair value of these non-designated derivatives are recorded directly to income and expense in the periods that they occur.
Foreign Currency Hedges
The Company routinely enters into forward contracts or swaps to economically hedge the currency exposure of intercompany debt and foreign currency denominated receivables and payables. The net currency positions of these non-designated contracts at December 31, 2025, were as follows (in thousands):
CurrencyActionQuantity
USD Contracts
Indonesian rupiahpurchase10,632,390 
Colombian pesopurchase67,686,355 
Mexican pesopurchase276,516 
Canadian dollarpurchase4,224 
Euro Contracts
British poundsell(395)
Polish zlotysell(51,337)
Thai bahtsell(550,013)
Hungarian forintpurchase356,793 
USDsell(2,880)
Commodity Hedges
The Company has entered into non-designated derivative contracts to manage the cost of anticipated purchases of natural gas. At December 31, 2025, these contracts consisted of natural gas swaps covering approximately 3.0 million metric million British thermal units (“MMBTUs”) representing approximately 52.3% of anticipated usage in North America for 2026. At December 31, 2025, there were no non-designated contracts covering anticipated aluminum usage for 2026.
Interest Rate Hedges
In anticipation of the offering of the Notes (see Note 11 for additional information), the Company entered into treasury lock derivative instruments with eleven banks, with a total notional principal amount of $900,000, on August 29, 2024. These instruments had the risk management objective of reducing the Company’s exposure to increases in the underlying Treasury index up to the date of pricing of the Notes. The derivatives were settled when the Notes priced on September 17, 2024, with the Company recognizing a loss on the settlement of $(11,088). The loss is included in “Interest expense” in the Company’s Consolidated Statements of Income for the year ended December 31, 2024.
The fair value of the Company’s non-designated derivatives position was a loss of $(1,113) and $(2,694) at December 31, 2025 and December 31, 2024, respectively.
The following table sets forth the location and fair values of the Company’s derivative instruments at December 31, 2025 and December 31, 2024:
  Fair Value at December 31
DescriptionBalance Sheet Location20252024
Derivatives designated as hedging instruments:
Commodity ContractsPrepaid expenses$1,508 $671 
Commodity ContractsOther Assets175 — 
Commodity ContractsAccrued expenses and other payables— (19)
Foreign Exchange ContractsPrepaid expenses1,131 2,068 
Foreign Exchange ContractsOther Assets33 — 
Foreign Exchange ContractsAccrued expenses and other payables(1,028)(3,909)
Foreign Exchange ContractsOther Liabilities(87)— 
Net investment hedgePrepaid expenses19,358 26,833 
Net investment hedgeOther Assets— 1,845 
Net investment hedgeAccrued expenses and other payables(58,594)— 
Net investment hedgeOther Liabilities(167,967)(16,759)
Derivatives not designated as hedging instruments:
Commodity ContractsPrepaid expenses$185 $961 
Commodity ContractsAccrued expenses and other payables(1,517)(574)
Foreign Exchange ContractsPrepaid expenses1,106 (59)
Foreign Exchange ContractsAccrued expenses and other payables(887)(3,022)
While certain of the Company’s derivative contract arrangements with its counterparties provide for the ability to settle contracts on a net basis, the Company reports its derivative positions on a gross basis. There are no collateral arrangements or requirements in these agreements.
The following tables set forth the effect of the Company’s derivative instruments on financial performance for the year ended December 31, 2025 and December 31, 2024, excluding the gains or losses on foreign currency cash flow hedges that were reclassified from accumulated other comprehensive income/(loss) to the carrying value of the capitalized expenditures:
DescriptionAmount of Gain or (Loss) Recognized in OCI on DerivativesLocation of Gain or (Loss) Reclassified from Accumulated OCI into IncomeAmount of Gain or (Loss) Reclassified from Accumulated OCI into Income
Derivatives in Cash Flow Hedging Relationships:
Year Ended December 31, 2025
Foreign Exchange Contracts$2,879 Net sales$3,811 
Cost of sales$(2,557)
Commodity Contracts$1,478 Cost of sales$447 
Year Ended December 31, 2024
Foreign Exchange Contracts$(4,994)Net sales$(1,174)
Cost of sales$(253)
Commodity Contracts$665 Cost of sales$(28)
Description
  
Gain or (Loss) RecognizedLocation of Gain or (Loss) Recognized in Income Statement
Derivatives not Designated as Hedging Instruments:
Year Ended December 31, 2025
Commodity Contracts$(1,546)Cost of sales
Foreign Exchange Contracts$6,683 Selling, general and administrative
Year Ended December 31, 2024
Commodity Contracts$(2,976)Cost of sales
Foreign Exchange Contracts$(8,168)Selling, general and administrative
Year Ended December 31, 2025Year Ended December 31, 2024
DescriptionNet SalesCost of salesNet SalesCost of sales
Total amount of income and expense line items presented in the Consolidated Statements of Income$3,811 $(2,110)$(1,174)$(281)
Gain or (loss) on cash flow hedging relationships:
Foreign exchange contracts:
Amount of gain or (loss) reclassified from accumulated other comprehensive income into net income$3,811 $(2,557)$(1,174)$(253)
Commodity contracts:
Amount of gain or (loss) reclassified from accumulated other comprehensive income into net income$— $447 $— $(28)
v3.25.4
Fair value measurements
12 Months Ended
Dec. 31, 2025
Fair Value Disclosures [Abstract]  
Fair value measurements Fair value measurements
Fair value is defined as an exit price representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. Fair value is a market-based measurement that is determined based on assumptions that market participants would use in pricing an asset or liability. A three-tier fair value hierarchy is used to prioritize the inputs in measuring fair value as follows:
Level 1 –Observable inputs such as quoted market prices in active markets;
Level 2 –Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and
Level 3 –Unobservable inputs for which there is little or no market data, which require the reporting entity to develop its own assumptions.
Assets that are calculated at net asset value (“NAV”) per share are not required to be categorized within the fair value hierarchy.
The following tables set forth information regarding the Company’s financial assets and financial liabilities that are measured at fair value on a recurring basis:
DescriptionDecember 31, 2025
Assets measured at NAV (f)
Level 1Level 2Level 3
Hedge derivatives, net:
Commodity contracts$1,683 $— $— $1,683 $— 
Foreign exchange contracts49 — — 49 — 
Net investment hedge(207,203)— — (207,203)— 
Non-hedge derivatives, net:
Commodity contracts(1,332)— — (1,332)— 
Foreign exchange contracts219 — — 219 — 
Postretirement benefit plan assets:
Common Collective Trust (a)
13,139 13,139 — — — 
Mutual funds (b)
25,885 — — 25,885 — 
Fixed income securities (c)
263,441 63,517 — 199,924 — 
Short-term investments (d)
3,184 — — 3,184 — 
Real estate funds (e)
5,019 5,019 — — — 
Cash and accrued income9,789 — 9,789 — — 
Total postretirement benefit plan assets$320,457 $81,675 $9,789 $228,993 $— 
DescriptionDecember 31, 2024
Assets measured at NAV (f)
Level 1Level 2Level 3
Hedge derivatives, net:
Commodity contracts652 $— $— $652 $— 
Foreign exchange contracts(1,841)— — (1,841)— 
Net investment hedge11,919 — — 11,919 — 
Non-hedge derivatives, net:
Commodity contracts387 — — 387 — 
Foreign exchange contracts(3,081)— — (3,081)— 
Postretirement benefit plan assets:
Common Collective Trust (a)
13,259 13,259 — — — 
Mutual funds (b)
43,059 — — 43,059 — 
Fixed income securities (c)
235,952 62,458 — 173,494 — 
Short-term investments (d)
3,493 — — 3,493 — 
Real estate funds (e)
480 480 — — — 
Cash and accrued income7,757 — 7,757 — — 
Total postretirement benefit plan assets$304,000 $76,197 $7,757 $220,046 $— 
a.Common collective trust investments consist of domestic and international large and mid capitalization equities, including emerging markets and funds invested in both short-term and long-term bonds. Underlying investments are generally valued at closing prices from national exchanges. Commingled funds, private securities, and limited partnerships are valued at unit values or NAVs provided by the investment managers.
b.Mutual fund investments are comprised of equity securities of corporations with large capitalizations and also include funds invested in corporate equities in international and emerging markets and funds invested in long-term bonds, which are valued at closing prices from national exchanges.
c.Fixed income securities include funds that invest primarily in government securities and long-term bonds. Underlying investments are generally valued at closing prices from national exchanges, fixed income pricing models, and independent financial analysts. Fixed income commingled funds are valued at unit values provided by the investment managers.
d.Short-term investments include several money market funds used for managing overall liquidity. Underlying investments are generally valued at closing prices from national exchanges. Commingled funds are valued at unit values provided by the investment managers.
e.Includes investments in real estate funds (including office, industrial, residential and retail). Underlying real estate securities are generally valued at closing prices from national exchanges.
f.Certain assets that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.
The Company’s pension plan assets comprise more than 96% of its total postretirement benefit plan assets. Accordingly, the assets of the Company’s various pension plans and retiree health and life insurance plans are not shown separately, but are combined in the tables above. Postretirement benefit plan assets are netted against postretirement benefit obligations to determine the funded status of each plan. The funded status is recognized in the Company’s Consolidated Balance Sheets as shown in Note 15.
As discussed in Note 12, the Company uses derivatives to mitigate the effect of commodity fluctuations, foreign currency fluctuations and, from time to time, interest rate movements. Fair value measurements for the Company’s derivatives are classified under Level 2 because such measurements are estimated based on observable inputs such as interest rates, yield curves, spot and future commodity prices and spot and future exchange rates. There were no transfers in or out of Level 1 or Level 2 fair value measurements during the years ended December 31, 2025 or 2024.
The Company measures certain non-financial assets and non-financial liabilities at fair value on a non-recurring basis. See Note 4 for a discussion of assets acquired and liabilities assumed in acquisitions and sold in dispositions, and Note 5 for a discussion of asset impairments associated with restructuring activities. The fair value of assets determined based on third-party appraisals and classified as Level 3 measurements due to the use of significant unobservable inputs was not material at December 31, 2025 or 2024.
The Company has an investment in the preferred stock of a nonaffiliated private company. This investment is accounted for under the measurement alternative of cost less impairment, adjusted for any qualifying observable price changes on a non-recurring basis. Observable price changes would consist of Level 2 inputs based on privately negotiated transactions with the nonaffiliated company. The total investment in preferred stock of $21,212 is included in “Other Assets” in the Company’s Consolidated Balance Sheet as of December 31, 2025.
For additional fair value information on the Company’s financial instruments, see Note 12.
v3.25.4
Share-based compensation plans
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Share-based compensation plans Share-based compensation plans
The Company provides share-based compensation to certain employees and non-employee directors in the form of RSUs, PCSUs, and other share-based awards. Beginning in 2024, share-based awards were issued pursuant to the Sonoco Products Company 2024 Omnibus Incentive Plan (the “2024 Plan”), which became effective upon approval by the shareholders on April 17, 2024. Awards issued from 2019 through 2023 were issued pursuant to the Sonoco Products Company 2019 Omnibus Incentive Plan (the “2019 Plan”).
As of the April 17, 2024 effective date, the 2024 Plan superseded the 2019 Plan and became the only plan under which equity-based compensation may be awarded to employees and non-employee directors. However, any awards under any of the prior plans that were outstanding on the effective date of the 2024 Plan remain subject to the terms and conditions, and continue to be governed, by such prior plans. Awards issued between January 1 and April 16, 2024 were effectively issued under the 2024 Plan when such awards were transferred over to be applied against the 2024 Plan’s reserve. Share reserve reductions for restricted and performance-based stock awards and stock appreciation rights originally granted under the 2019 Plan were weighted equally on a one-for-one basis in accordance with the shareholder-approved conversion formula included within the 2024 Plan. Share awards granted under all previous plans which are forfeited, expire or are canceled without delivery of shares, or which result in forfeiture of shares back to the Company, will be added back to the total shares available under the 2024 Plan. Shares of the Company’s common stock repurchased to satisfy employee tax withholding obligations in association with the exercise of RSUs and PCSUs, but not stock appreciation rights (“SARs”), will also be added back to the total shares available under the 2024 Plan.
At December 31, 2025, a total of 1,674,656 shares remain available for future grant under the 2024 Plan. The Company issues new shares for stock unit conversions and stock appreciation right exercises.
Accounting for share-based compensation
Total compensation cost for share-based payment arrangements was $17,787, $26,948 and $24,738, for 2025, 2024 and 2023, respectively. The related tax benefit recognized in net income was $4,475, $6,852, and $6,162, for the same years, respectively. Share-based compensation expense is included in “Selling, general and administrative expenses” in the Company’s Consolidated Statements of Income. The Company accounts for forfeitures of its share-based payment arrangements as they occur.
An “excess” tax benefit is created when the tax deduction for an exercised stock appreciation right or converted stock unit exceeds the compensation cost that has been recognized in income. The additional net excess tax benefit realized was $501, $257 and $978 for 2025, 2024 and 2023, respectively.
Restricted Stock Units
The Company grants awards of RSUs to executive officers and certain key management employees annually on a discretionary basis. These awards vest over a three-year period with one-third vesting on each anniversary date of the grant. The expense for these RSUs is recognized following the graded-vesting method, which results in front-loaded expense being recognized during the early years of the required service period. For awards granted prior to 2021, participants must be actively employed by the Company on the vesting date for shares to be issued, except in the event of the participant’s death, disability, or involuntary (or good reason) termination within two years of a change in control prior to full vesting, in which case shares will immediately vest. For awards granted since 2020, in the event of the participant’s death, disability or retirement prior to full vesting, shares will be issued on a pro rata basis up through the time the participant’s employment or service ceases. Once vested, these awards do not expire.
The Company from time to time grants special RSUs to certain of its executive officers and directors. These awards normally vest over a five-year period with one-third vesting on each of the third, fourth and fifth anniversaries of the grant, but in some circumstances may vest over a shorter period, or cliff vest at the end of the five-year period. Normally a participant must be actively employed by, or serving as a director of, the Company on the vesting date for shares to be issued, but the Company may make other arrangements in connection with termination of employment prior to the vesting date. Officers and directors can elect to defer receipt of RSUs, which will be issued in shares of Sonoco common stock in installments beginning no earlier than six months following separation from the Company or the Board of Directors (the “Board”), respectively. Key management employees are required to take receipt of the stock issued upon the vest date.
The weighted-average grant-date fair value of RSUs granted was $42.75, $52.41 and $56.87 per share in 2025, 2024 and 2023, respectively. The fair value of shares vesting during the year was $15,348, $13,190, and $10,320 for 2025, 2024 and 2023, respectively. Non-cash stock-based compensation associated with restricted stock grants totaled $13,421, $14,748 and $12,888 for 2025, 2024 and 2023, respectively. As of December 31, 2025, there was $11,264 of total unrecognized compensation cost related to nonvested RSUs. This cost is expected to be recognized over a weighted-average period of 30 months.
The activity related to RSUs for the year ended December 31, 2025 is as follows:
NonvestedVestedTotalAverage Grant Date Fair Value Per Share
Outstanding, December 31, 2024681,616 75,580 757,196 $53.43 
Granted451,499 — 451,499 $42.75 
Vested(327,019)327,019 — 
Converted— (284,530)(284,530)$54.28 
Cancelled(118,243)— (118,243)$50.13 
Dividend equivalents517 5,790 6,307 $43.90 
Outstanding, December 31, 2025688,370 123,859 812,229 $47.43 
Performance Contingent Restricted Stock Units
The Company grants PCSUs annually on a discretionary basis to executive officers and certain key management employees. The ultimate number of PCSUs awarded is dependent upon the degree to which performance, relative to defined targets related to earnings and return on invested capital is achieved over a three-year performance cycle and for the 2025 and 2024 PCSU grants only, a modifier for total stock return performance.
The Company estimates the fair value of its PCSUs based upon the Company’s stock price on the dates of grant and an estimate of the Company’s payout modifier based upon the projected total stock return performance relative to its peer group companies. The comparative market index for the awards that vest based on total stock return to shareholders is the S&P Composite 1500 Materials Index. If the Company’s actual total stock return for the three-year measurement period is determined to be between the 25th and 75th percentile relative to its peers, no additional modifier is triggered for the particular PCSU grant upon vesting. If the Company’s total stock return for the three-year measurement period is determined to be above the 75th percentile, the modifier adds 20% to the award’s vested share payout for total stock return performance in the top quartile, and if the Company’s return falls below the 25th percentile relative to its peers, the modifier reduces the award’s share payout by 20% for performance in the bottom quartile.
PCSUs granted vest at the end of the three-year performance period if the respective performance targets are met. No units will be awarded if the performance targets are not met. Upon vesting, PCSUs are convertible into common shares on a one-for-one basis. Officers can elect to defer receipt of PCSUs, which will be issued in shares of Sonoco common stock in installments beginning no earlier than six months following separation from the Company. Key management employees are required to take receipt of the stock issued upon the vest date. Except in the event of the participant’s death, disability, or retirement, if a participant is not employed by the Company at the end of the performance period, no PCSUs will vest. However, in the event of the participant’s death, disability or retirement prior to full vesting, shares will be issued on a pro rata basis up through the time the participant’s employment or service ceases. In the event of a change in control, as defined under the 2024 Plan, all unvested PCSUs will vest at target on a pro rata basis if the change in control occurs during the three-year performance period.
The activity related to PCSUs for the year ended December 31, 2025 is as follows:
NonvestedVestedTotalAverage Grant Date Fair Value Per Share
Outstanding, December 31, 2024283,675 350,081 633,756 $52.13
Granted272,478 — 272,478 $40.95
Performance adjustments(258,333)— (258,333)$42.17
Vested(75,263)75,263 — 
Converted— (309,397)(309,397)$51.94
Cancelled(46,162)— (46,162)$48.58
Dividend equivalents— 1,932 1,932 $45.20
Outstanding, December 31, 2025176,395 117,879 294,274 $51.25
2025 PCSU. As of December 31, 2025, the 2025 PCSUs to be awarded are estimated to range from 0 to 580,331 units, including the 20% total stock return modifier, and are tied to the three-year performance period ending December 31, 2027.
2024 PCSU. As of December 31, 2024, the 2024 PCSUs to be awarded are estimated to range from 0 to 415,611 units, including the 20% total stock return modifier, and are tied to the three-year performance period ending December 31, 2026.
2023 PCSU. The performance cycle for the 2023 PCSUs was completed on December 31, 2025. Outstanding stock units of 75,263 units were determined to have been earned. The fair value of these earned units was $3,285 as of December 31, 2025. No additional units were earned for the total stock return modifier since the Company’s stock return was between the 25th and 75th percentiles relative to its peers for the measurement period ended December 31, 2025.
2022 PCSU. The performance cycle for the 2022 PCSUs was completed on December 31, 2024. Outstanding stock units of 330,888 units were determined to have been earned. The fair value of these units was $16,164 as of December 31, 2024.
2021 PCSU. The performance cycle for the 2021 PCSUs was completed on December 31, 2023. Outstanding stock units of 225,530 units were determined to have been earned. The fair value of these units was $12,600 as of December 31, 2023.
The weighted-average grant-date fair value of PCSUs granted was $40.95, $50.54, and $55.04 per share in 2025, 2024 and 2023, respectively. Non-cash stock-based compensation associated with PCSUs totaled $2,599, $10,176 and $9,826 for 2025, 2024 and 2023, respectively. As of December 31, 2025, there was approximately $3,250 of total unrecognized compensation cost related to nonvested PCSUs. This cost is expected to be recognized over a weighted-average period of 15 months.
Deferred compensation plans
Certain officers of the Company receive a portion of their compensation, either current or deferred, in the form of stock equivalent units. Units are granted as of the day the cash compensation would have otherwise been paid using the closing price of the Company’s common stock on that day. Deferrals into stock equivalent units are converted into phantom stock equivalents as if Sonoco shares were actually purchased. The units immediately vest and earn dividend equivalents. Units are distributed in the form of common stock upon retirement over a period elected by the employee.
Non-employee directors may elect to defer a portion of their cash retainer or other fees (except chair retainers) into phantom stock equivalent units as if Sonoco shares were actually purchased. The deferred stock equivalent units accrue dividend equivalents, and are issued in shares of Sonoco common stock beginning six months following termination of Board service. Directors must elect to receive these deferred distributions in one, three or five annual installments.
The activity related to deferred compensation for equity award units granted to both employees and non-employee directors combined is as follows:
Total
Outstanding, December 31, 2024361,423 
Deferred42,013 
Converted(8,146)
Dividend equivalents16,857 
Outstanding, December 31, 2025412,147 
Compensation deferrals for employees and directors, all of which will be settled in Company stock after retirement, totaled $1,767, $2,024, and $2,024, during 2025, 2024, and 2023, respectively.
Stock appreciation rights
Through 2019, the Company granted SARs annually on a discretionary basis to key employees. These SARs had an exercise price equal to the closing market price on the date of the grant and can be settled only in stock. All outstanding SARs are vested as of December 31, 2025. The weighted average remaining contractual life for outstanding and exercisable SARs at December 31, 2025 was 3.3 years.
The activity related to SARs for the year ended December 31, 2025 is as follows: 
NonvestedVestedTotalWeighted-average Exercise Price
Outstanding, December 31, 2024— 663,404 663,404 $55.62 
Vested— — — $— 
Granted— — — $— 
Exercised— (35,972)(35,972)$45.11 
Forfeited/Expired— (111,279)(111,279)$58.22 
Outstanding, December 31, 2025— 516,153 516,153 $55.79 
Exercisable, December 31, 2025— 516,153 516,153 $55.79 
Noncash stock-based compensation expense associated with SARs totaled $0 for 2025, 2024 and 2023. As of December 31, 2025, there is no unrecognized compensation cost remaining.
The aggregate intrinsic value of SARs exercised during 2025, 2024, and 2023 was $0, $74, and $158 using the fair market value of the Company’s stock at December 31, 2025, 2024, and 2023, respectively. The aggregate intrinsic value for outstanding and exercisable SARs was $79 at December 31, 2025 using the fair market value of the Company’s stock on that date of $43.64 per share.
v3.25.4
Employee benefit plans
12 Months Ended
Dec. 31, 2025
Retirement Benefits [Abstract]  
Employee benefit plans Employee benefit plans
Retirement plans and retiree health and life insurance plans
The Company provides non-contributory defined benefit pension plans for certain of its employees in the United States, Mexico, Belgium, Germany, France, Italy, Switzerland, Spain, Ireland and Turkey. The Company also sponsors contributory defined benefit pension plans covering certain of its employees in the United Kingdom, Canada and the Netherlands, and provides postretirement healthcare and life insurance benefits to a limited number of its retirees and their dependents in the United States and Canada, based on certain age and/or service eligibility requirements.
The components of net periodic benefit cost/(income) include the following:
202520242023
Retirement Plans
Service cost$5,497 $3,456 $2,878 
Interest cost21,588 19,097 18,101 
Expected return on plan assets(13,667)(11,133)(9,451)
Amortization of prior service cost923 864 926 
Amortization of net actuarial loss3,871 4,472 4,300 
Effect of settlement loss42 530 1,010 
Effect of curtailment gain(263)— — 
Net periodic benefit cost$17,991 $17,286 $17,764 
Retiree Health and Life Insurance Plans
Service cost$134 $178 $230 
Interest cost919 919 507 
Expected return on plan assets(413)(392)(313)
Amortization of prior service cost375 385 — 
Amortization of net actuarial gain(1,160)(899)(768)
Net periodic benefit (income)/cost $(145)$191 $(344)
The following tables set forth the Plans’ obligations and assets at December 31:
 Retirement PlansRetiree Health and
Life Insurance Plans
  
2025202420252024
Change in Benefit Obligation
Benefit obligation at January 1$452,275 $413,340 $19,832 $22,571 
Service cost5,497 3,456 134 178 
Interest cost21,588 19,097 919 919 
Plan participant contributions306 31 — — 
Plan amendments675 615 (321)— 
Actuarial (gain)/loss(6,621)(18,935)1,027 (2,389)
Benefits paid(27,380)(28,263)(1,181)(1,418)
Impact of foreign exchange rates23,875 (8,926)16 (29)
Effect of settlements(8,576)(2,218)— — 
Effect of curtailments(408)— — — 
Other1,639 — — — 
Acquisitions42 74,078 — — 
Benefit obligation at December 31$462,912 $452,275 $20,426 $19,832 
 
 Retirement PlansRetiree Health and
Life Insurance Plans
  
2025202420252024
Change in Plan Assets
Fair value of plan assets at January 1$290,825 $295,587 $13,175 $13,213 
Actual return on plan assets13,722 (5,203)669 535 
Company contributions21,490 18,798 794 835 
Plan participant contributions306 77 — — 
Benefits paid(27,380)(28,263)(1,181)(1,360)
Impact of foreign exchange rates17,588 (7,200)— — 
Effect of settlements(8,576)(2,218)— — 
Expenses paid(1,945)(1,976)(29)(48)
Other 999 — — — 
Acquisitions— 21,223 — — 
Fair value of plan assets at December 31$307,029 $290,825 $13,428 $13,175 
Funded status of the Plans $(155,883)$(161,450)$(6,998)$(6,657)

 Retirement PlansRetiree Health and
Life Insurance Plans
  
2025202420252024
Total Recognized Amounts in the Consolidated Balance Sheets
Noncurrent assets $27,283 $24,919 $— $— 
Current liabilities (11,402)(11,382)(786)(817)
Noncurrent liabilities (171,764)(174,987)(6,212)(5,840)
Net liability$(155,883)$(161,450)$(6,998)$(6,657)
Items not yet recognized as a pre-tax component of net periodic benefit cost that are included in Accumulated Other Comprehensive Loss as of December 31, 2025 and 2024, are as follows:
 Retirement PlansRetiree Health and
Life Insurance Plans
  
2025202420252024
Net actuarial loss/(gain)$100,220 $109,718 $(5,747)$(7,706)
Prior service cost5,683 5,020 10,555 11,251 
 $105,903 $114,738 $4,808 $3,545 
The pre-tax amounts recognized in Other Comprehensive Loss/(Income) include the following:
 Retirement PlansRetiree Health and
Life Insurance Plans
  
202520242023202520242023
Adjustments arising during the period:
Net actuarial (gain)/loss$(4,998)$(238)$10,709 $799 $(2,485)$(451)
Prior service cost736 327 430 (321)— 11,637 
Net settlement/curtailment gain/(loss)
221 (530)(1,010)— — — 
Amortization recognized during the period:
Net actuarial (loss)/gain(3,871)(4,472)(4,300)1,160 899 768 
Prior service cost(923)(864)(926)(375)(385)— 
Total recognized in other comprehensive (income)/loss$(8,835)$(5,777)$4,903 $1,263 $(1,971)$11,954 
Total recognized in net periodic benefit cost and other comprehensive loss/(income)$9,156 $11,509 $22,707 $1,118 $(1,780)$11,610 
The accumulated benefit obligation (“ABO”) for all defined benefit plans was $469,719 and $440,126 at December 31, 2025 and 2024, respectively.
The projected benefit obligation (“PBO”), ABO and fair value of plan assets for pension plans with ABOs in excess of plan assets were, $293,402, $283,773 and $105,647, respectively, as of December 31, 2025, and $279,472, $270,720 and $94,384, respectively, as of December 31, 2024.
Eviosys acquisition
On December 4, 2024, the Company completed the acquisition of Eviosys, which included the assumption of several defined benefit plans (the “Eviosys Plans”), including non-contributory defined benefit pension plans for certain of its employees, primarily in Germany, France, Italy, Switzerland, Spain, and Ireland. The Company determined the acquisition-date fair values of the PBO and plan assets of the Eviosys Plans to be $74,120 and $21,223, respectively, resulting in a long-term and short-term unfunded pension obligations of $51,918 and $979, respectively.
RTS Packaging defined benefit plan
On September 8, 2023, the Company completed the acquisition of the remaining 65% ownership interest of the RTS Packaging joint venture, which included the assumption of the RTS Packaging Pension Plan (the “RTS Plan”). Since the formation of the original joint venture, the Company had recognized its 35% share of actuarial gains and losses related to the RTS Plan in “Accumulated other comprehensive loss.” Upon the acquisition of the remaining 65% interest in RTS Packaging, a pre-tax loss of $4,756 ($3,543 after tax) was reclassified out of “Accumulated other comprehensive loss” into earnings. The pre-tax loss is reflected in “Other (expenses)/ income, net” in the Company’s Consolidated Statements of Income for the year ended December 31, 2023.
Plan settlements, changes and amendments
On January 2, 2025, the RTS Plan was merged with the U.S. Active Plan. Accordingly, disclosures referring to the “U.S. Retirement Plans” or the “U.S. Active Plan” include the legacy RTS Plan.
The Company recognized net settlement losses totaling $42, $530, and $1,010 in 2025, 2024, and 2023, respectively, resulting primarily from payments made to certain participants in the Company’s non-union Canadian pension plan who elected a lump sum distribution option upon retirement. The net settlement losses in 2025 also reflect settlement gains related to lump sum distributions to participants for certain Eviosys plans as a result of plant closures. Settlements in 2023 also included payments associated with the termination of a pension plan in Taiwan. The curtailment gains recognized in 2025 relate primarily to the termination of certain Eviosys Plan participants as a result of plant closures.
The Company amended its U.S. Retiree Health and Life Insurance Plan in 2023 to expand the eligibility requirements for certain non-union hourly employees. The amendment resulted in an increase in both the accumulated postretirement benefit obligation and prior service cost component of accumulated other comprehensive loss of $11,637. The service cost is being amortized over the average life expectancy of the plan participants beginning in 2024.
Projected benefit payments
The following table sets forth the Company’s projected benefit payments for the next ten years:
YearRetirement PlansRetiree Health and Life Insurance Plans
2026$33,035 $1,341 
2027$31,416 $1,419 
2028$33,787 $1,483 
2029$33,314 $1,509 
2030$33,853 $1,387 
2031-2035$178,345 $8,723 
Assumptions
The following tables set forth the major actuarial assumptions used in determining the benefit obligation and net periodic benefit cost:
Weighted-average assumptions
used to determine benefit
obligations at December 31
U.S. Retirement PlansU.S. Retiree Health and Life Insurance PlansForeign Plans
Discount Rate
20255.28 %5.13 %5.02 %
20245.52 %5.32 %6.52 %
Rate of Compensation Increase
2025— %2.99 %2.46 %
2024— %3.02 %3.59 %
 
Weighted-average assumptions
used to determine net periodic benefit
cost for years ended December 31
U.S. Retirement PlansU.S. Retiree Health and Life Insurance PlansForeign Plans
Discount Rate
20255.52 %5.32 %6.52 %
20244.84 %4.68 %4.79 %
20235.01 %4.92 %4.97 %
Expected Long-term Rate of Return
20253.89 %4.64 %5.45 %
20243.08 %3.05 %4.36 %
20232.48 %2.45 %4.70 %
Rate of Compensation Increase
2025— %2.99 %2.46 %
2024— %3.03 %3.11 %
2023— %2.99 %3.29 %
The Company adjusts its discount rates at the end of each fiscal year based on yield curves of high-quality debt instruments over durations that match the expected benefit payouts of each plan. The expected long-term rate of return assumption is based on the Company’s current and expected future portfolio mix by asset class, and expected nominal returns of these asset classes using an economic “building block” approach.
Expectations for inflation and real interest rates are developed and various risk premiums are assigned to each asset class based primarily on historical performance. The assumed rate of compensation increase reflects historical experience and management’s expectations regarding future salary and incentive increases.
Medical trends
The U.S. Retiree Health and Life Insurance Plan makes up approximately 98% of the Retiree Health liability. Therefore, the following information relates to the U.S. plan only.
Healthcare Cost Trend RatePre-age 65Post-age 65
20256.20 %7.00 %
20246.17 %7.28 %
Ultimate Trend RatePre-age 65Post-age 65
20254.50 %4.50 %
20244.50 %4.50 %
Year at which the Rate Reaches
the Ultimate Trend Rate
Pre-age 65Post-age 65
202520362036
202420352035

Based on amendments to the U.S. plan approved in 1999, which became effective in 2003, cost increases borne by the Company are limited to the Urban CPI, as defined.
Retirement plan assets
The assets of the U.S., Eviosys, U.K., and Canadian defined benefit plans comprise approximately 92% of the total postretirement benefit plan assets. Therefore, the following disclosures relate only to the assets of these plans.
The following table sets forth the weighted-average asset allocations of the Company’s retirement plans at 2025 and 2024, by asset category.
Asset Category
  
U.S.EviosysU.K.Canada
Equity securities202534.3 %— %9.5 %31.5 %
202420.9 %— %21.0 %31.4 %
Debt securities202563.1 %79.9 %88.4 %68.5 %
202477.9 %85.1 %77.1 %68.6 %
Cash and short-term investments20252.6 %20.1 %2.1 %— %
20241.2 %14.9 %1.9 %— %
Total2025100.0 %100.0 %100.0 %100.0 %
2024100.0 %100.0 %100.0 %100.0 %
The Company employs a total-return investment approach whereby a mix of equities and fixed income investments are used to maximize the long-term return of plan assets for a desired level of risk. Alternative assets such as real estate funds, private equity funds and hedge funds may also be used to enhance expected long-term returns while improving portfolio diversification. Risk tolerance is established through consideration of plan liabilities, plan funded status and corporate financial condition. Investment risk is measured and monitored on an ongoing basis through periodic investment portfolio reviews and periodic asset/liability studies.
U.S. defined benefit plans
The Company has adopted investment guidelines for the Active Plan based on asset/liability studies. These guidelines established a dynamic derisking framework for shifting the allocation of assets to long-duration domestic fixed income from equity and other asset categories, as the relative funding ratio of the plan increased over time. The current target allocation (midpoint) for the Active Plan investment portfolio is: Equity Securities - 35% and Debt Securities – 65%.
United Kingdom defined benefit plan
The equity investments consist of direct ownership and funds and are diversified among U.K. and international stocks of small and large capitalization. The current target allocation (midpoint) for the investment portfolio is: Equity Securities – 10% and Debt Securities – 90%.
Canada defined benefit plan
The equity investments consist of direct ownership and funds and are diversified among Canadian and international stocks of primarily large capitalizations and short to intermediate duration corporate and government bonds. The current target allocation (midpoint) for the investment portfolio is 30% Equity Securities and 70% Debt Securities.
Eviosys defined benefit plans
The equity investments consist of direct ownership and funds and are diversified among international stocks of primarily large capitalizations and short to intermediate duration corporate and government bonds. The current target allocation (midpoint) for the investment portfolio is —% Equity Securities, 30% Cash and Short Term Investments and 70% Debt Securities.
Retiree health and life insurance plan assets
The following table sets forth the weighted-average asset allocations by asset category of the Company’s retiree health and life insurance plan.
Asset Category20252024
Equity securities—%—%
Debt securities100.0%100.0%
Cash—%—%
Total100.0%100.0%
Contributions
Based on current actuarial estimates, the Company anticipates that contributions to its defined benefit plans will be approximately $23,200 in 2026. No assurances can be made about funding requirements beyond 2026, however, as they will depend largely on actual investment returns and future actuarial assumptions, legislative actions, and changes to the Company’s benefit offerings.
Sonoco Retirement and Savings Plan
The Sonoco Retirement and Savings Plan (“Savings Plan”) is a defined contribution retirement plan provided for certain of the Company’s U.S. employees designed to meet the requirements of section 401(k) of the Internal Revenue Code. The Savings Plan allows participants to set aside a portion of their wages and salaries for retirement and encourages saving by matching a portion of their contributions with contributions from the Company. The Savings Plan provides for participant contributions of 1% to 100% of gross pay with the Company matching 100% of the first 6% of pretax and/or Roth compensation contributed by the participant. Participants are immediately fully vested in these matching contributions. The Company’s expenses related to the Savings Plan for 2025, 2024, and 2023 were approximately $33,300, $33,700 and $30,684, respectively.
Other plans
The Company also provides retirement and postretirement benefits to certain other non-U.S. employees through various Company-sponsored and local government sponsored defined contribution arrangements. For the most part, the liabilities related to these arrangements are funded in the period they arise. The Company’s expenses for these plans were not material for all years presented.
v3.25.4
Income taxes
12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Income taxes Income taxes
The provision for taxes on income for the years ended December 31 consists of the following:
202520242023
Pretax income
Domestic$529,172 $(35,733)$280,916 
Foreign235,929 99,219 208,111 
Total pretax income$765,101 $63,486 $489,027 
Current
Federal$59,956 $3,693 $54,319 
State10,732 1,916 11,282 
Foreign97,293 57,034 63,617 
Total current$167,981 $62,643 $129,218 
Deferred
Federal$30,415 $(34,828)$(3,307)
State14,220 (9,837)(1,646)
Foreign(29,030)(12,469)(4,535)
Total deferred$15,605 $(57,134)$(9,488)
Total taxes$183,586 $5,509 $119,730 
Deferred tax (liabilities)/assets are comprised of the following at December 31:
20252024
Property, plant and equipment$(235,929)$(266,278)
Intangibles(488,519)(545,330)
Leases(109,707)(76,225)
Outside basis in Metal Packaging (63,105)(68,649)
Other(192)— 
Gross deferred tax liabilities$(897,452)$(956,482)
Retiree health benefits$$245 
Foreign loss carryforwards110,055 79,314 
U.S. Federal loss and credit carryforwards31,980 34,082 
Capital loss carryforwards3,983 3,755 
U.S. State loss and credit carryforwards23,413 26,181 
Capitalized research and development costs67,894 103,043 
Net investment hedge50,524 — 
Employee benefits54,258 56,192 
Leases116,184 82,031 
Accrued liabilities and other assets44,023 71,370 
Gross deferred tax assets$502,318 $456,213 
Valuation allowance on deferred tax assets$(107,451)$(81,496)
Total deferred taxes, net1
$(502,585)$(581,765)
1 Total deferred taxes, net includes $(15,666) reclassified to discontinued operations on the Consolidated Balance Sheets at December 31, 2024. This includes a valuation allowance on deferred tax assets of $(4,628).
The Company has total federal net operating loss (“NOL”) carryforwards of approximately $31,556 remaining at December 31, 2025. These losses were acquired as part of an acquisition and annual usage is limited based on certain attributes existing at that time. The losses expire between 2029 and 2041. U.S. foreign tax credit carryforwards of approximately $25,601 exist at December 31, 2025, $22,474 of which expire in 2027, and $3,127 of which expire in 2035. Foreign subsidiary loss carryforwards of approximately $532,745 remain at December 31, 2025. Their use is limited to future taxable earnings of the respective foreign subsidiaries or filing groups. Approximately $309,722 of these loss carryforwards do not have an expiration date. Of the remaining foreign subsidiary loss carryforwards, approximately $193,878 expire within the next five years and approximately $29,145 expire between 2031 and 2045. Foreign subsidiary capital loss carryforwards of approximately $16,108 exist at December 31, 2025 and do not have an expiration date. Their use is limited to future capital gains of the respective foreign subsidiaries.
Approximately $9,242 in tax value of state loss carryforwards and $20,395 of state credit carryforwards remain at December 31, 2025. These state loss and credit carryforwards are limited based upon future taxable earnings of the respective entities or filing group and expire between 2026 and 2046. State loss and credit carryforwards are reflected at their “tax” value, as opposed to the amount of expected gross deduction due to the vastly different apportionment and statutory tax rates applicable to the various entities and states in which the Company files.
Statutory tax rate reconciliation
A reconciliation of the U.S. federal statutory tax rate to the actual provision for income taxes in the expanded format set forth by ASU 2023-09 for the year ended December 31, 2025 is as follows:
  
2025
U.S. Federal statutory tax rate$160,671 21.0 %
State and local income taxes, net of Federal income tax effect(a)
16,129 2.1 %
Foreign tax effects
  Luxembourg
   Valuation allowances10,826 1.4 %
   Other(5,572)(0.7)%
  Finland
   Nontaxable income(8,115)(1.1)%
   Other(479)(0.1)%
    Other foreign jurisdictions18,402 2.4 %
U.S. Federal tax effects
Effect of changes in tax laws or rates enacted in the current period— — %
Effect of cross-border tax laws
     Global intangible low-taxed income (GILTI), net of foreign tax credit (FTC)9,525 1.2 %
Tax on undistributed earnings of subsidiaries11,756 1.5 %
  Foreign branch inclusion10,479 1.4 %
     Other4,380 0.6 %
Tax credits(9,627)(1.3)%
Changes in valuation allowances34 — %
Nontaxable or nondeductible items
  Benefit for purchased credits(14,875)(1.9)%
     Other5,927 0.8 %
Changes in unrecognized tax benefits2,622 0.3 %
Other adjustments
     Disposition of business(29,994)(3.9)%
     Other1,497 0.2 %
Provision For Income Taxes$183,586 24.0 %

(a) State taxes in Tennessee, Illinois, California, Wisconsin and New Jersey make up the majority (greater than 50 percent) of the tax effect in this category.
A reconciliation of the U.S. federal statutory tax rate to the actual provision for income taxes for the years ended December 31, 2024 and 2023 is as follows:
  
20242023
U.S. Federal statutory tax rate$13,332 21.0 %$102,696 21.0 %
State income taxes, net of federal tax benefit(883)(1.4)%12,263 2.5 %
Valuation allowance7,763 12.2 %4,486 0.9 %
Tax examinations including change in reserve for uncertain tax positions(8,613)(13.6)%1,819 0.4 %
Adjustments to prior year deferred taxes(9,129)(14.4)%(2,489)(0.5)%
Foreign earnings taxed at other than U.S. rates12,271 19.3 %13,108 2.7 %
Divestiture of business(2,954)(4.7)%464 0.1 %
Effect of tax rate changes(1,552)(2.4)%387 0.1 %
Foreign withholding taxes5,344 8.4 %4,591 0.9 %
Tax credits(11,834)(18.6)%(18,848)(3.9)%
Global intangible low-taxed income (GILTI)(5,604)(8.8)%4,853 1.0 %
Foreign-derived intangible income(858)(1.4)%(1,106)(0.2)%
Foreign currency gain/(loss) on distributions of previously taxed income642 1.0 %(2,614)(0.5)%
IRC Subpart F Income916 1.4 %119 — %
Executive compensation limitation2,569 4.0 %3,767 0.8 %
Capitalized acquisition costs7,202 11.3 %104 — %
Other, net(3,103)(4.9)%(3,870)(0.8)%
Provision for income taxes$5,509 8.7 %$119,730 24.5 %

The “Change in unrecognized tax benefits” for 2025 and the change in “Tax examinations including change in reserve for uncertain tax positions” for 2024 and 2023 is shown net of associated deferred taxes and includes accrued interest. Included in the change are current year increases of approximately $1,732, $3,405 and $2,710 for 2025, 2024 and 2023, respectively. The change also includes adjustments for prior year items such as decreases related to lapses of statutes of limitations in international, federal and state jurisdictions as well as overall changes in facts and judgment. These adjustments changed the reserve by a total of approximately $(899), $(13,229) and $(891) in 2025, 2024 and 2023, respectively.
In many of the countries in which the Company operates, earnings are taxed at rates different than the U.S. federal tax rate. This difference is reflected in “Foreign tax effects” for 2025 and “Foreign earnings taxed at other than U.S. rates” for 2024 and 2023, along with other items, if any, that impacted taxes on foreign earnings in the periods presented.
The benefits included in “Adjustments to prior year deferred taxes” for 2024 and 2023 consist primarily of adjustments to deferred tax assets and liabilities arising from changes in estimates. The adjustment to deferred tax assets and liabilities in 2024 was driven largely by post-acquisition entity restructuring.
Of the $9,627 of tax credits for 2025, $3,008 relates to research and development tax credits. The GILTI tax, net of FTC in 2025 of $9,525 consists primarily of a prior year provision to return adjustment.
The benefit of $29,994 shown in “Disposition of business” is attributable to the sale of the U.S. ThermoSafe business and is due to a tax basis in the shares sold that is greater than the basis for accounting purposes.
The Company maintains its assertion that its undistributed foreign earnings prior to the Sonoco Metal Packaging EMEA acquisition, as well as current and future undistributed foreign earnings of its non-Sonoco Metal Packaging EMEA business, are indefinitely reinvested and, accordingly, has not recorded any deferred income tax liabilities that would be due if those earnings were repatriated. However, the Company does not assert that certain current and future earnings of its Sonoco Metal Packaging EMEA business are permanently reinvested. While the majority of the Company’s undistributed foreign earnings have already been taxed in the United States, a portion would be subject to foreign withholding and U.S. income taxes and credits if distributed. Computation of the deferred tax liability associated with unremitted earnings deemed to be indefinitely reinvested is not practicable at this time.
Income taxes paid
The following table sets forth income taxes paid, including payments for the acquisition of income tax credits, net of refunds, for the year ended December 31, 2025, disaggregated between foreign, domestic and state:
2025
Federal taxes paid$125,868 
State taxes paid30,926 
Foreign taxes paid108,107 
Total$264,901 
Income taxes paid, net of refunds, exceeded 5 percent of total income taxes paid, net of refunds, in the following jurisdictions:
2025
Foreign Taxes Paid
     Spain$20,109 
     Brazil$17,688 
Other$70,310 
Reserve for uncertain tax positions
The following table sets forth the reconciliation of the gross amounts of unrecognized tax benefits at the beginning and ending of the periods indicated: 
202520242023
Gross Unrecognized Tax Benefits at January 1$12,138 $21,677 $18,621 
Increases in prior years’ unrecognized tax benefits2,743 627 378 
Decreases in prior years’ unrecognized tax benefits(1,404)(1,915)(572)
Increases in current year unrecognized tax benefits688 4,325 4,395 
Decreases in unrecognized tax benefits from the lapse of statutes of limitations(235)(12,100)(1,094)
Settlements(748)(476)(51)
Gross Unrecognized Tax Benefits at December 31$13,182 $12,138 $21,677 
Of the unrecognized tax benefit balances at December 31, 2025 and December 31, 2024, $11,102 and $9,857, respectively, would have an impact on the effective tax rate if ultimately recognized.
Interest and/or penalties related to income taxes are reported as part of income tax expense. The Company had $2,817 and $1,667 accrued for interest related to uncertain tax positions at December 31, 2025 and December 31, 2024, respectively. Tax expense for the year ended December 31, 2025, includes net interest expense of $1,150, which is comprised of an interest benefit of $384 related to the adjustment of prior years’ items and interest expense of $1,534 on unrecognized tax benefits. The amounts listed above for accrued interest and interest expense do not reflect the benefit of a federal tax deduction which would be available if the interest were ultimately paid.
The Company and/or its subsidiaries file federal, state and local income tax returns in the United States and various foreign jurisdictions. With few exceptions, the Company is no longer subject to income tax examinations by tax authorities for years before 2019.
Although the Company’s estimate for the potential outcome for any uncertain tax issue is highly judgmental, management believes that any reasonably foreseeable outcomes related to these matters have been adequately provided for. However, future results may include favorable or unfavorable adjustments to estimated tax liabilities in the period the assessments are made or resolved or when statutes of limitation on potential assessments expire. Additionally, the jurisdictions in which earnings or deductions are realized may differ from current estimates. As a result, the effective tax rate may fluctuate significantly on a quarterly basis. The Company has operations in many countries outside of the United States and the taxes paid on those earnings are subject to varying rates. The Company is not dependent upon the favorable benefit of any one jurisdiction to an extent that loss of those benefits would have a material effect on the Company’s overall effective tax rate.
v3.25.4
Revenue recognition
12 Months Ended
Dec. 31, 2025
Revenue from Contract with Customer [Abstract]  
Revenue recognition Revenue recognition
The following tables set forth information about revenue disaggregated by primary geographic regions for the years ended December 31, 2025, 2024 and 2023. The tables also include a reconciliation of disaggregated revenue with reportable segments. The Company’s reportable segments are aligned by product nature as disclosed in Note 20.
Year Ended December 31, 2025Consumer PackagingIndustrial Paper PackagingAll OtherTotal
Primary geographical markets:
United States$1,864,861 $1,464,574 $285,486 $3,614,921 
EMEA2,789,400 361,878 56,160 3,207,438 
Canada18,539 85,875 — 104,414 
APAC100,482 148,012 1,065 249,559 
Other101,009 238,894 2,518 342,421 
Total$4,874,291 $2,299,233 $345,229 $7,518,753 
Year Ended December 31, 2024Consumer PackagingIndustrial Paper PackagingAll OtherTotal
Primary geographical markets:
United States$1,785,857 $1,431,232 $352,717 $3,569,806 
EMEA524,699 371,896 58,925 955,520 
Canada17,486 95,863 — 113,349 
APAC96,154 213,127 1,771 311,052 
Other107,656 237,370 10,612 355,638 
Total$2,531,852 $2,349,488 $424,025 $5,305,365 
Year Ended December 31, 2023Consumer PackagingIndustrial Paper PackagingAll OtherTotal
Primary geographical markets:
United States$1,817,268 $1,389,492 $494,112 $3,700,872 
EMEA431,189 389,261 64,936 885,386 
Canada16,076 100,095 — 116,171 
APAC94,136 233,446 1,812 329,394 
Other112,379 261,819 35,405 409,603 
Total$2,471,048 $2,374,113 $596,265 $5,441,426 

Contract assets represent goods produced without alternative use for which the Company is entitled to payment with margin prior to shipment. Upon shipment, the Company is entitled to bill the customer, and therefore amounts included in contract assets will be reduced with the recording of an account receivable as they represent an unconditional right to payment. Contract liabilities represent revenue deferred due to pricing mechanisms utilized by the Company in certain multi-year arrangements, volume rebates, and receipts of advanced payments. For multi-year arrangements with pricing mechanisms, the Company will generally defer revenue during the initial term of the arrangement, and will release the deferral over the back half of the contract term. Contract assets and liabilities are generally short in duration given the nature of products produced by the Company.
The following table sets forth information about contract assets and liabilities from contracts with customers. The balances of the contract assets and liabilities are located in “Other receivables” and “Accrued expenses and other payables”, respectively, in the Consolidated Balance Sheets.
December 31, 2025December 31, 2024
Contract Assets$77,978 $67,062 
Contract Liabilities$(58,784)$(60,024)
Significant changes in the contract assets and liabilities balances during the twelve months ended December 31, 2025 and 2024 were as follows:
December 31, 2025December 31, 2024
Contract Assets
Contract Liabilities
Contract Assets
Contract Liabilities
Beginning balance$67,062 $(60,024)$14,754 $(15,252)
Acquired/ sold as part of a business combination/ divestiture(53)(324)62,439 (47,478)
Revenue deferred or rebates accrued— (94,947)— (25,736)
Recognized as revenue— 1,183 — 2,341 
Rebates paid to customers— 95,328 — 26,101 
Increases due to rights to consideration for customer specific goods produced, but not billed during the period77,978 — 67,062 — 
Transferred to receivables from contract assets recognized at the beginning of the period and acquired as part of business combination(67,009)— (77,193)— 
Ending balance$77,978 $(58,784)$67,062 $(60,024)
v3.25.4
Commitments and contingencies
12 Months Ended
Dec. 31, 2025
Commitments and Contingencies Disclosure [Abstract]  
Commitments and contingencies Commitments and contingencies
In accordance with the requirements of ASC 450, “Contingencies,” the Company records accruals for estimated losses at the time information becomes available indicating that losses are probable and that the amounts are reasonably estimable. As is the case with other companies in similar industries, the Company faces exposure from actual or potential claims and legal proceedings from a variety of sources. Some of these exposures, as discussed below, have the potential to be material.
Environmental matters
The Company is subject to a variety of environmental and pollution control laws and regulations in all jurisdictions in which it operates.
Spartanburg
In connection with its acquisition of Tegrant in November 2011, the Company identified potential environmental contamination at a site in Spartanburg, South Carolina. At December 31, 2024, the Company’s accrual for environmental contingencies related to the Spartanburg site totaled $5,096 and was reflected in “Current liabilities of discontinued operations” on the Company’s Consolidated Balance Sheet at December 31, 2024 . The Spartanburg site and related environmental liabilities were part of the sale of TFP to Toppan, which was completed on April 1, 2025.
Other environmental matters
The Company has been named as a potentially responsible party at several other environmentally contaminated sites. All of the sites are also the responsibility of other parties. The potential remediation liabilities are shared with such other parties, and, in most cases, the Company’s share, if any, cannot be reasonably estimated at the current time. However, the Company does not believe that the resolution of these matters has a reasonable possibility of having a material adverse effect on the Company’s financial statements. At December 31, 2025 and 2024, the Company’s accrual for these other sites totaled $1,779 and $1,933, respectively, and are included in “Accrued expenses and other payables” on the Company’s Consolidated Balance Sheets.
Commitments
As of December 31, 2025, the Company had long-term obligations to purchase electricity and steam, which it uses in its production processes, as well as long-term purchase commitments for raw materials. These purchase commitments require the Company to make total payments of approximately $71,200, as follows: $23,700 in 2026; $24,500 in 2027; $23,000 in 2028; $0 in 2029, and a total of $0 from 2030 through 2034.
In addition,as of December 31, 2025, the Company has purchase commitments of approximately $93,900 to be paid in 2026 for the acquisition of tax credits that are expected to offset a portion of taxes payable currently recorded within “Accrued taxes” on the Company’s Consolidated Balance Sheets at December 31, 2025.
v3.25.4
Shareholders’ equity and earnings per share
12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
Shareholders' equity and earnings per share Shareholders’ equity and earnings per share
Earnings per share
The following table sets forth the computation of basic and diluted earnings/(loss) per share (in thousands, except per share data):
202520242023
Numerator:
Net income from continuing operations$591,038 $67,565 $379,644 
Net (income)/loss from continuing operations attributable to noncontrolling interests(375)180 (768)
Net income from continuing operations attributable to Sonoco590,663 67,745 378,876 
Net income attributable to Sonoco$1,003,011 $163,949 $474,959 
Denominator:
Weighted average common shares outstanding:
Basic99,124 98,637 98,294 
Dilutive effect of shared-based compensation447 653 596 
Diluted 99,571 99,290 98,890 
Per common share:
Basic earnings per common share:
Net income from continuing operations$5.96 $0.69 $3.85 
Net income attributable to Sonoco$10.12 $1.66 $4.83 
Diluted earnings per common share:
Net income from continuing operations$5.93 $0.68 $3.83 
Net income attributable to Sonoco$10.07 $1.65 $4.80 
Cash dividends$2.11 $2.07 $2.02 
No adjustments were made to “Net income attributable to Sonoco” in the computations of net income attributable to Sonoco per common share.
Anti-dilutive securities
Potentially dilutive securities are calculated in accordance with the treasury stock method, which assumes the proceeds from the exercise of all dilutive SARs are used to repurchase the Company’s common stock. Certain SARs are not dilutive because either the exercise price is greater than the average market price of the stock during the reporting period or assumed repurchases from proceeds from the exercise of the SARs were anti-dilutive.
The average number of shares that were not dilutive and therefore not included in the computation of diluted income per share was as follows for the years ended December 31, 2025, 2024 and 2023 (in thousands):
202520242023
Anti-dilutive stock appreciation rights513 408 352 
These SARs may become dilutive in future periods if the market price of the Company’s common stock appreciates.
Share repurchases
On April 20, 2021, the Board authorized the repurchase of the Company’s common stock in an aggregate amount of up to $350,000. No shares were purchased under this authorization during 2025 or 2024. A total of $137,972 remained available for share repurchases under this authorization as of December 31, 2025 and December 31, 2024.
The Company occasionally repurchases shares of its common stock to satisfy employee tax withholding obligations in association with the exercise of RSUs, PCSUs, and SARs. These repurchases, which are not part of a publicly announced plan or program, totaled 227,560 shares during 2025, 164,402 shares during 2024, and 175,665 shares during 2023, at a cost of $10,930, $9,246 and $10,617, respectively.
Noncontrolling interests
On April 1, 2025, the Company completed the sale of TFP which included the disposition of a noncontrolling interest position of $600, which is reflected in the Company’s total gain on the divestiture in “Net income from discontinued operations” in the Company’s Consolidated Statements of Income for the year ended December 31, 2025. See Note 4 for additional information.
On March 2, 2025, the Company completed the sale of its tube and core operations in Venezuela which included the disposition of a noncontrolling interest position of $310 which is reflected in the Company’s total loss on the divestiture. This loss is reported in “Gain/(Loss) on divestiture of business and other assets” in the Company’s Consolidated Statements of Income for the year ended December 31, 2025. See Note 4 for additional information.
On December 4, 2024, the Company completed the acquisition of Eviosys. The acquisition included operations in the Ivory Coast and Morocco, which are owned 85.2% and 99.34%, respectively, by the Company. The Company fully consolidates these operations and reflects the partner’s ownership in noncontrolling interests in its Consolidated Balance Sheets. During the twelve-month period ended December 31, 2025, the Company recorded measurement-period adjustments based on updated valuation information related to facts and circumstances existing as of the acquisition date that increased the previously reported fair value of noncontrolling interests by $2,346.
In November 2024, the Company completed the sale of two production facilities in China. In addition, a production facility that was less than 100% owned by the Company was divested as a part of the sale and the disposition of the noncontrolling interest of $2,043 is reflected in the Company’s total loss on the divestiture. This loss is reported in “Gain/(Loss) on divestiture of business and other assets” in the Company’s Consolidated Statements of Income for the year ended December 31, 2024. See Note 4 for additional information.
v3.25.4
Segment reporting
12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
Segment reporting Segment reporting
The Company operates under two reportable segments, Consumer Packaging and Industrial Paper Packaging, with all remaining businesses reported as All Other.
The products produced and sold within the Consumer Packaging segment are generally used to package a variety of consumer products and consist primarily of round and shaped rigid paper, steel and plastic containers; and metal and peelable membrane ends, closures, and components.
The primary products produced and sold within the Industrial Paper Packaging segment include paperboard tubes, cones, and cores; paper-based protective packaging; and uncoated recycled paperboard. Effective January 1, 2024, the Company began conducting its recycling operations, part of the Industrial Paper Packaging segment, as a procurement function. As a result, no recycling net sales were recorded and the margin from the Company’s recycling operations reduced “Cost of sales” for the years ended December 31, 2025 and 2024 as these activities are no longer a part of ongoing major operations.
The primary products produced within the All Other group of businesses consist of a variety of packaging materials, including plastic, paper, foam, and various other specialty materials. Following the sale of ThermoSafe in November 2025, the Company’s industrial and specialty plastics business is the only remaining business in the All Other category. Effective January 1, 2026, this business will be reported within the Industrial Paper Packaging segment and the use of the All Other category will be discontinued.
The Company’s chief operating decision maker (“CODM”) is the chief executive officer. The CODM assesses segment performance and allocates resources to each segment by using each segment’s operating profit. The chief operating decision maker uses operating profit for each segment in the annual budgeting and forecasting process as well as reviewing segment operating profit quarterly when making decisions about allocating capital and operating resources to segments. Disaggregated assets by segment are not disclosed since segment assets are not regularly provided to the CODM.
Segment operating profit viewed by the Company to evaluate segment performance does not include the following: restructuring/asset impairment charges; amortization of acquisition intangibles; gains/losses from the sale of businesses or other assets; acquisition, integration and divestiture-related costs; changes in LIFO inventory reserves; derivative gains/losses; or certain other items, if any, the exclusion of which the Company’s management believes improves the comparability and analysis of the ongoing operating performance of the business. All other general corporate expenses have been allocated as operating costs to each of the Company’s reportable segments and the All Other group of businesses, except for costs related to discontinued operations.
Segment financial information
The following table sets forth financial information about each of the Company’s reportable segments:
Year Ended December 31, 2025Consumer PackagingIndustrial Paper PackagingTotal Reportable Segments
Sales from external customers$4,874,291 $2,299,233 $7,173,524 
Intersegment sales(1)
22,547 121,153 143,700 
$4,896,838 $2,420,386 $7,317,224 
Reconciliation of sales
Other sales(2)
349,888 
Elimination of intersegment sales(148,359)
Total consolidated sales$7,518,753 
Less:(3)
Cost of sales(4)
$(3,950,750)$(1,726,225)
Other segment items(5)
(319,168)(381,707)
Segment operating profit$626,920 $312,454 $939,374 
Other segment disclosures:
Equity in earnings of affiliates, net of tax$226 $9,297 
Depreciation and amortization(6)
$209,618 $118,889 
Year Ended December 31, 2024Consumer PackagingIndustrial Paper PackagingTotal Reportable Segments
Sales from external customers$2,531,852 $2,349,488 $4,881,340 
Intersegment sales(1)
8,022 111,682 119,704 
$2,539,874 $2,461,170 $5,001,044 
Reconciliation of sales
Other sales(2)
431,107 
Elimination of intersegment sales(126,786)
Total consolidated sales$5,305,365 
Less:(3)
Cost of sales(4)
$(2,041,078)$(1,818,324)
Other segment items(5)
(203,964)(371,192)
Segment operating profit$294,832 $271,654 $566,486 
Other segment disclosures:
Equity in earnings of affiliates, net of tax$365 $9,223 
Depreciation and amortization(6)
$109,355 $116,149 


Year Ended December 31, 2023Consumer PackagingIndustrial Paper PackagingTotal Reportable Segments
Sales from external customers$2,471,048 $2,374,113 $4,845,161 
Intersegment sales(1)
5,171 101,822 106,993 
$2,476,219 $2,475,935 $4,952,154 
Reconciliation of sales
Other sales(2)
604,442 
Elimination of intersegment sales(115,170)
Total consolidated sales$5,441,426 
Less:(3)
Cost of sales(4)
$(1,999,514)$(1,809,803)
Other segment items(5)
(190,943)(348,215)
Segment operating profit$285,762 $317,917 $603,679 
Other segment disclosures:
Equity in earnings of affiliates, net of tax$564 $9,783 
Depreciation and amortization(6)
$95,340 $104,723 
(1)
Intersegment sales are recorded at a market-related transfer price.
(2)
Sales from businesses below the quantitative threshold are attributable to the group of businesses within All Other.
(3)
The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(4)
Cost of sales of reportable segments excludes certain costs, primarily changes in LIFO inventory reserves, net gains or losses from derivatives, and acquisition, integration and divestiture-related costs.
(5)
Other segment items consists of:
Consumer Packaging: Labor and benefits, consulting and professional services, travel, communication, facilities and supplies.
Industrial Paper Packaging: Labor and benefits, consulting and professional services, travel, communication, facilities and supplies.
(6)
Represents significant segment expenses that are regularly provided to the CODM and are included in cost of sales and other segment items within segment operating profit.
Reconciliation of segment operating profit to income from continuing operations before income taxes:202520242023
Segment operating profit$939,374 $566,486 $603,679 
Other operating profits(1)
50,813 53,278 85,148 
Unallocated amounts:
Restructuring/Asset impairment charges, net
(66,215)(65,370)(47,909)
Amortization of acquisition intangibles(182,431)(78,595)(67,323)
Gain/(Loss) on divestiture of business371,717 (23,452)78,929 
Acquisition, integration and divestiture-related costs(54,158)(91,600)(24,624)
Changes in LIFO inventory reserves(58)6,263 11,817 
Derivative (losses)/gains(1,730)7,225 1,912 
Other corporate costs, net(2)
(35,242)(46,675)(42,254)
Other operating (charges)/income, net(3)
(4,335)(982)(10,326)
Other (expense)/income, net(4)
(27,481)(104,200)39,657 
Non-operating pension costs(12,215)(13,842)(14,312)
Interest expense(233,485)(172,620)(135,393)
Interest income20,547 27,570 10,026 
Income from continuing operations before income taxes$765,101 $63,486 $489,027 

(1)
Operating profit from segments below the quantitative threshold are attributable to the group of businesses within All Other.
(2)
Other corporate costs represent recurring operating expenses previously allocated to TFP that will remain with Sonoco subsequent to the divestiture, net of income earned under a transition services agreement with Toppan.
(3)
Primarily consists of highly inflationary accounting in Turkey and other miscellaneous charges in 2025, 2024, and 2023.
(4)
In 2025, these expenses relate to charges from third-party financial institutions related to the Company’s centralized treasury program under which the Company sells certain trade accounts receivable in order to accelerate its cash collection cycle, primarily within the Consumer Packaging segment. In 2024, the expense primarily relates to a net loss on foreign currency remeasurement, partially offset by a gain from the fair value remeasurement of an equity investment.
Reconciliation of other segment disclosures to consolidated totals:202520242023
Equity in earnings of affiliates, net of tax
Consumer Packaging$226 $365 $564 
Industrial Paper Packaging9,297 9,223 9,783 
Reportable Segment Total9,523 9,588 10,347 
Adjustments— — — 
Consolidated Total$9,523 $9,588 $10,347 
Depreciation and amortization
Consumer Packaging$209,618 $109,355 $95,340 
Industrial Paper Packaging118,889 116,149 104,723 
Reportable Segment Total328,507 225,504 200,063 
Other(1)
191,160 90,557 81,966 
Consolidated Total$519,667 $316,061 $282,029 
(1)
Other represents depreciation and amortization expense for the All Other group of businesses and total amortization of acquisition intangibles for Sonoco, excluding discontinued operations.
Geographic regions
Sales to unaffiliated customers and long-lived assets by geographic region are as follows:
202520242023
Sales to Unaffiliated Customers
United States$3,614,921 $3,569,806 $3,700,872 
EMEA3,207,438 955,520 885,386 
Canada104,414 113,349 116,171 
APAC249,559 311,052 329,394 
All other342,421 355,638 409,603 
Total$7,518,753 $5,305,365 $5,441,426 
Long-lived Assets
United States$2,462,090 $2,695,885 $2,779,178 
EMEA4,893,882 4,690,098 617,949 
Canada27,214 35,750 39,842 
APAC180,882 176,547 157,235 
All other478,462 300,623 149,530 
Total$8,042,530 $7,898,903 $3,743,734 
Sales are attributed to countries/regions based upon the plant location from which products are shipped. Long-lived assets are comprised of property, plant and equipment, goodwill, other intangible assets, and investments in affiliates (see Notes 1, 7 and 9).
v3.25.4
Accumulated other comprehensive loss
12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
Accumulated other comprehensive loss Accumulated other comprehensive loss
The following table summarizes the components of accumulated other comprehensive loss and the changes in accumulated other comprehensive loss, net of tax as applicable, for the years ended December 31, 2025 and 2024:
Foreign
Currency
Items
Defined
Benefit
Pension Items
Gains and Losses on Cash Flow Hedges
Accumulated
Other
Comprehensive
Loss
Balance at December 31, 2023
$(267,578)$(99,627)$943 $(366,262)
Other comprehensive (loss)/income before reclassifications(146,856)4,636 (3,213)(145,433)
Amounts reclassified from accumulated other comprehensive loss to net income3,503 4,378 1,080 8,961 
Other comprehensive (loss)/income(143,353)9,014 (2,133)(136,472)
Balance at December 31, 2024
$(410,931)$(90,613)$(1,190)$(502,734)
Other comprehensive income before reclassifications484,608 1,159 3,486 489,253 
Amounts reclassified from accumulated other comprehensive loss to net income50,550 1,496 (1,361)50,685 
Other comprehensive income535,158 2,655 2,125 539,938 
Balance at December 31, 2025
$124,227 $(87,958)$935 $37,204 



The following table summarizes the amounts reclassified from accumulated other comprehensive loss and the affected line items in the consolidated statements of net income for the years ended December 31, 2025 and 2024:
Amount Reclassified from Accumulated Other Comprehensive Income/(Loss)
Details about Accumulated Other
Comprehensive
Income/(Loss) Components
Year Ended December 31, 2025Year Ended December 31, 2024Affected Line Item in the Consolidated Statements of Net Income
Foreign currency items (see Note 4)
Currency translation adjustment (“CTA”) loss on TFP divestiture
$(47,955)$— Net income from discontinued operations
CTA loss on Venezuela divestiture(3,792)— Gain/(Loss) on divestiture of business and other assets
CTA gain on ThermoSafe divestiture1,197 — Gain/(Loss) on divestiture of business and other assets
CTA loss on Protexic and China divestitures— (3,503)Gain/(Loss) on divestiture of business and other assets
(50,550)(3,503)Net income
Defined benefit pension items (see Note 15)
Effect of settlement loss(42)(530)Non-operating pension costs
Effect of curtailment gain263 — Non-operating pension costs
Amortization of defined benefit pension items(4,009)(4,822)Non-operating pension costs
(3,788)(5,352)Income from continuing operations before income taxes
Income tax impact2,292 974 Provision for income taxes
(1,496)(4,378)Net income
Gains/(losses) on cash flow hedges (see Note 12)
Foreign exchange contracts3,811 (1,174)Net Sales
Foreign exchange contracts(2,557)(253)Cost of sales
Commodity contracts447 (28)Cost of sales
1,701 (1,455)Income from continuing operations before income taxes
Income tax impact(340)375 Provision for income taxes
1,361 (1,080)Net income
Amounts reclassified to net income from accumulated other comprehensive income/(loss)$(50,685)$(8,961)Net income

The following table summarizes the tax expense/(benefit) for the components of other comprehensive income/(loss):
For the year ended December 31, 2025
For the year ended December 31, 2024
Before Tax AmountTaxAfter Tax AmountBefore Tax AmountTaxAfter Tax Amount
Foreign currency items:
Other comprehensive income/(loss) before reclassifications$428,732 $55,876 $484,608 $(140,210)$(6,646)$(146,856)
Amounts reclassified from accumulated other comprehensive income/(loss) to net income50,550 — 50,550 3,503 — 3,503 
Net other comprehensive income/(loss) from foreign currency items479,282 55,876 535,158 (136,707)(6,646)(143,353)
Defined benefit pension items:
Other comprehensive income before reclassifications3,784 (2,625)1,159 2,395 2,241 4,636 
Amounts reclassified from accumulated other comprehensive income/(loss) to net income3,788 (2,292)1,496 5,352 (974)4,378 
Net other comprehensive income from defined benefit pension items7,572 (4,917)2,655 7,747 1,267 9,014 
Cash flow hedges:
Other comprehensive income/(loss) before reclassifications4,357 (871)3,486 (4,329)1,116 (3,213)
Amounts reclassified from accumulated other comprehensive (loss)/income to net income
(1,701)340 (1,361)1,455 (375)1,080 
Net other comprehensive income/(loss) from cash flow hedges2,656 (531)2,125 (2,874)741 (2,133)
Other comprehensive income/(loss)$489,510 $50,428 $539,938 $(131,834)$(4,638)$(136,472)
v3.25.4
Schedule II - Valuation and Qualifying Accounts
12 Months Ended
Dec. 31, 2025
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
Schedule of valuation and qualifying accounts disclosure
Column AColumn BColumn C - Additions Column D Column E
Description
Balance at
Beginning
of Year
Charged to
Costs and
Expenses
 
Charged to
Other
 Deductions 
Balance
at End
of Year
2025
Allowance for Doubtful Accounts$10,989 $1,783   $1,124 1$1,384 2$12,512 
LIFO Reserve33,265 58 3— — 33,323 
Valuation Allowance on Deferred Tax Assets76,868 36,862   (6,279)4— 5107,451 
2024
Allowance for Doubtful Accounts$18,868 $3,457   $(199)1$11,137 2$10,989 
LIFO Reserve39,528 (6,263)3— — 33,265 
Valuation Allowance on Deferred Tax Assets66,266 7,921   2,681 4— 576,868 
2023
Allowance for Doubtful Accounts$14,280 $6,479   $160 1$2,051 2$18,868 
LIFO Reserve51,342 (11,814)3— — 39,528 
Valuation Allowance on Deferred Tax Assets79,427 4,432   (17,593)4— 566,266 
1    Includes translation adjustments and other insignificant adjustments.
2    Includes amounts written off.
3    Includes adjustments based on pricing and inventory levels.
4    Includes translation adjustments and increases to deferred tax assets which were previously fully reserved.
5    Includes utilization of capital loss carryforwards, net operating loss carryforwards and other deferred tax assets.
All other schedules not included have been omitted because they are not required, are not applicable or the required information is given in the financial statements or notes thereto.
v3.25.4
Insider Trading Arrangements
3 Months Ended
Dec. 31, 2025
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.25.4
Insider Trading Policies and Procedures
12 Months Ended
Dec. 31, 2025
Insider Trading Policies and Procedures [Line Items]  
Insider Trading Policies and Procedures Adopted true
v3.25.4
Cybersecurity Risk Management and Strategy Disclosure
12 Months Ended
Dec. 31, 2025
Cybersecurity Risk Management, Strategy, and Governance [Line Items]  
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
The Company’s approach to risk management is designed to identify, assess, prioritize, and manage significant risk exposures that could affect the Company’s ability to execute its corporate strategy and fulfill its business objectives. The Company manages enterprise risk through its Risk Management Committee (“RMC”) chaired by the Company’s Vice President of Compliance, Risk and Audit with direct oversight from the Company’s General Counsel. The RMC, which is made up of senior leadership across a variety of business functions, defines the Company’s enterprise risk framework based upon analysis of industry and peer benchmarking as well as company-specific data analysis.
As a component of the Company’s enterprise risk management program, the Company’s cybersecurity risk management program outlines the Company’s cybersecurity risk management practices and capabilities, including the division of responsibilities for reviewing the Company’s cybersecurity risk exposure and risk tolerance, tracking emerging information risks, and ensuring proper escalation of certain key risks for periodic review by the Board and its committees. Cybersecurity risk is evaluated within the population of all enterprise risks in the framework and is included in assessments overseen by the RMC that identify the risks of highest priority to the Company. For these highest priority risks, including cybersecurity risks, the RMC designates risk owners, sets common reporting processes, and monitors risk mitigation and treatment strategies to support business continuity.
The Company’s cybersecurity risk management program leverages the National Institute of Standards and Technology (“NIST”) Cybersecurity Framework for identifying, assessing, and managing material risks from cybersecurity threats. This approach combines prevention and detection techniques, informed by internal and external sources, to identify and analyze potential threat activities. When a threat is identified, a cyber incident response plan outlines the Company’s procedures for containing, remediating, and recovering from the cybersecurity incident. Cybersecurity tenets are also incorporated into the Company’s technology policies.
The Company’s cybersecurity risk management program focuses on vulnerability management, access management, and user awareness training. Among other things, the Company implements scheduled patching and system updates, proactively scans for vulnerabilities, and engages qualified third-party experts to assess the Company’s IT infrastructure and identify vulnerabilities and opportunities for continued focus and improvement. When vulnerabilities are identified, the Company’s IT management team receives reports that assess each vulnerability and track progress in remediating that vulnerability. The IT management team also collaborates with supply chain management and the Company’s third party risk management program to onboard and monitor key third-party service providers to address the potential risk of cybersecurity threats through the use of such third parties. Annual cybersecurity training is mandatory for all users with access to the Company’s IT systems, and the Company conducts targeted monthly tests to promote phishing awareness. In addition to these prevention methods, the Company seeks to detect potential threats through external intelligence and monitoring solutions. External commercial or governmental agencies are also engaged to assess potential threat activity relevant to the Company where appropriate. The Company also monitors server and endpoint devices across the organization to detect signs of a cyberattack.
The Company has implemented and maintains an information security incident response plan (“IR Plan”), which includes processes to assess, escalate, contain, investigate, and remediate cybersecurity incidents. Upon notification of a potential cybersecurity threat, management defines the threat based on its nature as an information security event, alert, incident, or breach, and all cybersecurity incidents are categorized by level of severity based on the impact of the incident to the Company’s operations. A technical incident response team is responsible for technical response activities, including information gathering and forensic analysis, containment, and remediation efforts. The Company’s Crisis
Management Team drives the Company’s enterprise-level crisis response process, leads decisions around response strategies, coordinates resources required to execute such strategies, and oversees all cybersecurity incidents categorized as Critical and High.
Although the Company did not experience a material cybersecurity incident during the year ended December 31, 2025, the scope and impact of any future incident cannot be predicted. See “Item 1A. Risk Factors – Risks Related to Information Technology and Cybersecurity” for more information on the Company’s cybersecurity-related risks.
Cybersecurity Risk Management Processes Integrated [Flag] true
Cybersecurity Risk Management Processes Integrated [Text Block] Cybersecurity risk is evaluated within the population of all enterprise risks in the framework and is included in assessments overseen by the RMC that identify the risks of highest priority to the Company. For these highest priority risks, including cybersecurity risks, the RMC designates risk owners, sets common reporting processes, and monitors risk mitigation and treatment strategies to support business continuity.
The Company’s cybersecurity risk management program leverages the National Institute of Standards and Technology (“NIST”) Cybersecurity Framework for identifying, assessing, and managing material risks from cybersecurity threats. This approach combines prevention and detection techniques, informed by internal and external sources, to identify and analyze potential threat activities. When a threat is identified, a cyber incident response plan outlines the Company’s procedures for containing, remediating, and recovering from the cybersecurity incident. Cybersecurity tenets are also incorporated into the Company’s technology policies.
The Company’s cybersecurity risk management program focuses on vulnerability management, access management, and user awareness training. Among other things, the Company implements scheduled patching and system updates, proactively scans for vulnerabilities, and engages qualified third-party experts to assess the Company’s IT infrastructure and identify vulnerabilities and opportunities for continued focus and improvement. When vulnerabilities are identified, the Company’s IT management team receives reports that assess each vulnerability and track progress in remediating that vulnerability. The IT management team also collaborates with supply chain management and the Company’s third party risk management program to onboard and monitor key third-party service providers to address the potential risk of cybersecurity threats through the use of such third parties. Annual cybersecurity training is mandatory for all users with access to the Company’s IT systems, and the Company conducts targeted monthly tests to promote phishing awareness. In addition to these prevention methods, the Company seeks to detect potential threats through external intelligence and monitoring solutions. External commercial or governmental agencies are also engaged to assess potential threat activity relevant to the Company where appropriate. The Company also monitors server and endpoint devices across the organization to detect signs of a cyberattack.
The Company has implemented and maintains an information security incident response plan (“IR Plan”), which includes processes to assess, escalate, contain, investigate, and remediate cybersecurity incidents. Upon notification of a potential cybersecurity threat, management defines the threat based on its nature as an information security event, alert, incident, or breach, and all cybersecurity incidents are categorized by level of severity based on the impact of the incident to the Company’s operations. A technical incident response team is responsible for technical response activities, including information gathering and forensic analysis, containment, and remediation efforts. The Company’s Crisis
Management Team drives the Company’s enterprise-level crisis response process, leads decisions around response strategies, coordinates resources required to execute such strategies, and oversees all cybersecurity incidents categorized as Critical and High.
Cybersecurity Risk Management Third Party Engaged [Flag] true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] false
Cybersecurity Risk Board of Directors Oversight [Text Block]
As part of its broader oversight activities, the Board oversees risks from information security threats and other risks identified by the RMC, both directly and by way of delegation to the Audit Committee. As reflected in its charter, the Audit Committee oversees and specifically discusses the guidelines and policies by which the Company assesses and manages its cybersecurity risk exposures, as well as the steps management has taken to monitor and control such exposures. The Audit Committee also oversees the Company’s internal control over financial reporting, including with respect to financial reporting-related information systems. In addition to any communications of specifically identified cybersecurity events, the Audit Committee receives and discusses quarterly updates on cybersecurity activities, including review of annual external assessment results, training compliance and discussion of cybersecurity risks and resolutions, and is responsible for elevating significant matters to the full Board as events arise. The Board receives an annual update and provides feedback on the Company’s cybersecurity governance processes, risk management plan, and any significant activities related thereto, and also reviews risk management practices in the course of its review of the Company’s corporate strategy, business plans, Board committee reports, and other presentations. In addition to the ordinary-course Board and Audit Committee reporting and oversight described above, the Company also maintains disclosure controls and procedures designed for prompt reporting to the Board and timely public disclosure, as appropriate, of material events covered by our risk management framework, including information security risks.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] The Company’s day-to-day management of cybersecurity risks is led by the Chief Information Security Officer (“CISO”) with direct oversight from the Chief Information Officer (“CIO”)
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]
The Company’s day-to-day management of cybersecurity risks is led by the Chief Information Security Officer (“CISO”) with direct oversight from the Chief Information Officer (“CIO”). The Company’s IR Plan includes a defined escalation matrix for critical or high severity information security events involving notifications to the CISO and CIO, who further escalate critical or high severity events to the Company’s Crisis Management Team, which consists of senior management from IT, including the CIO and CISO, Human Resources, Risk and Internal Audit, Marketing and Communications, Legal, and Finance. The Crisis Management Team further elevates sufficiently critical and high severity events to the Company’s Cyber Incident Review Committee (“CIRC”), which consists of the CIO, Chief Financial Officer, Chief Accounting Officer, VP of Investor Relations, VP of Compliance, Risk and Audit, and General Counsel, or their delegates. Additional senior management from relevant business units are added to the CIRC as needed based on the nature of identified cybersecurity incidents. The CIRC preliminarily evaluates whether an incident is material and provides a proposal to the CEO and CFO, who work in consultation with the committee to make a final determination of materiality. Such determination is communicated to the Audit Committee of the Board (the “Audit Committee”).
The Company’s Crisis Management Team has relevant expertise and experience to assess and remediate cyber threats. The CIO has over 18 years of experience in IT and security, and the CISO has over 30 years of IT experience and over 12 years of information security experience.
As part of its broader oversight activities, the Board oversees risks from information security threats and other risks identified by the RMC, both directly and by way of delegation to the Audit Committee. As reflected in its charter, the Audit Committee oversees and specifically discusses the guidelines and policies by which the Company assesses and manages its cybersecurity risk exposures, as well as the steps management has taken to monitor and control such exposures. The Audit Committee also oversees the Company’s internal control over financial reporting, including with respect to financial reporting-related information systems. In addition to any communications of specifically identified cybersecurity events, the Audit Committee receives and discusses quarterly updates on cybersecurity activities, including review of annual external assessment results, training compliance and discussion of cybersecurity risks and resolutions, and is responsible for elevating significant matters to the full Board as events arise. The Board receives an annual update and provides feedback on the Company’s cybersecurity governance processes, risk management plan, and any significant activities related thereto, and also reviews risk management practices in the course of its review of the Company’s corporate strategy, business plans, Board committee reports, and other presentations.
Cybersecurity Risk Role of Management [Text Block]
The Company’s day-to-day management of cybersecurity risks is led by the Chief Information Security Officer (“CISO”) with direct oversight from the Chief Information Officer (“CIO”). The Company’s IR Plan includes a defined escalation matrix for critical or high severity information security events involving notifications to the CISO and CIO, who further escalate critical or high severity events to the Company’s Crisis Management Team, which consists of senior management from IT, including the CIO and CISO, Human Resources, Risk and Internal Audit, Marketing and Communications, Legal, and Finance. The Crisis Management Team further elevates sufficiently critical and high severity events to the Company’s Cyber Incident Review Committee (“CIRC”), which consists of the CIO, Chief Financial Officer, Chief Accounting Officer, VP of Investor Relations, VP of Compliance, Risk and Audit, and General Counsel, or their delegates. Additional senior management from relevant business units are added to the CIRC as needed based on the nature of identified cybersecurity incidents. The CIRC preliminarily evaluates whether an incident is material and provides a proposal to the CEO and CFO, who work in consultation with the committee to make a final determination of materiality. Such determination is communicated to the Audit Committee of the Board (the “Audit Committee”).
The Company’s Crisis Management Team has relevant expertise and experience to assess and remediate cyber threats. The CIO has over 18 years of experience in IT and security, and the CISO has over 30 years of IT experience and over 12 years of information security experience.
As part of its broader oversight activities, the Board oversees risks from information security threats and other risks identified by the RMC, both directly and by way of delegation to the Audit Committee. As reflected in its charter, the Audit Committee oversees and specifically discusses the guidelines and policies by which the Company assesses and manages its cybersecurity risk exposures, as well as the steps management has taken to monitor and control such exposures. The Audit Committee also oversees the Company’s internal control over financial reporting, including with respect to financial reporting-related information systems. In addition to any communications of specifically identified cybersecurity events, the Audit Committee receives and discusses quarterly updates on cybersecurity activities, including review of annual external assessment results, training compliance and discussion of cybersecurity risks and resolutions, and is responsible for elevating significant matters to the full Board as events arise. The Board receives an annual update and provides feedback on the Company’s cybersecurity governance processes, risk management plan, and any significant activities related thereto, and also reviews risk management practices in the course of its review of the Company’s corporate strategy, business plans, Board committee reports, and other presentations. In addition to the ordinary-course Board and Audit Committee reporting and oversight described above, the Company also maintains disclosure controls and procedures designed for prompt reporting to the Board and timely public disclosure, as appropriate, of material events covered by our risk management framework, including information security risks.
Cybersecurity Risk Management Positions or Committees Responsible [Flag] true
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]
The Company’s day-to-day management of cybersecurity risks is led by the Chief Information Security Officer (“CISO”) with direct oversight from the Chief Information Officer (“CIO”). The Company’s IR Plan includes a defined escalation matrix for critical or high severity information security events involving notifications to the CISO and CIO, who further escalate critical or high severity events to the Company’s Crisis Management Team, which consists of senior management from IT, including the CIO and CISO, Human Resources, Risk and Internal Audit, Marketing and Communications, Legal, and Finance. The Crisis Management Team further elevates sufficiently critical and high severity events to the Company’s Cyber Incident Review Committee (“CIRC”), which consists of the CIO, Chief Financial Officer, Chief Accounting Officer, VP of Investor Relations, VP of Compliance, Risk and Audit, and General Counsel, or their delegates. Additional senior management from relevant business units are added to the CIRC as needed based on the nature of identified cybersecurity incidents. The CIRC preliminarily evaluates whether an incident is material and provides a proposal to the CEO and CFO, who work in consultation with the committee to make a final determination of materiality. Such determination is communicated to the Audit Committee of the Board (the “Audit Committee”).
The Company’s Crisis Management Team has relevant expertise and experience to assess and remediate cyber threats. The CIO has over 18 years of experience in IT and security, and the CISO has over 30 years of IT experience and over 12 years of information security experience.
As part of its broader oversight activities, the Board oversees risks from information security threats and other risks identified by the RMC, both directly and by way of delegation to the Audit Committee. As reflected in its charter, the Audit Committee oversees and specifically discusses the guidelines and policies by which the Company assesses and manages its cybersecurity risk exposures, as well as the steps management has taken to monitor and control such exposures. The Audit Committee also oversees the Company’s internal control over financial reporting, including with respect to financial reporting-related information systems. In addition to any communications of specifically identified cybersecurity events, the Audit Committee receives and discusses quarterly updates on cybersecurity activities, including review of annual external assessment results, training compliance and discussion of cybersecurity risks and resolutions, and is responsible for elevating significant matters to the full Board as events arise.
Cybersecurity Risk Management Expertise of Management Responsible [Text Block] The Company’s Crisis Management Team has relevant expertise and experience to assess and remediate cyber threats. The CIO has over 18 years of experience in IT and security, and the CISO has over 30 years of IT experience and over 12 years of information security experience
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]
The Company’s day-to-day management of cybersecurity risks is led by the Chief Information Security Officer (“CISO”) with direct oversight from the Chief Information Officer (“CIO”). The Company’s IR Plan includes a defined escalation matrix for critical or high severity information security events involving notifications to the CISO and CIO, who further escalate critical or high severity events to the Company’s Crisis Management Team, which consists of senior management from IT, including the CIO and CISO, Human Resources, Risk and Internal Audit, Marketing and Communications, Legal, and Finance. The Crisis Management Team further elevates sufficiently critical and high severity events to the Company’s Cyber Incident Review Committee (“CIRC”), which consists of the CIO, Chief Financial Officer, Chief Accounting Officer, VP of Investor Relations, VP of Compliance, Risk and Audit, and General Counsel, or their delegates. Additional senior management from relevant business units are added to the CIRC as needed based on the nature of identified cybersecurity incidents. The CIRC preliminarily evaluates whether an incident is material and provides a proposal to the CEO and CFO, who work in consultation with the committee to make a final determination of materiality. Such determination is communicated to the Audit Committee of the Board (the “Audit Committee”).
The Company’s Crisis Management Team has relevant expertise and experience to assess and remediate cyber threats. The CIO has over 18 years of experience in IT and security, and the CISO has over 30 years of IT experience and over 12 years of information security experience.
As part of its broader oversight activities, the Board oversees risks from information security threats and other risks identified by the RMC, both directly and by way of delegation to the Audit Committee. As reflected in its charter, the Audit Committee oversees and specifically discusses the guidelines and policies by which the Company assesses and manages its cybersecurity risk exposures, as well as the steps management has taken to monitor and control such exposures. The Audit Committee also oversees the Company’s internal control over financial reporting, including with respect to financial reporting-related information systems. In addition to any communications of specifically identified cybersecurity events, the Audit Committee receives and discusses quarterly updates on cybersecurity activities, including review of annual external assessment results, training compliance and discussion of cybersecurity risks and resolutions, and is responsible for elevating significant matters to the full Board as events arise. The Board receives an annual update and provides feedback on the Company’s cybersecurity governance processes, risk management plan, and any significant activities related thereto, and also reviews risk management practices in the course of its review of the Company’s corporate strategy, business plans, Board committee reports, and other presentations. In addition to the ordinary-course Board and Audit Committee reporting and oversight described above, the Company also maintains disclosure controls and procedures designed for prompt reporting to the Board and timely public disclosure, as appropriate, of material events covered by our risk management framework, including information security risks.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] true
v3.25.4
Summary of significant accounting policies (Policies)
12 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
Basis of presentation
Basis of presentation
The Consolidated Financial Statements include the accounts of Sonoco Products Company and its majority-owned subsidiaries (the “Company” or “Sonoco”) after elimination of intercompany accounts and transactions.
On December 18, 2024, the Company announced that it had entered into an agreement to sell its Thermoformed and Flexibles Packaging business and its global Trident business (collectively, “TFP”) to TOPPAN Holdings Inc. (“Toppan”). The sale, which reflects the completion of the Company’s previously announced strategic review of TFP, closed on April 1, 2025. In accordance with applicable accounting guidance, the results of TFP, previously part of the Company’s Consumer Packaging segment, are presented as discontinued operations in the Consolidated Statements of Income and, as such, have been excluded from both continuing operations and segment results for all periods presented in this Annual Report on Form 10-K. Further, the Company reclassified the assets and liabilities of TFP as assets and liabilities of discontinued operations in the Consolidated Balance Sheet as of December 31, 2024. The Consolidated Statements of Comprehensive Income, Changes in Total Equity, and Cash Flows are presented on a consolidated basis for both continuing operations and discontinued operations. All amounts, percentages and disclosures for all periods presented in this Annual Report on Form 10-K reflect only the continuing operations of Sonoco unless otherwise noted. See Note 2 for additional information. Certain prior period financial information has been reclassified to conform with the current period presentation.
Investment in affiliates
Investments in affiliated companies in which the Company does not control the investee or in which the Company is not the primary beneficiary but has the ability to exercise significant influence over the investee’s financial and operating decisions, are accounted for by the equity method of accounting. Income applicable to these equity investments is reported in “Equity in earnings of affiliates, net of tax” in the Consolidated Statements of Income.
Estimates and assumptions
Estimates and assumptions
The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Revenue recognition
Revenue recognition
The Company records revenue generally at a point in time when control transfers to the customer either upon shipment or delivery, depending on the terms of sale. Additionally, in certain cases, control transfers over time in conjunction with production where the Company is entitled to payment with margin for products produced that are customer specific and without alternative use. For products that meet these two criteria, the Company recognizes over time revenue under the input method as goods are produced. The Company commonly enters into Master Supply Arrangements with customers to provide goods and/or services over specific time periods. Customers submit purchase orders with quantities and prices to create a contract for accounting purposes. Shipping and handling expenses are considered a fulfillment cost, and are included in “Cost of sales,” and freight charged to customers is included in “Net sales” in the Company’s Consolidated Statements of Income.
The Company has rebate agreements with certain customers. These rebates are recorded as reductions of sales and are accrued using sales data and rebate percentages specific to each customer agreement. Accrued customer rebates are included in “Accrued expenses and other payables” in the Company’s Consolidated Balance Sheets.
Payment terms under the Company’s arrangements are typically short term in nature. The Company provides prompt payment discounts to certain customers if invoices are paid within a predetermined period. Prompt payment discounts are determinable within a short period after the originating sale and like sales returns, are treated as a reduction of revenue.
Accounts receivable and allowance for doubtful accounts
Accounts receivable and allowance for doubtful accounts
The Company’s trade accounts receivable are non-interest bearing and are recorded at the invoiced amounts. The allowance for doubtful accounts represents the Company’s best estimate of the amount of expected credit losses in existing accounts receivable. The Company performs an evaluation of lifetime expected credit losses inherent in its accounts receivable at each balance sheet date. Such an evaluation includes consideration of historical loss experience, trends in customer payment frequency, present economic conditions, and judgment about the future financial health of its customers and industry sector. The allowance for doubtful accounts is monitored on a regular basis and adjustments are made as needed to ensure that the account properly reflects the Company’s best estimate of uncollectible trade accounts receivable. Account balances are charged off against the allowance for doubtful accounts when the Company determines that the receivable will not be recovered.
Accounts payable and supply chain financing
Accounts payable and supply chain financing
The Company facilitates voluntary supply chain financing programs (the “SCF Programs”) to provide certain of its suppliers with the opportunity to sell receivables due from the Company to the participating financial institutions in the programs. Such sales are conducted at the sole discretion of both the suppliers and the financial institutions on a nonrecourse basis at a rate that leverages the Company’s credit rating and thus might be more beneficial to the supplier. No guarantees are provided by the Company or any of our subsidiaries under the SCF Programs. The Company’s responsibility under the agreements is limited to making payment to the financial institutions for confirmed invoices based on the terms originally negotiated with its suppliers. Both the Company and the financial institutions have the right to terminate the SCF Programs by providing 30 days prior written notice to the other party. The Company does not enter into any agreements with suppliers regarding their participation in the SCF Programs.
Research and development
Research and development
Research and development costs are charged to expense as incurred and include salaries and other directly related expenses.
Restructuring and asset impairment
Restructuring and asset impairment
Costs associated with exit or disposal activities are recognized when the liability is incurred. Identifying and calculating the cost to exit operations requires certain assumptions to be made about anticipated future liabilities, including severance costs, contractual obligations, and disposition of property, plant and equipment and leased assets. If assets become impaired as a result of a restructuring action, they are written down to fair value, less estimated costs to sell, if applicable. A number of significant estimates and assumptions are involved in the determination of fair value. The Company considers historical experience and all available information at the time the estimates are made; however, the amounts that are ultimately realized upon the sale of divested assets may differ from the estimated fair values reflected in the Company’s Consolidated Financial Statements.
Cash and cash equivalents
Cash and cash equivalents
Cash equivalents are composed of highly liquid investments with an original maturity to the Company of three months or less when purchased. Cash equivalents are recorded at cost, which approximates fair market value. The Company’s cash and cash equivalents are primarily placed with large sophisticated creditworthy financial institutions thereby limiting the Company’s credit exposure.
Inventories
Inventories
The majority of the Company’s inventories are accounted for using the first-in, first-out (FIFO) method or average cost methods and are stated at the lower of cost or net realizable value.
The last in, first out (“LIFO”) method is used for the valuation of certain of the Company’s domestic inventories, primarily metal, internally manufactured paper and paper purchased from third parties, and approximated 9% of total inventories at both December 31, 2025 and December 31, 2024. Inventories accounted for using the LIFO method are stated at the lower of cost or market. If the FIFO method of accounting had been used for all inventories, total inventory would have been higher by $33,323 and $33,265 at December 31, 2025 and 2024, respectively.
Property, plant and equipment
Property, plant and equipment
Property, plant and equipment assets represent the original cost of land, buildings and equipment, less depreciation, computed under the straight-line method over the estimated useful lives of the assets, and are reviewed for impairment whenever events indicate the carrying value may not be recoverable. Equipment lives generally range from 3 to 11 years, and buildings range from 15 to 40 years.
Expenditures for repairs and maintenance are charged to expense as incurred. When properties are retired or otherwise disposed of, the cost and accumulated depreciation are eliminated from the asset and related allowance accounts, respectively. Gains or losses upon disposal are credited or charged to income as incurred.
The Company sold its timberland properties in March 2023. Prior to the sale, these timber resources were stated at cost and depletion expense was recognized based on the estimated number of units of timber cut during the period.
Leases
Leases
At the inception of a contract, the Company assesses whether the contract is, or contains, a lease. The assessment is based on (1) whether the contract involves the use of a distinct identified asset, (2) whether the Company obtains the right to substantially all the economic benefit from the use of the asset throughout the period, and (3) whether the Company has the right to direct the use of the asset. When the Company determines a lease exists, a leased asset and corresponding lease liability are recorded on its consolidated balance sheet. Lease contracts with a term of 12 months or less are not recorded in the consolidated balance sheet in conjunction with the Company’s practical expedient election under ASC 842, “Leases.” Leased assets represent the Company’s right to use an underlying asset during the lease term and are reviewed for impairment whenever events indicate the carrying value may not be recoverable. Lease liabilities represent the Company’s obligation arising from the lease. The Company’s leased assets and liabilities may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise those options. The Company has lease agreements with non-lease components that relate to lease components (e.g., common area maintenance such as cleaning or landscaping, etc.). The Company accounts for each lease and any non-lease components associated with that lease as a single lease component for all underlying asset classes in accordance with the scope of the lease accounting standard.
Leased assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. When the implicit rate in the Company’s leases is not readily determinable, the Company calculates its lease liabilities using discount rates based upon the Company’s incremental secured borrowing rate, which contemplates and reflects a particular geographical region’s interest rate for the leases active within that region of the Company’s global operations. The Company further utilizes a portfolio approach by assigning a “short” rate to contracts with lease terms of 10 years or less and a “long” rate for contracts greater than 10 years. Lease payments may be fixed or variable, however, only fixed payments or in-substance fixed payments are included in determining the lease liability. Variable lease payments are recognized in operating expenses in the period in which the expense is paid during the lease term.
The Company recognizes fixed lease expense for operating leases on a straight-line basis over the lease term. For finance leases, the Company recognizes interest expense on the lease liability using the effective interest method over the lease term and the finance lease asset balance is amortized on a straight-line basis.
Goodwill
Goodwill
Goodwill is not amortized. The Company assesses its goodwill for impairment annually during the third quarter, or from time to time when warranted by the facts and circumstances surrounding individual reporting units or the Company as a whole. In performing the impairment test, the Company compares the fair value of the reporting unit with its carrying amount, and if the carrying value of the reporting unit exceeds the fair value of that reporting unit, an impairment charge is recognized for the excess.
In determining the fair value of the reporting units, management considers both the income approach and the market approach. Fair value is estimated using a discounted cash flow model (income valuation approach) based on projections of future years’ operating results and associated cash flows combined with comparable trading and transaction multiples based on guideline public companies. The calculated estimated fair value of the reporting unit reflects a number of significant management assumptions and estimates including the forecast of sales growth during the discrete period, EBITDA, and discount rates. Changes in these assumptions could materially impact the estimated fair value.
The Company’s projections incorporate management’s best estimates of the expected future results, which include expectations related to new and retained business and future operating margins. Projected future cash flo
Impairment of long-lived, intangible and other assets
Impairment of long-lived, intangible and other assets
Other intangible assets are amortized using the straight-line method when management has determined that the straight-line method approximates the pattern of consumption of the respective intangible assets, or in relation to the specific pattern of consumption of the assets if the straight-line method does not provide a fair approximation of the consumption of benefits. The useful lives of the Company’s intangible assets generally range from 3 to 20 years. The Company has no intangibles with indefinite lives. The Company evaluates its intangible assets for impairment whenever indicators of impairment exist.
Assumptions and estimates used in the evaluation of potential impairment can result in adjustments affecting the carrying values of long-lived, intangible and other assets and the recognition of impairment expense in the Company’s Consolidated Financial Statements. The Company evaluates its long-lived assets (property, plant and equipment), definite-lived intangible assets and other assets (including right of use lease assets, notes receivable and equity and other investments) for impairment whenever indicators of impairment exist, or when it commits to sell the asset. If the sum of the undiscounted expected future cash flows from a long-lived asset, definite-lived intangible, or other asset group is less
than the carrying value of that asset group, an asset impairment charge is recognized. Key assumptions and estimates used in the projection of expected future cash flows generally include price levels, sales growth, profit margins and asset life. The amount of an impairment charge, if any, is calculated as the excess of the asset’s carrying value over its fair value, generally represented by the discounted future cash flows from that asset or, in the case of assets the Company evaluates for sale, estimated sale proceeds less costs to sell. The Company takes into consideration historical data and experience together with all other relevant information available when estimating the fair values of its assets. However, fair values that could be realized in actual transactions may differ from the estimates used to evaluate impairment. In addition, changes in the assumptions and estimates may result in a different conclusion regarding impairment.
Income taxes
Income taxes
The Company provides for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are determined based on differences between financial reporting requirements and tax laws. Assets and liabilities are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.
Derivatives
Derivatives
The Company uses derivatives to mitigate the effect of fluctuations in some of its raw material and energy costs, foreign currencies, and, from time to time, interest rates. The Company purchases commodities such as metal and energy, generally at market or at fixed prices that are established with the vendor as part of the purchase process for quantities expected to be consumed in the ordinary course of business. The Company may enter into commodity futures or swaps to manage the effect of price fluctuations. The Company may use foreign currency forward contracts and other risk management instruments to manage exposure to changes in foreign currency cash flows and the translation of monetary assets and liabilities on the Company’s consolidated financial statements. The Company is exposed to interest-rate fluctuations as a result of using debt as a source of financing for its operations. The Company may from time to time use traditional, unleveraged interest rate swaps to manage its exposure to interest rate movements. Additionally, the Company elected the normal purchase, normal sale scope exception for physical commodity contracts that meet the definition of a derivative. Derivative instruments, to the extent in an asset position, expose the Company to credit loss in the event of nonperformance by the counterparties to the derivative agreements. The Company manages its exposure to counterparty credit risk through minimum credit standards, diversification of counterparties and procedures to monitor concentrations of credit risk. The Company may enter into financial derivative contracts that may contain credit-risk-related contingent features, which could result in a counterparty requesting immediate payment or demanding immediate and ongoing full overnight collateralization on derivative instruments in net liability positions.
The Company records its derivatives as assets or liabilities on the balance sheet at fair value using published market prices or estimated values based on current price and/or rate quotes and discounted estimated cash flows. Changes in the fair value of derivatives designated as accounting hedges are recognized in net income, and otherwise are recognized in other comprehensive income. Amounts in accumulated other comprehensive income/(loss) are reclassified into earnings in the same period or periods during which the hedged forecasted transaction affects earnings. It is the Company’s policy not to speculate in derivative instruments.
Stock-Based Compensation Plans
Share-Based Compensation Plans
The Company utilizes share-based compensation in the form of restricted stock units (“RSUs”), performance contingent restricted stock units (“PCSUs”), and other share-based awards. The fair value of the Company’s RSUs is equal to the closing price of the Company’s stock on the date of grant discounted for any projected dividends that are not eligible to be received during the vesting period. The amount of share-based compensation expense associated with PCSUs is based on estimates of future performance using measures defined in the stock plan descriptions for each award granted. As of December 31, 2025, these performance measures include the following:
Adjusted earnings per share — three-year sum of forecasted future and historical annual adjusted earnings per share for the three-year measurement period associated with each award; and
Return on invested capital — three-year simple average of annual returns calculated by dividing 1) adjusted operating profit after tax (derived from historical or projected earnings) by 2) the average of total historical or projected debt plus equity for the respective annual periods.
For the awards granted in 2025 and 2024, the performance payout will be subject to adjustment by a total stock return modifier as determined by the Company’s relative performance within its targeted peer group for each grant. Changes in estimates regarding the future achievement of these performance measures may result in significant fluctuations from period to period in the amount of share-based compensation expense recognized in the Company’s Consolidated Financial Statements.
Pension and Postretirement Benefit Plans
Pension and Postretirement Benefit Plans
The Company provides non-contributory defined benefit pension plans for certain of its employees in the United States, Mexico, Belgium, Germany, Greece, France, and Turkey. The Company also sponsors contributory defined benefit pension plans covering certain of its employees in the United Kingdom, Canada and the Netherlands, and provides postretirement healthcare and life insurance benefits to a limited number of its retirees and their dependents in the United States and Canada, based on certain age and/or service eligibility requirements. The actuarial valuations used to evaluate the plans employ key assumptions that can have a significant effect on the calculated amounts.
The Company adjusts its discount rates at the end of each fiscal year based on yield curves of high-quality debt instruments over durations that match the expected benefit payouts of each plan. The expected rate of return assumption is derived by taking into consideration the targeted plan asset allocation, projected future returns by asset class and active investment management. A third-party asset return model is used to develop an expected range of returns on plan investments over a 12- to 30-year period, with the expected rate of return selected from a best estimate range within the total range of projected results. The Company periodically re-balances its plan asset portfolio in order to maintain the targeted allocation levels. The rate of compensation increase assumption is generally based on salary and incentive compensation increases.
Other assumptions and estimates impacting the projected liabilities of these plans include inflation, participant withdrawal and mortality rates, medical cost trends, and retirement ages. The Company evaluates the assumptions used in projecting the pension and postretirement liabilities and associated expenses annually. These judgments, assumptions and estimates may affect the carrying value of pension and postretirement plan net assets and liabilities and pension and postretirement plan expenses in the Company’s Consolidated Financial Statements.
Business combinations
Business combinations
The Company’s acquisitions of businesses are accounted for in accordance with ASC 805, “Business Combinations.” The Company recognizes the identifiable assets acquired, the liabilities assumed, and any noncontrolling interests in an acquired business at their fair values as of the date of acquisition. Goodwill is measured as the excess of consideration transferred, also measured at fair value, over the net of the acquisition date fair values of the identifiable assets acquired and liabilities assumed. The acquisition method of accounting requires the Company to make significant estimates and assumptions regarding the fair values of the elements of a business combination as of the date of acquisition, including the fair values of identifiable intangible assets; property, plant and equipment; deferred tax asset valuation allowances; liabilities including those related to debt, pensions and other postretirement plans; uncertain tax positions; contingent consideration and contingencies. This method also requires the Company to refine these estimates over a measurement period not to exceed one year to reflect new information obtained about facts and circumstances that existed as of the acquisition date that, if known, would have affected the measurement of the amounts recognized as of that date. If the Company is required to adjust provisional amounts that were recorded for the fair values of assets and liabilities in connection with acquisitions, these adjustments could have a material impact on its financial condition and results of operations.
Significant estimates and assumptions in estimating the fair value of acquired patents, customer lists, trademarks, proprietary technology, and other identifiable intangible assets include future cash flows that the Company expects to generate from the acquired assets, discount rate, customer attrition rate, and long-term revenue growth projections. Projecting discounted future cash flows requires the Company to make significant estimates regarding projected revenues, projected earnings before interest, taxes, depreciation, and amortization margins, discount rates and customer attrition rates. If the subsequent actual results and updated projections of the underlying business activity change compared with the assumptions and projections used to develop these values, the Company could record impairment charges. In addition, the Company has estimated the economic lives of certain acquired assets, and these lives are used to calculate depreciation on property, plant and equipment and amortization expense on definite-lived intangible assets. If the estimates of the economic lives change, depreciation or amortization expenses could be increased or decreased, or the acquired assets could be impaired.
For leases acquired in a business combination, the Company measures the lease liability at the present value of the remaining lease payments, as if the acquired lease were a new lease of the Company at the acquisition date. The Company measures the right-of-use asset at the same amount as the lease liability as adjusted to reflect favorable or unfavorable terms of the lease when compared with market terms.
Reportable segments
Reportable segments
The Company identifies its reportable segments by evaluating the level of detail reviewed by the chief operating decision maker and the similarities among operating segments related to gross profit margins, nature of products sold, nature of the production processes, type and class of customer, methods used to distribute products, and nature of the regulatory environment. Of these factors, the Company believes that the most significant in determining the aggregation of operating segments are the nature of the products and the type of customers served. The Company’s operating and reporting structure consists of two reportable segments, Consumer Packaging and Industrial Paper Packaging, with all remaining businesses reported as All Other. Effective January 1, 2026, the All Other business will be reported within the Industrial Paper Packaging segment and the use of All Other will be discontinued.
Commitments and contingencies
Contingencies
Pursuant to GAAP for accounting for contingencies, accruals for estimated losses are recorded at the time information becomes available indicating that losses are probable and that the amounts are reasonably estimable. Amounts so accrued are not discounted. Changes in estimates and assumptions could impact the carrying value of the accruals from one period to another as additional information becomes known.
In accordance with the requirements of ASC 450, “Contingencies,” the Company records accruals for estimated losses at the time information becomes available indicating that losses are probable and that the amounts are reasonably estimable. As is the case with other companies in similar industries, the Company faces exposure from actual or potential claims and legal proceedings from a variety of sources. Some of these exposures, as discussed below, have the potential to be material.
Foreign currency translation
Foreign currency translation
The Company’s foreign operations are exposed to political, geopolitical, and cultural risks, but the risks are mitigated by diversification and the relative stability of the countries in which the Company has significant operations. Because the economy in Turkey is considered highly inflationary under GAAP, the Company considers the U.S. dollar to be the functional currency for these operations and uses the official exchange rate when remeasuring the financial assets and liabilities of these operations. The remeasurement adjustments are recorded against earnings within the Company’s Consolidated Statements of Income.
New accounting pronouncements New accounting pronouncements
In November 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses,” which requires companies to disclose disaggregated amounts relating to (a) inventory purchases; (b) employee compensation; (c) depreciation; (d) intangible asset amortization; and (e) depreciation, depletion, and amortization. Further, this guidance will require companies to include certain amounts that are already required to be disclosed under current U.S. GAAP in the same disclosure as the other disaggregation requirements, disclose a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively and disclose the total amount of selling expenses and, in annual reporting periods, an entity’s definition of selling expenses. The standard is intended to benefit investors by providing more detailed expense disclosures that would be useful in making capital allocation decisions. This guidance is effective for public business entities for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027 but early adoption is permitted. ASU 2024-03 should be applied on a prospective basis, but retrospective application is permitted. The Company is currently evaluating the potential impact of adopting this new guidance on its consolidated financial statements and related disclosures.
In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” which modifies the rules on income tax disclosures to require disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid. The standard is intended to benefit investors by providing more detailed income tax disclosures that would be useful in making capital allocation decisions. The Company adopted this standard on a prospective basis as of January 1, 2025 and included the expanded annual disclosures in this Annual Report on Form 10-K.
Other than the pronouncements discussed above, there have been no other newly issued nor newly applicable accounting pronouncements that have had, or are expected to have, a material impact on the Company’s financial statements.
Fair value measurement
Fair value is defined as an exit price representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. Fair value is a market-based measurement that is determined based on assumptions that market participants would use in pricing an asset or liability. A three-tier fair value hierarchy is used to prioritize the inputs in measuring fair value as follows:
Level 1 –Observable inputs such as quoted market prices in active markets;
Level 2 –Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and
Level 3 –Unobservable inputs for which there is little or no market data, which require the reporting entity to develop its own assumptions.
v3.25.4
Summary of significant accounting policies (Tables)
12 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
Schedule of Affiliated Companies
Affiliated companies over which the Company exercised a significant influence at December 31, 2025, included:
Entity
Ownership Interest
Cascades Conversion, Inc.50.0 %
Cascades Sonoco, Inc.50.0 %
ISI Robotics, LLC32.3 %
Showa Products Company Ltd.22.2 %
Papertech Energía, S.L.25.0 %
Weidenhammer New Packaging, LLC40.0 %
Schedule of Inventory
Details of the Company’s inventory balances at December 31, 2025 and 2024 are as follows:
20252024
Inventories:
Finished goods$370,303 $359,086 
Work in process161,313 135,004 
Materials and supplies589,393 522,049 
Inventories$1,121,009 $1,016,139 
v3.25.4
Discontinued operations (Tables)
12 Months Ended
Dec. 31, 2025
Discontinued Operations and Disposal Groups [Abstract]  
Schedules of Discontinued Operations
As disclosed in Note 1, as a result of the Company entering into an agreement to sell TFP on December 18, 2024, the assets and liabilities of TFP were classified as discontinued operations in the Consolidated Balance Sheet as of December 31, 2024 as presented below:
  
2024
Cash and cash equivalents$12,050 
Trade accounts receivable, net of allowances of $2,582
209,379 
Other receivables46,001 
Inventories
Finished and in process80,573 
Materials and supplies94,083 
Prepaid expenses8,788 
Current assets of discontinued operations$450,874 
Property, plant and equipment, net of accumulated depreciation of $465,923
262,662 
Goodwill502,621 
Other intangible assets, net of accumulated amortization of $206,437
103,593 
Deferred income taxes262 
Right of use asset-operating leases75,855 
Other assets19,317 
Noncurrent Assets of Discontinued Operations$964,310 
Payable to suppliers172,720 
Accrued expenses and other payables62,562 
Notes payable and current portion of long-term debt6,774 
Current liabilities of discontinued operations$242,056 
Long-term debt29,850 
Noncurrent operating lease liabilities67,789 
Deferred income taxes15,928 
Other liabilities344 
Noncurrent Liabilities of Discontinued Operations$113,911 
The following table presents key components of “Net income from discontinued operations” for the years ended December 31, 2025, 2024, and 2023:
 Year Ended December 31,
  
202520242023
Net sales$320,678 $1,291,461 $1,339,866 
Cost of sales250,854 1,037,196 1,106,970 
Gross profit69,824 254,265 232,896 
Selling, general and administrative expenses31,607 122,488 97,131 
Restructuring/Asset impairment charges, net426 3,740 9,024 
Gain on divestiture of business
606,633 — — 
Operating profit644,424 128,037 126,741 
Other (expense)/income, net
(182)— — 
Interest expense1
24,911 13,396 1,293 
Interest income281 1,668 357 
Income from discontinued operations before income taxes619,612 116,309 125,805 
Provision for income taxes207,264 19,934 29,548 
Net income from discontinued operations412,348 96,375 96,257 
Net income from discontinued operations attributable to noncontrolling interests— (171)(174)
Net income attributable to discontinued operations$412,348 $96,204 $96,083 
Weighted average common shares outstanding:
Basic99,124 98,637 98,294 
Diluted99,571 99,290 98,890 
Per common share:
Net income attributable to discontinued operations:
Basic$4.16 $0.97 $0.98 
Diluted$4.14 $0.97 $0.97 
1 Includes $24,060 and $9,528 of interest expense in 2025 and 2024, respectively, relating to certain debt contractually required to be repaid by the Company upon completion of the TFP divestiture. No such interest expense is reflected in 2023 as the debt was drawn on December 2, 2024 and repaid on April 3, 2025. See Note 11 for additional information.
The following table presents significant cash flow items from discontinued operations for the years ended December 31, 2025, 2024, and 2023:
 Year Ended December 31,
  
202520242023
Depreciation and amortization (a)
$(311)$58,798 $58,959 
Purchases of property, plant and equipment$(5,572)$(65,321)$(55,624)
(a) Subsequent to entering the agreement to sell TFP on December 8, 2024, depreciation was no longer recognized on TFP’s property, plant and equipment, and amortization was no longer recognized on TFP’s other intangible assets or right of use assets-operating leases, in accordance with ASC 360, “Property, Plant, and Equipment.”
v3.25.4
Acquisitions and divestitures (Tables)
12 Months Ended
Dec. 31, 2025
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
Schedule of Preliminary Fair Value Of Assets Acquired And Measurement Period Adjustments
During 2025, the Company finalized its valuation of the assets acquired and liabilities assumed in the Eviosys acquisition. The final fair values, reflecting adjustments made during the measurement period, are as follows:
Initial Preliminary AllocationMeasurement Period AdjustmentsFinal Allocation
Trade accounts receivable$300,385 $(5,151)$295,234 
Other receivables114,634 2,009 116,643 
Inventories445,945 (12,938)433,007 
Prepaid expenses47,509 (2,976)44,533 
Property, plant and equipment1,057,779 (55,127)1,002,652 
Right of use asset - operating leases43,566 43,571 
Other intangible assets1,967,678 42,379 2,010,057 
Goodwill1,285,518 (27,399)1,258,119 
Long-term deferred income taxes39,023 14,853 53,876 
Other assets3,330 23 3,353 
Payable to suppliers(518,766)1,673 (517,093)
Accrued expenses and other payables(168,529)(3,167)(171,696)
Accrued wages and other compensation(41,749)(57)(41,806)
Notes payable and current portion of long-term debt(76,438)(5)(76,443)
Noncurrent operating lease liabilities(32,022)— (32,022)
Pension and other postretirement benefits(51,849)(69)(51,918)
Long-term debt— (34)(34)
Deferred income taxes(599,941)31,772 (568,169)
Other long-term liabilities(16,714)27 (16,687)
Noncontrolling Interests
(9,533)(2,346)(11,879)
Net assets acquired$3,789,826 $(16,528)$3,773,298 
Schedule Of Proforma Supplemental Information
The following table presents the financial results for Eviosys from December 4, 2024, the date of acquisition, through December 31, 2024:
Supplemental Information
December 4 to
Eviosys
December 31, 2024
Net sales$115,031 
Net loss
$15,086 
The following table presents the Company’s pro forma consolidated results for the years ended December 31, 2024 and December 31, 2023, assuming the acquisition of Eviosys had occurred on January 1, 2023. This pro forma information is presented for informational purposes only and does not purport to represent the results of operations that would have been achieved if the acquisition had been completed at the beginning of 2023, nor is it necessarily indicative of future consolidated results.
Pro Forma Supplemental Information Years Ended
ConsolidatedDecember 31, 2024
December 31, 2023
Net sales$7,546,920 $8,032,135 
Net income from continuing operations
$157,389 $105,116 
Net income attributable to Sonoco1
$253,593 $200,589 
1 Includes results of discontinued operations
Schedule of the Purchase Consideration Transferred for the Acquisitions
The following table provides a summary of the purchase consideration (as defined under ASC 805) transferred for the acquisition of the remaining interest in RTS Packaging and the acquisition of the Chattanooga Mill:
Purchase Consideration
Cash consideration, net of cash acquired $313,388 
Fair value of previously held interest in RTS Packaging59,472 
Final working capital settlement
452 
Settlement of preexisting relationships1,235 
Purchase consideration transferred$374,547 
Schedule of Acquisition, Integration, and Divestiture-Related Costs
Acquisition, integration, and divestiture-related costs from continuing operations incurred in 2025, 2024 and 2023, were as follows:
 Year Ended December 31,
202520242023
Cost of sales$17,053 $5,806 $5,227 
Selling, general and administrative expenses37,078 85,794 19,397 
Interest expense— 33,569 — 
Total acquisition, integration, and divestiture-related costs$54,131 $125,169 $24,624 
v3.25.4
Restructuring and asset impairment (Tables)
12 Months Ended
Dec. 31, 2025
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring and Restructuring-Related Asset Impairment Expenses by Type Incurred and by Reportable Segment
Following are the total restructuring and asset impairment charges, net of adjustments, recognized during the periods presented:
 Year Ended December 31,
  
202520242023
Restructuring and restructuring-related asset impairment charges, net
$66,215 $65,370 $47,909 
Other asset impairments— — — 
Restructuring/Asset impairment charges, net
$66,215 $65,370 $47,909 
The table below sets forth restructuring and restructuring-related asset impairment charges by type incurred:
 Year Ended December 31,
202520242023
Severance and Termination Benefits$68,795 $37,307 $15,543 
Asset Impairment/Disposal of Assets(15,333)15,719 24,415 
Other Costs12,753 12,344 7,951 
Restructuring and restructuring-related asset impairment charges, net
$66,215 $65,370 $47,909 
The table below sets forth restructuring and restructuring-related asset impairment charges by reportable segment:
 Year Ended December 31,
202520242023
Consumer Packaging$54,200 $19,259 $4,111 
Industrial Paper Packaging8,307 33,923 38,754 
All Other1,434 2,547 
Corporate3,703 10,754 2,497 
Restructuring and restructuring-related asset impairment charges, net
$66,215 $65,370 $47,909 
Schedule of Restructuring Accrual Activity
The following table sets forth the activity in the restructuring accrual included in “Accrued expenses and other payables” in the Company’s Consolidated Balance Sheets:
Accrual ActivitySeverance
and Termination
Benefits
Asset
Impairment/ Disposal
of Assets
Other
Costs
Total
Liability at December 31, 2023$8,864 $— $272 $9,136 
2024 charges37,307 15,719 12,344 65,370 
Cash (payments)/receipts(21,653)9,680 (11,610)(23,583)
Asset write downs/disposals— (25,399)— (25,399)
Foreign currency translation(484)— (97)(581)
Liability at December 31, 2024$24,034 $— $909 $24,943 
2025 charges/(gains)68,795 (15,333)12,753 66,215 
Cash (payments)/receipts(38,367)45,675 (10,779)(3,471)
Asset write downs/disposals— (30,342)— (30,342)
Foreign currency translation1,166 — 644 1,810 
Liability at December 31, 2025$55,628 $— $3,527 $59,155 
v3.25.4
Property, plant and equipment (Tables)
12 Months Ended
Dec. 31, 2025
Property, Plant and Equipment [Abstract]  
Schedule of Property, Plant and Equipment
Details of the Company’s property, plant and equipment at December 31 are as follows:
20252024
Land$324,635 $314,278 
Buildings1,046,723 967,237 
Machinery and equipment4,020,202 3,726,377 
Construction in progress282,948 337,796 
5,674,508 5,345,688 
Accumulated depreciation(2,876,708)(2,626,941)
Property, plant and equipment, net$2,797,800 $2,718,747 
v3.25.4
Leases (Tables)
12 Months Ended
Dec. 31, 2025
Leases [Abstract]  
Schedule of Balance Sheet Location and Values of Company's Lease Assets and Lease Liabilities
The following table sets forth the balance sheet location and values of the Company’s lease assets and lease liabilities at December 31, 2025 and December 31, 2024:
ClassificationBalance Sheet LocationDecember 31, 2025December 31, 2024
Lease Assets
Operating lease assetsRight of Use Asset-Operating Leases$307,450 $307,688 
Finance lease assetsOther Assets49,059 76,831 
Total lease assets$356,509 $384,519 
Lease Liabilities
Current operating lease liabilitiesAccrued expenses and other payables$53,978 $52,648 
Current finance lease liabilitiesNotes payable and current portion of long-term debt11,617 22,284 
Total current lease liabilities$65,595 $74,932 
Noncurrent operating lease liabilitiesNoncurrent Operating Lease Liabilities$263,192 $258,735 
Noncurrent finance lease liabilitiesLong-term Debt41,925 45,344 
Total noncurrent lease liabilities$305,117 $304,079 
Total lease liabilities$370,712 $379,011 
Schedule of Components of Company's Total Lease Costs and Other Lease Related Information
The following table sets forth the components of the Company’s total lease cost for the years ended December 31, 2025, 2024, and 2023:
Lease Cost202520242023
Operating lease cost(a)$62,687 $49,327 $43,524 
Finance lease cost:
     Amortization of lease asset(a) (b)13,051 12,871 11,789 
     Interest on lease liabilities(c)3,100 3,711 3,912 
Variable lease cost(a) (d)48,807 31,404 32,016 
Impairment charges(e)2,526 — — 
Total lease cost$130,171 $97,313 $91,241 
(a) Production-related costs are included in “Cost of sales” and administrative costs are included in “Selling, general and administrative expenses” in the Consolidated Statements of Income.
(b) Included in depreciation and amortization.
(c) Included in interest expense.
(d) Also includes short term lease costs, which are deemed immaterial.
(e) Impairment charges are included in “Restructuring/Asset impairment charges, net” in the Company’s Consolidated Statements of Income. See Note 5 for additional information.
Schedule of Five-year Maturity of Operating Lease Liabilities
The following table sets forth the five-year maturity schedule of the Company’s lease liabilities as of December 31, 2025:
Maturity of Lease LiabilitiesOperating LeasesFinance LeasesTotal
2026$54,712 $11,841 $66,553 
202747,158 10,382 57,540 
202842,551 8,750 51,301 
202939,459 6,512 45,971 
203035,978 4,845 40,823 
Beyond 2030177,821 20,207 198,028 
Total lease payments$397,679 $62,537 $460,216 
Less: Interest(80,509)(8,995)(89,504)
Lease Liabilities$317,170 $53,542 $370,712 
Schedule of Five-year Maturity Finance Lease Liabilities
The following table sets forth the five-year maturity schedule of the Company’s lease liabilities as of December 31, 2025:
Maturity of Lease LiabilitiesOperating LeasesFinance LeasesTotal
2026$54,712 $11,841 $66,553 
202747,158 10,382 57,540 
202842,551 8,750 51,301 
202939,459 6,512 45,971 
203035,978 4,845 40,823 
Beyond 2030177,821 20,207 198,028 
Total lease payments$397,679 $62,537 $460,216 
Less: Interest(80,509)(8,995)(89,504)
Lease Liabilities$317,170 $53,542 $370,712 
Schedule of Weighted Average Remaining Lease Terms, Discounts Rates and Other Lease Information
The following tables set forth the Company’s weighted average remaining lease term and discount rates used in the calculation of its outstanding lease liabilities at December 31, 2025, 2024, and 2023, along with other lease-related information for those years:
Lease Term and Discount Rate202520242023
Weighted-average remaining lease term (years):
Operating leases 9.610.110.0
Finance leases8.26.77.1
Weighted-average discount rate:
Operating leases5.09%4.97%5.07%
Finance leases4.65%5.16%5.27%
Other Information202520242023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows used by operating leases$59,172 $48,380 $43,638 
Operating cash flows used by finance leases$3,100 $3,711 $3,912 
Financing cash flows used by finance leases$14,997 $15,433 $14,617 
Noncash investing and financing activities:
Leased assets obtained in exchange for new operating lease liabilities$42,646 $66,585 $18,225 
Leased assets obtained in exchange for new finance lease liabilities$20,579 $11,925 $7,755 
Modification to leased assets for increase in operating lease liabilities$17,621 $37,731 $4,431 
Modification to leased assets for increase/(decrease) in finance lease liabilities$(31,502)$53 $18 
Termination reclasses to decrease operating lease assets$8,440 $5,765 $5,702 
Termination reclasses to decrease operating lease liabilities$8,544 $5,768 $6,063 
Termination reclasses to decrease finance lease assets$303 $270 $1,429 
Termination reclasses to decrease finance lease liabilities$305 $271 $482 
v3.25.4
Goodwill and other intangible assets (Tables)
12 Months Ended
Dec. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Changes in Goodwill
Changes in the carrying amount of goodwill by segment for the year ended December 31, 2025, are as follows:
Consumer
Packaging
Industrial Paper PackagingAll OtherTotal
Balance as of January 1, 2025
$1,807,971 $486,636 $231,050 $2,525,657 
Divestitures— (2,043)(173,250)(175,293)
Measurement period adjustments(27,399)— — (27,399)
Foreign currency translation167,419 23,783 (2,556)188,646 
Balance as of December 31, 2025
$1,947,991 $508,376 $55,244 $2,511,611 
Schedule of Other Intangible Assets
Details at December 31 are as follows:
20252024
Other Intangible Assets, Gross:
Patents$29,403 $28,941 
Customer lists2,895,345 2,679,372 
Trade names28,417 38,623 
Proprietary technology234,336 226,936 
Other2,054 2,339 
Total Other Intangible Assets, Gross$3,189,555 $2,976,211 
Accumulated Amortization:
Patents$(18,706)$(15,955)
Customer lists(431,704)(332,680)
Trade names(12,488)(13,239)
Proprietary technology
(41,990)(26,203)
Other (1,193)(1,436)
Total Accumulated Amortization$(506,081)$(389,513)
Other Intangible Assets, Net$2,683,474 $2,586,698 
v3.25.4
Supply chain financing (Tables)
12 Months Ended
Dec. 31, 2025
Investments, Debt and Equity Securities [Abstract]  
Schedule of Supply Chain Finance Program
The following table sets forth the balance sheet location and rollforward of the Company’s outstanding obligations confirmed under its SCF Programs for the years ended December 31, 2025 and 2024:
Balance Sheet Location20252024
Confirmed obligations outstanding at the beginning of the yearPayable to suppliers$28,496 $24,779 
Invoices confirmed during the year (a) (b)
187,392 96,785 
Confirmed invoices paid during the year (b) (c)
(162,766)(93,068)
Confirmed obligations outstanding at the end of the yearPayable to suppliers$53,122 $28,496 

(a) Invoices confirmed in 2025 exclude $7,763 of obligations under SCF Programs divested upon the sale of ThermoSafe on November 3, 2025 and invoices confirmed in 2024 include $7,547 of obligations assumed upon the acquisition of Eviosys on December 4, 2024.
(b) The net payment of these obligations, exclusive of the $7,547 of obligations acquired in the acquisition of Eviosys in 2024, is included in “Net cash provided by operating activities” in the Company’s Consolidated Statements of Cash Flows.
(c) Excludes $6,342 of obligations under SCF Programs divested upon the sale of ThermoSafe on November 3, 2025.
v3.25.4
Debt (Tables)
12 Months Ended
Dec. 31, 2025
Debt Disclosure [Abstract]  
Schedule of Debt
Details of the Company’s debt at December 31 were as follows:
20252024
364-Day term loan due December 2025$— $1,493,568 
Term loan due December 2026— 698,167 
Syndicated term loan due August 2028498,320 497,674 
1.80% notes due February 2025
— 399,933 
4.45% notes due September 2026
498,749 496,869 
2.25% notes due February 2027
299,443 298,930 
4.60% notes due September 2029
595,694 594,519 
3.125% notes due May 2030
597,528 596,958 
2.85% notes due February 2032
496,824 496,302 
5.00% notes due September 2034
690,857 689,802 
5.75% notes due November 2040
536,314 536,282 
Other foreign denominated debt, average rate of 5.5% in 2025 and 6.0% in 2024
40,016 155,048 
Finance lease obligations53,542 67,628 
Other debt19,638 18,341 
Total debt$4,326,925 $7,040,021 
Less: Notes payable and current portion of long-term debt(537,952)(2,054,525)
Long-term debt$3,788,973 $4,985,496 
The Notes consisted of the following:
Principal AmountIssuance Costs and DiscountsNet ProceedsInterest RateMaturity
2026 Notes$500,000 (3,697)$496,303 4.45 %September 1, 2026
2029 Notes600,000 (5,851)594,149 4.60 %September 1, 2029
2034 Notes700,000 (10,542)689,458 5.00 %September 1, 2034
Total$1,800,000 $(20,090)$1,779,910 
Schedule of Debt Maturities
The principal requirements of debt maturing in the next five years are:
  
20262027202820292030
Debt maturities by year$537,952 $316,438 $513,555 $600,802 $602,236 
v3.25.4
Financial instruments and derivatives (Tables)
12 Months Ended
Dec. 31, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Carrying Amounts and Fair Values of Financial Instruments
The following table sets forth the carrying amounts and fair values of the Company’s significant financial instruments for which the carrying amount differs from the fair value.
 December 31, 2025December 31, 2024
  
Carrying
Amount
Fair
Value
Carrying
Amount
Fair
Value
Long-term debt, net of current portion$3,788,973 $3,728,480 $4,985,496 $4,800,455 
Schedule of Net Positions of Foreign Contracts The net positions of these contracts at December 31, 2025, were as follows (in thousands):
CurrencyActionQuantity
USD Contracts
Colombian pesopurchase9,732,940 
Mexican pesopurchase163,250 
Polish zlotypurchase87,110 
Danish kronepurchase105,120 
Swedish kronasell(1,902)
Canadian dollarpurchase15,274 
Europurchase3,326 
Turkish lirapurchase79,562 
British poundsell(6,985)
USDpurchase9,639 
Euro Contracts
Europurchase4,741 
Polish zlotypurchase3,650 
British poundpurchase2,850 
USDpurchase8,720 
Hungarian forintpurchase9,026,735 
Swiss francpurchase2,274 
Schedule of Net positions of Other Derivatives Contract The net currency positions of these non-designated contracts at December 31, 2025, were as follows (in thousands):
CurrencyActionQuantity
USD Contracts
Indonesian rupiahpurchase10,632,390 
Colombian pesopurchase67,686,355 
Mexican pesopurchase276,516 
Canadian dollarpurchase4,224 
Euro Contracts
British poundsell(395)
Polish zlotysell(51,337)
Thai bahtsell(550,013)
Hungarian forintpurchase356,793 
USDsell(2,880)
Schedule of Location and Fair Values of Derivative Instruments
The following table sets forth the location and fair values of the Company’s derivative instruments at December 31, 2025 and December 31, 2024:
  Fair Value at December 31
DescriptionBalance Sheet Location20252024
Derivatives designated as hedging instruments:
Commodity ContractsPrepaid expenses$1,508 $671 
Commodity ContractsOther Assets175 — 
Commodity ContractsAccrued expenses and other payables— (19)
Foreign Exchange ContractsPrepaid expenses1,131 2,068 
Foreign Exchange ContractsOther Assets33 — 
Foreign Exchange ContractsAccrued expenses and other payables(1,028)(3,909)
Foreign Exchange ContractsOther Liabilities(87)— 
Net investment hedgePrepaid expenses19,358 26,833 
Net investment hedgeOther Assets— 1,845 
Net investment hedgeAccrued expenses and other payables(58,594)— 
Net investment hedgeOther Liabilities(167,967)(16,759)
Derivatives not designated as hedging instruments:
Commodity ContractsPrepaid expenses$185 $961 
Commodity ContractsAccrued expenses and other payables(1,517)(574)
Foreign Exchange ContractsPrepaid expenses1,106 (59)
Foreign Exchange ContractsAccrued expenses and other payables(887)(3,022)
Schedule of Effect of Derivative Instruments on Financial Performance
The following tables set forth the effect of the Company’s derivative instruments on financial performance for the year ended December 31, 2025 and December 31, 2024, excluding the gains or losses on foreign currency cash flow hedges that were reclassified from accumulated other comprehensive income/(loss) to the carrying value of the capitalized expenditures:
DescriptionAmount of Gain or (Loss) Recognized in OCI on DerivativesLocation of Gain or (Loss) Reclassified from Accumulated OCI into IncomeAmount of Gain or (Loss) Reclassified from Accumulated OCI into Income
Derivatives in Cash Flow Hedging Relationships:
Year Ended December 31, 2025
Foreign Exchange Contracts$2,879 Net sales$3,811 
Cost of sales$(2,557)
Commodity Contracts$1,478 Cost of sales$447 
Year Ended December 31, 2024
Foreign Exchange Contracts$(4,994)Net sales$(1,174)
Cost of sales$(253)
Commodity Contracts$665 Cost of sales$(28)
Description
  
Gain or (Loss) RecognizedLocation of Gain or (Loss) Recognized in Income Statement
Derivatives not Designated as Hedging Instruments:
Year Ended December 31, 2025
Commodity Contracts$(1,546)Cost of sales
Foreign Exchange Contracts$6,683 Selling, general and administrative
Year Ended December 31, 2024
Commodity Contracts$(2,976)Cost of sales
Foreign Exchange Contracts$(8,168)Selling, general and administrative
Year Ended December 31, 2025Year Ended December 31, 2024
DescriptionNet SalesCost of salesNet SalesCost of sales
Total amount of income and expense line items presented in the Consolidated Statements of Income$3,811 $(2,110)$(1,174)$(281)
Gain or (loss) on cash flow hedging relationships:
Foreign exchange contracts:
Amount of gain or (loss) reclassified from accumulated other comprehensive income into net income$3,811 $(2,557)$(1,174)$(253)
Commodity contracts:
Amount of gain or (loss) reclassified from accumulated other comprehensive income into net income$— $447 $— $(28)
v3.25.4
Fair value measurements (Tables)
12 Months Ended
Dec. 31, 2025
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured on Recurring Basis
The following tables set forth information regarding the Company’s financial assets and financial liabilities that are measured at fair value on a recurring basis:
DescriptionDecember 31, 2025
Assets measured at NAV (f)
Level 1Level 2Level 3
Hedge derivatives, net:
Commodity contracts$1,683 $— $— $1,683 $— 
Foreign exchange contracts49 — — 49 — 
Net investment hedge(207,203)— — (207,203)— 
Non-hedge derivatives, net:
Commodity contracts(1,332)— — (1,332)— 
Foreign exchange contracts219 — — 219 — 
Postretirement benefit plan assets:
Common Collective Trust (a)
13,139 13,139 — — — 
Mutual funds (b)
25,885 — — 25,885 — 
Fixed income securities (c)
263,441 63,517 — 199,924 — 
Short-term investments (d)
3,184 — — 3,184 — 
Real estate funds (e)
5,019 5,019 — — — 
Cash and accrued income9,789 — 9,789 — — 
Total postretirement benefit plan assets$320,457 $81,675 $9,789 $228,993 $— 
DescriptionDecember 31, 2024
Assets measured at NAV (f)
Level 1Level 2Level 3
Hedge derivatives, net:
Commodity contracts652 $— $— $652 $— 
Foreign exchange contracts(1,841)— — (1,841)— 
Net investment hedge11,919 — — 11,919 — 
Non-hedge derivatives, net:
Commodity contracts387 — — 387 — 
Foreign exchange contracts(3,081)— — (3,081)— 
Postretirement benefit plan assets:
Common Collective Trust (a)
13,259 13,259 — — — 
Mutual funds (b)
43,059 — — 43,059 — 
Fixed income securities (c)
235,952 62,458 — 173,494 — 
Short-term investments (d)
3,493 — — 3,493 — 
Real estate funds (e)
480 480 — — — 
Cash and accrued income7,757 — 7,757 — — 
Total postretirement benefit plan assets$304,000 $76,197 $7,757 $220,046 $— 
a.Common collective trust investments consist of domestic and international large and mid capitalization equities, including emerging markets and funds invested in both short-term and long-term bonds. Underlying investments are generally valued at closing prices from national exchanges. Commingled funds, private securities, and limited partnerships are valued at unit values or NAVs provided by the investment managers.
b.Mutual fund investments are comprised of equity securities of corporations with large capitalizations and also include funds invested in corporate equities in international and emerging markets and funds invested in long-term bonds, which are valued at closing prices from national exchanges.
c.Fixed income securities include funds that invest primarily in government securities and long-term bonds. Underlying investments are generally valued at closing prices from national exchanges, fixed income pricing models, and independent financial analysts. Fixed income commingled funds are valued at unit values provided by the investment managers.
d.Short-term investments include several money market funds used for managing overall liquidity. Underlying investments are generally valued at closing prices from national exchanges. Commingled funds are valued at unit values provided by the investment managers.
e.Includes investments in real estate funds (including office, industrial, residential and retail). Underlying real estate securities are generally valued at closing prices from national exchanges.
f.Certain assets that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.
v3.25.4
Share-based compensation plans (Tables)
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Activity Related to Restricted Stock Units
The activity related to RSUs for the year ended December 31, 2025 is as follows:
NonvestedVestedTotalAverage Grant Date Fair Value Per Share
Outstanding, December 31, 2024681,616 75,580 757,196 $53.43 
Granted451,499 — 451,499 $42.75 
Vested(327,019)327,019 — 
Converted— (284,530)(284,530)$54.28 
Cancelled(118,243)— (118,243)$50.13 
Dividend equivalents517 5,790 6,307 $43.90 
Outstanding, December 31, 2025688,370 123,859 812,229 $47.43 
Schedule of Activity Related to Performance Contingent Restricted Stock Units
The activity related to PCSUs for the year ended December 31, 2025 is as follows:
NonvestedVestedTotalAverage Grant Date Fair Value Per Share
Outstanding, December 31, 2024283,675 350,081 633,756 $52.13
Granted272,478 — 272,478 $40.95
Performance adjustments(258,333)— (258,333)$42.17
Vested(75,263)75,263 — 
Converted— (309,397)(309,397)$51.94
Cancelled(46,162)— (46,162)$48.58
Dividend equivalents— 1,932 1,932 $45.20
Outstanding, December 31, 2025176,395 117,879 294,274 $51.25
Schedule of Other Share-Based Compensation, Activity
The activity related to deferred compensation for equity award units granted to both employees and non-employee directors combined is as follows:
Total
Outstanding, December 31, 2024361,423 
Deferred42,013 
Converted(8,146)
Dividend equivalents16,857 
Outstanding, December 31, 2025412,147 
Schedule of Company's SARs
The activity related to SARs for the year ended December 31, 2025 is as follows: 
NonvestedVestedTotalWeighted-average Exercise Price
Outstanding, December 31, 2024— 663,404 663,404 $55.62 
Vested— — — $— 
Granted— — — $— 
Exercised— (35,972)(35,972)$45.11 
Forfeited/Expired— (111,279)(111,279)$58.22 
Outstanding, December 31, 2025— 516,153 516,153 $55.79 
Exercisable, December 31, 2025— 516,153 516,153 $55.79 
v3.25.4
Employee benefit plans (Tables)
12 Months Ended
Dec. 31, 2025
Retirement Benefits [Abstract]  
Schedule of Components of Net Periodic Benefit Cost/(Income)
The components of net periodic benefit cost/(income) include the following:
202520242023
Retirement Plans
Service cost$5,497 $3,456 $2,878 
Interest cost21,588 19,097 18,101 
Expected return on plan assets(13,667)(11,133)(9,451)
Amortization of prior service cost923 864 926 
Amortization of net actuarial loss3,871 4,472 4,300 
Effect of settlement loss42 530 1,010 
Effect of curtailment gain(263)— — 
Net periodic benefit cost$17,991 $17,286 $17,764 
Retiree Health and Life Insurance Plans
Service cost$134 $178 $230 
Interest cost919 919 507 
Expected return on plan assets(413)(392)(313)
Amortization of prior service cost375 385 — 
Amortization of net actuarial gain(1,160)(899)(768)
Net periodic benefit (income)/cost $(145)$191 $(344)
Schedule of Plans' Obligations
The following tables set forth the Plans’ obligations and assets at December 31:
 Retirement PlansRetiree Health and
Life Insurance Plans
  
2025202420252024
Change in Benefit Obligation
Benefit obligation at January 1$452,275 $413,340 $19,832 $22,571 
Service cost5,497 3,456 134 178 
Interest cost21,588 19,097 919 919 
Plan participant contributions306 31 — — 
Plan amendments675 615 (321)— 
Actuarial (gain)/loss(6,621)(18,935)1,027 (2,389)
Benefits paid(27,380)(28,263)(1,181)(1,418)
Impact of foreign exchange rates23,875 (8,926)16 (29)
Effect of settlements(8,576)(2,218)— — 
Effect of curtailments(408)— — — 
Other1,639 — — — 
Acquisitions42 74,078 — — 
Benefit obligation at December 31$462,912 $452,275 $20,426 $19,832 
Schedule of Fair Value of Plan Assets
 Retirement PlansRetiree Health and
Life Insurance Plans
  
2025202420252024
Change in Plan Assets
Fair value of plan assets at January 1$290,825 $295,587 $13,175 $13,213 
Actual return on plan assets13,722 (5,203)669 535 
Company contributions21,490 18,798 794 835 
Plan participant contributions306 77 — — 
Benefits paid(27,380)(28,263)(1,181)(1,360)
Impact of foreign exchange rates17,588 (7,200)— — 
Effect of settlements(8,576)(2,218)— — 
Expenses paid(1,945)(1,976)(29)(48)
Other 999 — — — 
Acquisitions— 21,223 — — 
Fair value of plan assets at December 31$307,029 $290,825 $13,428 $13,175 
Funded status of the Plans $(155,883)$(161,450)$(6,998)$(6,657)
Schedule of Recognized Amounts in Consolidated Balance Sheets
 Retirement PlansRetiree Health and
Life Insurance Plans
  
2025202420252024
Total Recognized Amounts in the Consolidated Balance Sheets
Noncurrent assets $27,283 $24,919 $— $— 
Current liabilities (11,402)(11,382)(786)(817)
Noncurrent liabilities (171,764)(174,987)(6,212)(5,840)
Net liability$(155,883)$(161,450)$(6,998)$(6,657)
Schedule of Amounts Recognized in Other Comprehensive Loss/(Income)
Items not yet recognized as a pre-tax component of net periodic benefit cost that are included in Accumulated Other Comprehensive Loss as of December 31, 2025 and 2024, are as follows:
 Retirement PlansRetiree Health and
Life Insurance Plans
  
2025202420252024
Net actuarial loss/(gain)$100,220 $109,718 $(5,747)$(7,706)
Prior service cost5,683 5,020 10,555 11,251 
 $105,903 $114,738 $4,808 $3,545 
The pre-tax amounts recognized in Other Comprehensive Loss/(Income) include the following:
 Retirement PlansRetiree Health and
Life Insurance Plans
  
202520242023202520242023
Adjustments arising during the period:
Net actuarial (gain)/loss$(4,998)$(238)$10,709 $799 $(2,485)$(451)
Prior service cost736 327 430 (321)— 11,637 
Net settlement/curtailment gain/(loss)
221 (530)(1,010)— — — 
Amortization recognized during the period:
Net actuarial (loss)/gain(3,871)(4,472)(4,300)1,160 899 768 
Prior service cost(923)(864)(926)(375)(385)— 
Total recognized in other comprehensive (income)/loss$(8,835)$(5,777)$4,903 $1,263 $(1,971)$11,954 
Total recognized in net periodic benefit cost and other comprehensive loss/(income)$9,156 $11,509 $22,707 $1,118 $(1,780)$11,610 
Schedule of Company's Projected Benefit Payments
The following table sets forth the Company’s projected benefit payments for the next ten years:
YearRetirement PlansRetiree Health and Life Insurance Plans
2026$33,035 $1,341 
2027$31,416 $1,419 
2028$33,787 $1,483 
2029$33,314 $1,509 
2030$33,853 $1,387 
2031-2035$178,345 $8,723 
Schedule of Major Actuarial Assumptions Used in Determining PBO, ABO and Net Periodic Cost
The following tables set forth the major actuarial assumptions used in determining the benefit obligation and net periodic benefit cost:
Weighted-average assumptions
used to determine benefit
obligations at December 31
U.S. Retirement PlansU.S. Retiree Health and Life Insurance PlansForeign Plans
Discount Rate
20255.28 %5.13 %5.02 %
20245.52 %5.32 %6.52 %
Rate of Compensation Increase
2025— %2.99 %2.46 %
2024— %3.02 %3.59 %
 
Weighted-average assumptions
used to determine net periodic benefit
cost for years ended December 31
U.S. Retirement PlansU.S. Retiree Health and Life Insurance PlansForeign Plans
Discount Rate
20255.52 %5.32 %6.52 %
20244.84 %4.68 %4.79 %
20235.01 %4.92 %4.97 %
Expected Long-term Rate of Return
20253.89 %4.64 %5.45 %
20243.08 %3.05 %4.36 %
20232.48 %2.45 %4.70 %
Rate of Compensation Increase
2025— %2.99 %2.46 %
2024— %3.03 %3.11 %
2023— %2.99 %3.29 %
Schedule of Health Care Cost Trend Rates
The U.S. Retiree Health and Life Insurance Plan makes up approximately 98% of the Retiree Health liability. Therefore, the following information relates to the U.S. plan only.
Healthcare Cost Trend RatePre-age 65Post-age 65
20256.20 %7.00 %
20246.17 %7.28 %
Ultimate Trend RatePre-age 65Post-age 65
20254.50 %4.50 %
20244.50 %4.50 %
Year at which the Rate Reaches
the Ultimate Trend Rate
Pre-age 65Post-age 65
202520362036
202420352035
Schedule of Weighted-Average Asset Allocations
The following table sets forth the weighted-average asset allocations of the Company’s retirement plans at 2025 and 2024, by asset category.
Asset Category
  
U.S.EviosysU.K.Canada
Equity securities202534.3 %— %9.5 %31.5 %
202420.9 %— %21.0 %31.4 %
Debt securities202563.1 %79.9 %88.4 %68.5 %
202477.9 %85.1 %77.1 %68.6 %
Cash and short-term investments20252.6 %20.1 %2.1 %— %
20241.2 %14.9 %1.9 %— %
Total2025100.0 %100.0 %100.0 %100.0 %
2024100.0 %100.0 %100.0 %100.0 %
The following table sets forth the weighted-average asset allocations by asset category of the Company’s retiree health and life insurance plan.
Asset Category20252024
Equity securities—%—%
Debt securities100.0%100.0%
Cash—%—%
Total100.0%100.0%
v3.25.4
Income taxes (Tables)
12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Schedule of Provision For Taxes on Income
The provision for taxes on income for the years ended December 31 consists of the following:
202520242023
Pretax income
Domestic$529,172 $(35,733)$280,916 
Foreign235,929 99,219 208,111 
Total pretax income$765,101 $63,486 $489,027 
Current
Federal$59,956 $3,693 $54,319 
State10,732 1,916 11,282 
Foreign97,293 57,034 63,617 
Total current$167,981 $62,643 $129,218 
Deferred
Federal$30,415 $(34,828)$(3,307)
State14,220 (9,837)(1,646)
Foreign(29,030)(12,469)(4,535)
Total deferred$15,605 $(57,134)$(9,488)
Total taxes$183,586 $5,509 $119,730 
Schedule of Deferred tax (Liabilities)/Assets
Deferred tax (liabilities)/assets are comprised of the following at December 31:
20252024
Property, plant and equipment$(235,929)$(266,278)
Intangibles(488,519)(545,330)
Leases(109,707)(76,225)
Outside basis in Metal Packaging (63,105)(68,649)
Other(192)— 
Gross deferred tax liabilities$(897,452)$(956,482)
Retiree health benefits$$245 
Foreign loss carryforwards110,055 79,314 
U.S. Federal loss and credit carryforwards31,980 34,082 
Capital loss carryforwards3,983 3,755 
U.S. State loss and credit carryforwards23,413 26,181 
Capitalized research and development costs67,894 103,043 
Net investment hedge50,524 — 
Employee benefits54,258 56,192 
Leases116,184 82,031 
Accrued liabilities and other assets44,023 71,370 
Gross deferred tax assets$502,318 $456,213 
Valuation allowance on deferred tax assets$(107,451)$(81,496)
Total deferred taxes, net1
$(502,585)$(581,765)
1 Total deferred taxes, net includes $(15,666) reclassified to discontinued operations on the Consolidated Balance Sheets at December 31, 2024. This includes a valuation allowance on deferred tax assets of $(4,628).
Schedule of Reconciliation of U.S. Federal Statutory Tax Rate to Actual Consolidated Tax Expense
A reconciliation of the U.S. federal statutory tax rate to the actual provision for income taxes in the expanded format set forth by ASU 2023-09 for the year ended December 31, 2025 is as follows:
  
2025
U.S. Federal statutory tax rate$160,671 21.0 %
State and local income taxes, net of Federal income tax effect(a)
16,129 2.1 %
Foreign tax effects
  Luxembourg
   Valuation allowances10,826 1.4 %
   Other(5,572)(0.7)%
  Finland
   Nontaxable income(8,115)(1.1)%
   Other(479)(0.1)%
    Other foreign jurisdictions18,402 2.4 %
U.S. Federal tax effects
Effect of changes in tax laws or rates enacted in the current period— — %
Effect of cross-border tax laws
     Global intangible low-taxed income (GILTI), net of foreign tax credit (FTC)9,525 1.2 %
Tax on undistributed earnings of subsidiaries11,756 1.5 %
  Foreign branch inclusion10,479 1.4 %
     Other4,380 0.6 %
Tax credits(9,627)(1.3)%
Changes in valuation allowances34 — %
Nontaxable or nondeductible items
  Benefit for purchased credits(14,875)(1.9)%
     Other5,927 0.8 %
Changes in unrecognized tax benefits2,622 0.3 %
Other adjustments
     Disposition of business(29,994)(3.9)%
     Other1,497 0.2 %
Provision For Income Taxes$183,586 24.0 %

(a) State taxes in Tennessee, Illinois, California, Wisconsin and New Jersey make up the majority (greater than 50 percent) of the tax effect in this category.
A reconciliation of the U.S. federal statutory tax rate to the actual provision for income taxes for the years ended December 31, 2024 and 2023 is as follows:
  
20242023
U.S. Federal statutory tax rate$13,332 21.0 %$102,696 21.0 %
State income taxes, net of federal tax benefit(883)(1.4)%12,263 2.5 %
Valuation allowance7,763 12.2 %4,486 0.9 %
Tax examinations including change in reserve for uncertain tax positions(8,613)(13.6)%1,819 0.4 %
Adjustments to prior year deferred taxes(9,129)(14.4)%(2,489)(0.5)%
Foreign earnings taxed at other than U.S. rates12,271 19.3 %13,108 2.7 %
Divestiture of business(2,954)(4.7)%464 0.1 %
Effect of tax rate changes(1,552)(2.4)%387 0.1 %
Foreign withholding taxes5,344 8.4 %4,591 0.9 %
Tax credits(11,834)(18.6)%(18,848)(3.9)%
Global intangible low-taxed income (GILTI)(5,604)(8.8)%4,853 1.0 %
Foreign-derived intangible income(858)(1.4)%(1,106)(0.2)%
Foreign currency gain/(loss) on distributions of previously taxed income642 1.0 %(2,614)(0.5)%
IRC Subpart F Income916 1.4 %119 — %
Executive compensation limitation2,569 4.0 %3,767 0.8 %
Capitalized acquisition costs7,202 11.3 %104 — %
Other, net(3,103)(4.9)%(3,870)(0.8)%
Provision for income taxes$5,509 8.7 %$119,730 24.5 %
Schedule of Income Taxes Paid
The following table sets forth income taxes paid, including payments for the acquisition of income tax credits, net of refunds, for the year ended December 31, 2025, disaggregated between foreign, domestic and state:
2025
Federal taxes paid$125,868 
State taxes paid30,926 
Foreign taxes paid108,107 
Total$264,901 
Income taxes paid, net of refunds, exceeded 5 percent of total income taxes paid, net of refunds, in the following jurisdictions:
2025
Foreign Taxes Paid
     Spain$20,109 
     Brazil$17,688 
Other$70,310 
Schedule of Unrecognized Tax Benefits
The following table sets forth the reconciliation of the gross amounts of unrecognized tax benefits at the beginning and ending of the periods indicated: 
202520242023
Gross Unrecognized Tax Benefits at January 1$12,138 $21,677 $18,621 
Increases in prior years’ unrecognized tax benefits2,743 627 378 
Decreases in prior years’ unrecognized tax benefits(1,404)(1,915)(572)
Increases in current year unrecognized tax benefits688 4,325 4,395 
Decreases in unrecognized tax benefits from the lapse of statutes of limitations(235)(12,100)(1,094)
Settlements(748)(476)(51)
Gross Unrecognized Tax Benefits at December 31$13,182 $12,138 $21,677 
v3.25.4
Revenue recognition (Tables)
12 Months Ended
Dec. 31, 2025
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
The following tables set forth information about revenue disaggregated by primary geographic regions for the years ended December 31, 2025, 2024 and 2023. The tables also include a reconciliation of disaggregated revenue with reportable segments. The Company’s reportable segments are aligned by product nature as disclosed in Note 20.
Year Ended December 31, 2025Consumer PackagingIndustrial Paper PackagingAll OtherTotal
Primary geographical markets:
United States$1,864,861 $1,464,574 $285,486 $3,614,921 
EMEA2,789,400 361,878 56,160 3,207,438 
Canada18,539 85,875 — 104,414 
APAC100,482 148,012 1,065 249,559 
Other101,009 238,894 2,518 342,421 
Total$4,874,291 $2,299,233 $345,229 $7,518,753 
Year Ended December 31, 2024Consumer PackagingIndustrial Paper PackagingAll OtherTotal
Primary geographical markets:
United States$1,785,857 $1,431,232 $352,717 $3,569,806 
EMEA524,699 371,896 58,925 955,520 
Canada17,486 95,863 — 113,349 
APAC96,154 213,127 1,771 311,052 
Other107,656 237,370 10,612 355,638 
Total$2,531,852 $2,349,488 $424,025 $5,305,365 
Year Ended December 31, 2023Consumer PackagingIndustrial Paper PackagingAll OtherTotal
Primary geographical markets:
United States$1,817,268 $1,389,492 $494,112 $3,700,872 
EMEA431,189 389,261 64,936 885,386 
Canada16,076 100,095 — 116,171 
APAC94,136 233,446 1,812 329,394 
Other112,379 261,819 35,405 409,603 
Total$2,471,048 $2,374,113 $596,265 $5,441,426 
Schedule of Contract Asset and Liabilities
The following table sets forth information about contract assets and liabilities from contracts with customers. The balances of the contract assets and liabilities are located in “Other receivables” and “Accrued expenses and other payables”, respectively, in the Consolidated Balance Sheets.
December 31, 2025December 31, 2024
Contract Assets$77,978 $67,062 
Contract Liabilities$(58,784)$(60,024)
Significant changes in the contract assets and liabilities balances during the twelve months ended December 31, 2025 and 2024 were as follows:
December 31, 2025December 31, 2024
Contract Assets
Contract Liabilities
Contract Assets
Contract Liabilities
Beginning balance$67,062 $(60,024)$14,754 $(15,252)
Acquired/ sold as part of a business combination/ divestiture(53)(324)62,439 (47,478)
Revenue deferred or rebates accrued— (94,947)— (25,736)
Recognized as revenue— 1,183 — 2,341 
Rebates paid to customers— 95,328 — 26,101 
Increases due to rights to consideration for customer specific goods produced, but not billed during the period77,978 — 67,062 — 
Transferred to receivables from contract assets recognized at the beginning of the period and acquired as part of business combination(67,009)— (77,193)— 
Ending balance$77,978 $(58,784)$67,062 $(60,024)
v3.25.4
Shareholders’ equity and earnings per share (Tables)
12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
Schedule of Earnings /(Loss) Per Share
The following table sets forth the computation of basic and diluted earnings/(loss) per share (in thousands, except per share data):
202520242023
Numerator:
Net income from continuing operations$591,038 $67,565 $379,644 
Net (income)/loss from continuing operations attributable to noncontrolling interests(375)180 (768)
Net income from continuing operations attributable to Sonoco590,663 67,745 378,876 
Net income attributable to Sonoco$1,003,011 $163,949 $474,959 
Denominator:
Weighted average common shares outstanding:
Basic99,124 98,637 98,294 
Dilutive effect of shared-based compensation447 653 596 
Diluted 99,571 99,290 98,890 
Per common share:
Basic earnings per common share:
Net income from continuing operations$5.96 $0.69 $3.85 
Net income attributable to Sonoco$10.12 $1.66 $4.83 
Diluted earnings per common share:
Net income from continuing operations$5.93 $0.68 $3.83 
Net income attributable to Sonoco$10.07 $1.65 $4.80 
Cash dividends$2.11 $2.07 $2.02 
Schedule of Shares Not Included in Computations of Diluted Income Per Share
The average number of shares that were not dilutive and therefore not included in the computation of diluted income per share was as follows for the years ended December 31, 2025, 2024 and 2023 (in thousands):
202520242023
Anti-dilutive stock appreciation rights513 408 352 
v3.25.4
Segment reporting (Tables)
12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
Schedule of Financial Segment Information
The following table sets forth financial information about each of the Company’s reportable segments:
Year Ended December 31, 2025Consumer PackagingIndustrial Paper PackagingTotal Reportable Segments
Sales from external customers$4,874,291 $2,299,233 $7,173,524 
Intersegment sales(1)
22,547 121,153 143,700 
$4,896,838 $2,420,386 $7,317,224 
Reconciliation of sales
Other sales(2)
349,888 
Elimination of intersegment sales(148,359)
Total consolidated sales$7,518,753 
Less:(3)
Cost of sales(4)
$(3,950,750)$(1,726,225)
Other segment items(5)
(319,168)(381,707)
Segment operating profit$626,920 $312,454 $939,374 
Other segment disclosures:
Equity in earnings of affiliates, net of tax$226 $9,297 
Depreciation and amortization(6)
$209,618 $118,889 
Year Ended December 31, 2024Consumer PackagingIndustrial Paper PackagingTotal Reportable Segments
Sales from external customers$2,531,852 $2,349,488 $4,881,340 
Intersegment sales(1)
8,022 111,682 119,704 
$2,539,874 $2,461,170 $5,001,044 
Reconciliation of sales
Other sales(2)
431,107 
Elimination of intersegment sales(126,786)
Total consolidated sales$5,305,365 
Less:(3)
Cost of sales(4)
$(2,041,078)$(1,818,324)
Other segment items(5)
(203,964)(371,192)
Segment operating profit$294,832 $271,654 $566,486 
Other segment disclosures:
Equity in earnings of affiliates, net of tax$365 $9,223 
Depreciation and amortization(6)
$109,355 $116,149 


Year Ended December 31, 2023Consumer PackagingIndustrial Paper PackagingTotal Reportable Segments
Sales from external customers$2,471,048 $2,374,113 $4,845,161 
Intersegment sales(1)
5,171 101,822 106,993 
$2,476,219 $2,475,935 $4,952,154 
Reconciliation of sales
Other sales(2)
604,442 
Elimination of intersegment sales(115,170)
Total consolidated sales$5,441,426 
Less:(3)
Cost of sales(4)
$(1,999,514)$(1,809,803)
Other segment items(5)
(190,943)(348,215)
Segment operating profit$285,762 $317,917 $603,679 
Other segment disclosures:
Equity in earnings of affiliates, net of tax$564 $9,783 
Depreciation and amortization(6)
$95,340 $104,723 
(1)
Intersegment sales are recorded at a market-related transfer price.
(2)
Sales from businesses below the quantitative threshold are attributable to the group of businesses within All Other.
(3)
The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(4)
Cost of sales of reportable segments excludes certain costs, primarily changes in LIFO inventory reserves, net gains or losses from derivatives, and acquisition, integration and divestiture-related costs.
(5)
Other segment items consists of:
Consumer Packaging: Labor and benefits, consulting and professional services, travel, communication, facilities and supplies.
Industrial Paper Packaging: Labor and benefits, consulting and professional services, travel, communication, facilities and supplies.
(6)
Represents significant segment expenses that are regularly provided to the CODM and are included in cost of sales and other segment items within segment operating profit.
Reconciliation of segment operating profit to income from continuing operations before income taxes:202520242023
Segment operating profit$939,374 $566,486 $603,679 
Other operating profits(1)
50,813 53,278 85,148 
Unallocated amounts:
Restructuring/Asset impairment charges, net
(66,215)(65,370)(47,909)
Amortization of acquisition intangibles(182,431)(78,595)(67,323)
Gain/(Loss) on divestiture of business371,717 (23,452)78,929 
Acquisition, integration and divestiture-related costs(54,158)(91,600)(24,624)
Changes in LIFO inventory reserves(58)6,263 11,817 
Derivative (losses)/gains(1,730)7,225 1,912 
Other corporate costs, net(2)
(35,242)(46,675)(42,254)
Other operating (charges)/income, net(3)
(4,335)(982)(10,326)
Other (expense)/income, net(4)
(27,481)(104,200)39,657 
Non-operating pension costs(12,215)(13,842)(14,312)
Interest expense(233,485)(172,620)(135,393)
Interest income20,547 27,570 10,026 
Income from continuing operations before income taxes$765,101 $63,486 $489,027 

(1)
Operating profit from segments below the quantitative threshold are attributable to the group of businesses within All Other.
(2)
Other corporate costs represent recurring operating expenses previously allocated to TFP that will remain with Sonoco subsequent to the divestiture, net of income earned under a transition services agreement with Toppan.
(3)
Primarily consists of highly inflationary accounting in Turkey and other miscellaneous charges in 2025, 2024, and 2023.
(4)
In 2025, these expenses relate to charges from third-party financial institutions related to the Company’s centralized treasury program under which the Company sells certain trade accounts receivable in order to accelerate its cash collection cycle, primarily within the Consumer Packaging segment. In 2024, the expense primarily relates to a net loss on foreign currency remeasurement, partially offset by a gain from the fair value remeasurement of an equity investment.
Reconciliation of other segment disclosures to consolidated totals:202520242023
Equity in earnings of affiliates, net of tax
Consumer Packaging$226 $365 $564 
Industrial Paper Packaging9,297 9,223 9,783 
Reportable Segment Total9,523 9,588 10,347 
Adjustments— — — 
Consolidated Total$9,523 $9,588 $10,347 
Depreciation and amortization
Consumer Packaging$209,618 $109,355 $95,340 
Industrial Paper Packaging118,889 116,149 104,723 
Reportable Segment Total328,507 225,504 200,063 
Other(1)
191,160 90,557 81,966 
Consolidated Total$519,667 $316,061 $282,029 
(1)
Other represents depreciation and amortization expense for the All Other group of businesses and total amortization of acquisition intangibles for Sonoco, excluding discontinued operations.
Schedule of Sales to Unaffiliated Customers and Long-Lived Assets by Geographic Region
Sales to unaffiliated customers and long-lived assets by geographic region are as follows:
202520242023
Sales to Unaffiliated Customers
United States$3,614,921 $3,569,806 $3,700,872 
EMEA3,207,438 955,520 885,386 
Canada104,414 113,349 116,171 
APAC249,559 311,052 329,394 
All other342,421 355,638 409,603 
Total$7,518,753 $5,305,365 $5,441,426 
Long-lived Assets
United States$2,462,090 $2,695,885 $2,779,178 
EMEA4,893,882 4,690,098 617,949 
Canada27,214 35,750 39,842 
APAC180,882 176,547 157,235 
All other478,462 300,623 149,530 
Total$8,042,530 $7,898,903 $3,743,734 
v3.25.4
Accumulated other comprehensive loss (Tables)
12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
Schedule of Components of Accumulated Other Comprehensive Income/(Loss)
The following table summarizes the components of accumulated other comprehensive loss and the changes in accumulated other comprehensive loss, net of tax as applicable, for the years ended December 31, 2025 and 2024:
Foreign
Currency
Items
Defined
Benefit
Pension Items
Gains and Losses on Cash Flow Hedges
Accumulated
Other
Comprehensive
Loss
Balance at December 31, 2023
$(267,578)$(99,627)$943 $(366,262)
Other comprehensive (loss)/income before reclassifications(146,856)4,636 (3,213)(145,433)
Amounts reclassified from accumulated other comprehensive loss to net income3,503 4,378 1,080 8,961 
Other comprehensive (loss)/income(143,353)9,014 (2,133)(136,472)
Balance at December 31, 2024
$(410,931)$(90,613)$(1,190)$(502,734)
Other comprehensive income before reclassifications484,608 1,159 3,486 489,253 
Amounts reclassified from accumulated other comprehensive loss to net income50,550 1,496 (1,361)50,685 
Other comprehensive income535,158 2,655 2,125 539,938 
Balance at December 31, 2025
$124,227 $(87,958)$935 $37,204 
Schedule of Effects on Net Income of Significant Amounts Reclassified from Accumulated Other Comprehensive Income/(Loss)
The following table summarizes the amounts reclassified from accumulated other comprehensive loss and the affected line items in the consolidated statements of net income for the years ended December 31, 2025 and 2024:
Amount Reclassified from Accumulated Other Comprehensive Income/(Loss)
Details about Accumulated Other
Comprehensive
Income/(Loss) Components
Year Ended December 31, 2025Year Ended December 31, 2024Affected Line Item in the Consolidated Statements of Net Income
Foreign currency items (see Note 4)
Currency translation adjustment (“CTA”) loss on TFP divestiture
$(47,955)$— Net income from discontinued operations
CTA loss on Venezuela divestiture(3,792)— Gain/(Loss) on divestiture of business and other assets
CTA gain on ThermoSafe divestiture1,197 — Gain/(Loss) on divestiture of business and other assets
CTA loss on Protexic and China divestitures— (3,503)Gain/(Loss) on divestiture of business and other assets
(50,550)(3,503)Net income
Defined benefit pension items (see Note 15)
Effect of settlement loss(42)(530)Non-operating pension costs
Effect of curtailment gain263 — Non-operating pension costs
Amortization of defined benefit pension items(4,009)(4,822)Non-operating pension costs
(3,788)(5,352)Income from continuing operations before income taxes
Income tax impact2,292 974 Provision for income taxes
(1,496)(4,378)Net income
Gains/(losses) on cash flow hedges (see Note 12)
Foreign exchange contracts3,811 (1,174)Net Sales
Foreign exchange contracts(2,557)(253)Cost of sales
Commodity contracts447 (28)Cost of sales
1,701 (1,455)Income from continuing operations before income taxes
Income tax impact(340)375 Provision for income taxes
1,361 (1,080)Net income
Amounts reclassified to net income from accumulated other comprehensive income/(loss)$(50,685)$(8,961)Net income
Schedule of Before and After Tax Amounts for Comprehensive Income (Loss) Components
The following table summarizes the tax expense/(benefit) for the components of other comprehensive income/(loss):
For the year ended December 31, 2025
For the year ended December 31, 2024
Before Tax AmountTaxAfter Tax AmountBefore Tax AmountTaxAfter Tax Amount
Foreign currency items:
Other comprehensive income/(loss) before reclassifications$428,732 $55,876 $484,608 $(140,210)$(6,646)$(146,856)
Amounts reclassified from accumulated other comprehensive income/(loss) to net income50,550 — 50,550 3,503 — 3,503 
Net other comprehensive income/(loss) from foreign currency items479,282 55,876 535,158 (136,707)(6,646)(143,353)
Defined benefit pension items:
Other comprehensive income before reclassifications3,784 (2,625)1,159 2,395 2,241 4,636 
Amounts reclassified from accumulated other comprehensive income/(loss) to net income3,788 (2,292)1,496 5,352 (974)4,378 
Net other comprehensive income from defined benefit pension items7,572 (4,917)2,655 7,747 1,267 9,014 
Cash flow hedges:
Other comprehensive income/(loss) before reclassifications4,357 (871)3,486 (4,329)1,116 (3,213)
Amounts reclassified from accumulated other comprehensive (loss)/income to net income
(1,701)340 (1,361)1,455 (375)1,080 
Net other comprehensive income/(loss) from cash flow hedges2,656 (531)2,125 (2,874)741 (2,133)
Other comprehensive income/(loss)$489,510 $50,428 $539,938 $(131,834)$(4,638)$(136,472)
v3.25.4
Summary of significant accounting policies - Schedule of Affiliated Companies (Details)
Dec. 31, 2025
Cascades Conversion, Inc.  
Noncontrolling Interest [Line Items]  
Ownership Interest 50.00%
Cascades Sonoco, Inc.  
Noncontrolling Interest [Line Items]  
Ownership Interest 50.00%
ISI Robotics, LLC  
Noncontrolling Interest [Line Items]  
Ownership Interest 32.30%
Showa Products Company Ltd.  
Noncontrolling Interest [Line Items]  
Ownership Interest 22.20%
Papertech Energía, S.L.  
Noncontrolling Interest [Line Items]  
Ownership Interest 25.00%
Weidenhammer New Packaging, LLC  
Noncontrolling Interest [Line Items]  
Ownership Interest 40.00%
v3.25.4
Summary of significant accounting policies - Additional Information (Details)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 04, 2024
USD ($)
Dec. 31, 2025
USD ($)
Dec. 31, 2025
USD ($)
segment
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Jun. 30, 2024
Mar. 31, 2024
Jan. 26, 2023
Summary Of Significant Accounting Policies [Line Items]                
Cash dividends from affiliated companies     $ 24,822 $ 11,926 $ 9,389      
Investments in affiliated companies and other net investing proceeds     6,469 9,978 2,781      
Carrying value of equity investments   $ 49,644 49,644 67,801        
Research and development costs     $ 21,500 $ 23,000 $ 23,900      
Percentage of LIFO inventory (percent)   9.00% 9.00% 9.00%        
LIFO inventory amount   $ 33,323 $ 33,323 $ 33,265        
Portfolio approach, lease, short rate term (or less)     10 years          
Portfolio approach, lease, long rate term (greater than)     10 years          
Number of reportable segments | segment     2          
Minimum                
Summary Of Significant Accounting Policies [Line Items]                
Useful lives of intangible asset   3 years 3 years          
Expected range of return on plan investments, term     12 years          
Minimum | Equipment                
Summary Of Significant Accounting Policies [Line Items]                
Property plant and equipment, useful life   3 years 3 years          
Minimum | Buildings                
Summary Of Significant Accounting Policies [Line Items]                
Property plant and equipment, useful life   15 years 15 years          
Maximum                
Summary Of Significant Accounting Policies [Line Items]                
Useful lives of intangible asset   20 years 20 years          
Expected range of return on plan investments, term     30 years          
Maximum | Equipment                
Summary Of Significant Accounting Policies [Line Items]                
Property plant and equipment, useful life   11 years 11 years          
Maximum | Buildings                
Summary Of Significant Accounting Policies [Line Items]                
Property plant and equipment, useful life   40 years 40 years          
Eviosys                
Summary Of Significant Accounting Policies [Line Items]                
Trade receivables sold and derecognized $ 73,487              
Customers that sponsor/promote multi-vendor supply chain finance arrangements | Revenue Benchmark | Customer concentration | Multi-Vendor Supply Chain Finance Arrangement                
Summary Of Significant Accounting Policies [Line Items]                
Customer concentrations (percent)     10.00% 12.00%        
Chilean Tube                
Summary Of Significant Accounting Policies [Line Items]                
Ownership Interest   19.50% 19.50%          
Sustainable Protective Packaging Solutions                
Summary Of Significant Accounting Policies [Line Items]                
Ownership Interest   39.90% 39.90%     39.90% 20.50%  
Cascades                
Summary Of Significant Accounting Policies [Line Items]                
Proceeds from dividends received   $ 26,266            
Cash dividends from affiliated companies     $ 19,811          
Investments in affiliated companies and other net investing proceeds     $ 6,455          
Dispositions | Northstar                
Summary Of Significant Accounting Policies [Line Items]                
Consideration from disposal, equity interest percentage received               2.70%
v3.25.4
Summary of significant accounting policies - Schedule of Inventory (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Accounting Policies [Abstract]    
Finished goods $ 370,303 $ 359,086
Work in process 161,313 135,004
Materials and supplies 589,393 522,049
Inventories $ 1,121,009 $ 1,016,139
v3.25.4
Discontinued operations - Balance Sheet (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Disposal Group, Including Discontinued Operations [Line Items]    
Current assets of discontinued operations $ 0 $ 450,874
Current liabilities of discontinued operations 0 242,056
Deferred income taxes   15,666
Noncurrent Liabilities of Discontinued Operations $ 0 113,911
Discontinued Operations, Disposed of by Sale    
Disposal Group, Including Discontinued Operations [Line Items]    
Cash and cash equivalents   12,050
Trade accounts receivable, net of allowances of $$2,582   209,379
Other receivables   46,001
Finished and in process   80,573
Materials and supplies   94,083
Prepaid expenses   8,788
Current assets of discontinued operations   450,874
Property, plant and equipment, net of accumulated depreciation of $465,923   262,662
Goodwill   502,621
Other intangible assets, net of accumulated amortization of $206,437   103,593
Deferred income taxes   262
Right of use asset-operating leases   75,855
Other assets   19,317
Noncurrent Assets of Discontinued Operations   964,310
Payable to suppliers   172,720
Accrued expenses and other payables   62,562
Notes payable and current portion of long-term debt   6,774
Current liabilities of discontinued operations   242,056
Long-term debt   29,850
Noncurrent operating lease liabilities   67,789
Deferred income taxes   15,928
Other liabilities   344
Noncurrent Liabilities of Discontinued Operations   $ 113,911
v3.25.4
Discontinued Operations - Balance Sheet (Parenthetical) (Details) - Discontinued Operations, Disposed of by Sale
$ in Thousands
Dec. 31, 2024
USD ($)
Disposal Group, Including Discontinued Operations [Line Items]  
Trade accounts receivable, net of allowances $ 2,582
Property plant and equipment, accumulated depreciation 465,923
Intangible assets, accumulated amortization $ 206,437
v3.25.4
Discontinued operations - Income Statement (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Disposal Group, Including Discontinued Operations [Line Items]      
Net income from discontinued operations $ 412,348 $ 96,375 $ 96,257
Net income from discontinued operations attributable to noncontrolling interests $ 0 $ (171) $ (174)
Weighted average common shares outstanding:      
Basic (in shares) 99,124 98,637 98,294
Diluted (in shares) 99,571 99,290 98,890
Net income attributable to discontinued operations:      
Basic (usd per share) $ 4.16 $ 0.97 $ 0.98
Diluted (usd per share) $ 4.14 $ 0.97 $ 0.97
Discontinued Operations, Disposed of by Sale      
Disposal Group, Including Discontinued Operations [Line Items]      
Net sales $ 320,678 $ 1,291,461 $ 1,339,866
Cost of sales 250,854 1,037,196 1,106,970
Gross profit 69,824 254,265 232,896
Selling, general and administrative expenses 31,607 122,488 97,131
Restructuring/Asset impairment charges, net 426 3,740 9,024
Gain on divestiture of business 606,633 0 0
Operating profit 644,424 128,037 126,741
Other (expense)/income, net (182) 0 0
Interest expense 24,911 13,396 1,293
Interest income 281 1,668 357
Income from discontinued operations before income taxes 619,612 116,309 125,805
Provision for income taxes 207,264 19,934 29,548
Net income from discontinued operations 412,348 96,375 96,257
Net income from discontinued operations attributable to noncontrolling interests 0 (171) (174)
Net income attributable to discontinued operations $ 412,348 $ 96,204 $ 96,083
Weighted average common shares outstanding:      
Basic (in shares) 99,124 98,637 98,294
Diluted (in shares) 99,571 99,290 98,890
Net income attributable to discontinued operations:      
Basic (usd per share) $ 4.16 $ 0.97 $ 0.98
Diluted (usd per share) $ 4.14 $ 0.97 $ 0.97
Discontinued Operations, Disposed of by Sale | TFP      
Disposal Group, Including Discontinued Operations [Line Items]      
Interest expense $ 24,060 $ 9,528  
v3.25.4
Discontinued operations - Cash Flows Statement (Details) - Discontinued Operations, Disposed of by Sale - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Disposal Group, Including Discontinued Operations [Line Items]      
Depreciation and amortization $ (311)    
Depreciation and amortization   $ 58,798 $ 58,959
Purchases of property, plant and equipment $ (5,572) $ (65,321) $ (55,624)
v3.25.4
Acquisitions and divestitures - Acquisitions - Additional Information (Details)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 04, 2024
USD ($)
termLoanFacility
Jun. 01, 2024
USD ($)
Dec. 01, 2023
USD ($)
Sep. 08, 2023
USD ($)
Jun. 29, 2025
USD ($)
Jun. 30, 2024
USD ($)
Dec. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
acquisition
Business Combination [Line Items]                  
Cash received in final net working capital settlement of acquisition [1]             $ 16,528    
Cash consideration, net of cash acquired [1]               $ 3,793,569 $ 372,616
Industira Paranaense de Tubos Conicais LTDA                  
Business Combination [Line Items]                  
Asset purchase   $ 2,660              
Eviosys                  
Business Combination [Line Items]                  
Total consideration $ 3,789,826                
Cash received in final net working capital settlement of acquisition         $ 16,528        
Number of term loan facilities used in acquisition | termLoanFacility 2                
Remeasurement loss $ 113,697                
Payments for settlement of foreign currency forward contracts $ 34,414                
Expected value of goodwill to be tax deductible             485,000    
Acquisition and divestiture-related costs               267,886  
2023 Acquisitions                  
Business Combination [Line Items]                  
Number of acquisitions | acquisition                 2
Cash consideration, net of cash acquired                 $ 372,616
Inapel                  
Business Combination [Line Items]                  
Total consideration     $ 64,390            
Cash consideration, net of cash acquired     $ 59,228            
Contingent purchase liability           $ 2,340   $ 2,333  
Final working capital settlement           $ 489      
RTS Packaging                  
Business Combination [Line Items]                  
Voting interest acquired       65.00%          
Interest held in acquiree before subsequent acquisition (percent)       35.00%          
Business combination, carrying value       $ 8,654          
Business combination, net gain       $ 44,029          
Business Combination, Achieved in Stages, Preacquisition Equity Interest in Acquiree, Remeasurement, Gain, Statement of Income or Comprehensive Income [Extensible Enumeration]       Other (expense)/income, net          
Accumulated other comprehensive loss including foreign currency translation losses       $ 2,033          
Accumulated other comprehensive loss including define pension plan, before tax       4,756          
RTS Packaging and Chattanooga Mill                  
Business Combination [Line Items]                  
Total consideration       374,547          
Expected value of goodwill to be tax deductible             $ 83,000    
Cash consideration, net of cash acquired       313,388          
Final working capital settlement       452          
Fair value of previously held interest in RTS Packaging       59,472          
Chattanooga Mill                  
Business Combination [Line Items]                  
Settlement of unfavorable contract       $ 7,086          
[1]
1The Company received a final net working capital settlement of $16,528 during 2025 related to the acquisition of Titan Holdings I B.V. (“Eviosys”).
v3.25.4
Acquisitions and divestitures - Schedule of Preliminary Fair Value Of Assets Acquired And Measurement Period Adjustments (Details) - USD ($)
$ in Thousands
12 Months Ended 13 Months Ended
Dec. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Dec. 04, 2024
Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less) [Abstract]        
Goodwill $ 2,511,611 $ 2,511,611 $ 2,525,657  
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments [Abstract]        
Goodwill (27,399)      
Eviosys        
Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less) [Abstract]        
Trade accounts receivable 295,234 295,234   $ 300,385
Other receivables 116,643 116,643   114,634
Inventories 433,007 433,007   445,945
Prepaid expenses 44,533 44,533   47,509
Property, plant and equipment 1,002,652 1,002,652   1,057,779
Right of use asset - operating leases 43,571 43,571   43,566
Other intangible assets 2,010,057 2,010,057   1,967,678
Goodwill 1,258,119 1,258,119   1,285,518
Long-term deferred income taxes 53,876 53,876   39,023
Other assets 3,353 3,353   3,330
Payable to suppliers (517,093) (517,093)   (518,766)
Accrued expenses and other payables (171,696) (171,696)   (168,529)
Accrued wages and other compensation (41,806) (41,806)   (41,749)
Notes payable and current portion of long-term debt (76,443) (76,443)   (76,438)
Noncurrent operating lease liabilities (32,022) (32,022)   (32,022)
Pension and other postretirement benefits (51,918) (51,918)   (51,849)
Long-term debt (34) (34)   0
Deferred income taxes (568,169) (568,169)   (599,941)
Other long-term liabilities (16,687) (16,687)   (16,714)
Noncontrolling Interests (11,879) (11,879)   (9,533)
Net assets acquired $ 3,773,298 3,773,298   $ 3,789,826
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments [Abstract]        
Trade accounts receivable   (5,151)    
Other receivables   2,009    
Inventories   (12,938)    
Prepaid expenses   (2,976)    
Property, plant and equipment   (55,127)    
Right of use asset - operating leases   5    
Other intangible assets   42,379    
Goodwill   (27,399)    
Long-term deferred income taxes   14,853    
Other assets   23    
Payable to suppliers   1,673    
Accrued expenses and other payables   (3,167)    
Accrued wages and other compensation   (57)    
Notes payable and current portion of long-term debt   (5)    
Pension and other postretirement benefits   (69)    
Long-term debt   (34)    
Deferred income taxes   31,772    
Other long-term liabilities   27    
Noncontrolling Interests   (2,346)    
Net assets acquired   $ (16,528)    
v3.25.4
Acquisitions and divestitures - Schedule of Pro Forma and Supplemental Information (Details) - Eviosys - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Dec. 31, 2024
Dec. 31, 2024
Dec. 31, 2023
Supplemental Information      
Net sales $ 115,031    
Net loss $ 15,086    
Pro Forma Supplemental Information      
Net sales   $ 7,546,920 $ 8,032,135
Net income from continuing operations   157,389 105,116
Net income attributable to Sonoco   $ 253,593 $ 200,589
v3.25.4
Acquisitions and divestitures - Schedule of the Purchase Consideration Transferred for the Acquisitions (Details) - USD ($)
$ in Thousands
12 Months Ended
Sep. 08, 2023
Dec. 31, 2024
Dec. 31, 2023
Business Combination [Line Items]      
Cash consideration, net of cash acquired [1]   $ 3,793,569 $ 372,616
RTS Packaging and Chattanooga Mill      
Business Combination [Line Items]      
Cash consideration, net of cash acquired $ 313,388    
Fair value of previously held interest in RTS Packaging 59,472    
Final working capital settlement 452    
Settlement of preexisting relationships 1,235    
Purchase consideration transferred $ 374,547    
[1]
1The Company received a final net working capital settlement of $16,528 during 2025 related to the acquisition of Titan Holdings I B.V. (“Eviosys”).
v3.25.4
Acquisitions and divestitures - Divestiture of Businesses (Details)
a in Thousands
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Nov. 03, 2025
USD ($)
Apr. 30, 2025
USD ($)
Apr. 01, 2025
USD ($)
Mar. 02, 2025
USD ($)
Jan. 17, 2025
USD ($)
Dec. 23, 2024
USD ($)
Apr. 01, 2024
USD ($)
Jul. 01, 2023
USD ($)
Mar. 29, 2023
USD ($)
a
Jan. 26, 2023
USD ($)
Nov. 30, 2024
USD ($)
productionFacility
Sep. 29, 2024
USD ($)
Apr. 02, 2023
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Mar. 31, 2026
USD ($)
Feb. 28, 2025
USD ($)
Jun. 30, 2024
USD ($)
Business Combination [Line Items]                                        
Gain/(Loss) on divestiture of business and other assets                             $ 978,350,000 $ (23,452,000) $ 57,104,000      
Total taxes                             183,586,000 5,509,000 119,730,000      
Goodwill, impairment loss                             0          
Gain/(Loss) on divestiture of business and other assets                             $ 371,717,000 (23,452,000) 78,929,000      
Discontinued Operations, Disposed of by Sale                                        
Business Combination [Line Items]                                        
Disposed assets net book value                               $ 964,310,000        
Discontinued Operations, Disposed of by Sale | TFP                                        
Business Combination [Line Items]                                        
Consideration for disposal of business held for sale     $ 1,807,493,000                                  
Write-off of net assets in divestiture     1,112,489,000                                  
Reclassification of cumulative translation adjustment gain (loss)     47,955,000                                  
Disposition transaction fees     25,205,000                                  
Gain/(Loss) on divestiture of business and other assets     606,633,000                                  
Total taxes     199,457,000                                  
Gain (loss) on divestiture of business, after tax     $ 407,176,000                                  
Discontinued Operations, Disposed of by Sale | TFP | Forecast                                        
Business Combination [Line Items]                                        
Liability for working capital settlement related to disposal                                   $ 15,211,000    
Dispositions | ThermoSafe                                        
Business Combination [Line Items]                                        
Write-off of net assets in divestiture $ 265,777,000                                      
Reclassification of cumulative translation adjustment gain (loss) 1,197,000                                      
Disposition transaction fees 13,233,000                                      
Gain/(Loss) on divestiture of business and other assets 378,014,000                                      
Cash and debt free, purchase price 655,827,000                                      
Additional consideration for disposal of business held for sale 75,000,000                                      
Goodwill, impairment loss $ 173,250,000                                      
Dispositions | Black Diamond Capital Management LLC                                        
Business Combination [Line Items]                                        
Consideration for disposal of business held for sale             $ 80,267,000                          
Working capital adjustment                       $ 1,805,000                
Write off of assets as part of the sale totaling             905,000                          
Dispositions | Protective Solutions "Protexic"                                        
Business Combination [Line Items]                                        
Write-off of net assets in divestiture             74,644,000                          
Goodwill, impairment loss             $ 16,559,000                          
Goodwill, Impairment Loss, Statement of Income or Comprehensive Income [Extensible Enumeration]             Gain/(Loss) on divestiture of business and other assets                          
Cumulative translation adjustment losses             $ 2,913,000                          
Dispositions | US BulkSak Business                                        
Business Combination [Line Items]                                        
Consideration for disposal of business held for sale               $ 1,096,000           $ 20,271,000     $ 20,271,000      
Goodwill, impairment loss               $ 3,333,000                        
Goodwill, Impairment Loss, Statement of Income or Comprehensive Income [Extensible Enumeration]               Gain/(Loss) on divestiture of business and other assets                        
Proceeds from the sale of business, net                           18,271,000            
Write off of assets as part of the sale totaling               $ 6,834,000                        
Funding of escrow funds                                     $ 2,000,000  
Net assets disposed               13,437,000                        
Gain/(Loss) on divestiture of business and other assets               $ 85,000                        
Dispositions | Sonoco Sustainability Solutions                                        
Business Combination [Line Items]                                        
Goodwill, impairment loss                         $ 3,042,000              
Goodwill, Impairment Loss, Statement of Income or Comprehensive Income [Extensible Enumeration]                         Gain/(Loss) on divestiture of business and other assets              
Proceeds from the sale of business, net                   $ 13,839,000                    
Write off of assets as part of the sale totaling                         $ 4,274,000              
Funding of escrow funds                   1,500,000                    
Gain/(Loss) on divestiture of business and other assets                         $ 11,065,000              
Consideration from disposal, equity interest, value received                                       $ 1,250,000
Dispositions | Northstar                                        
Business Combination [Line Items]                                        
Proceeds from the sale of business, net           $ 8,630,000                            
Gain/(Loss) on divestiture of business and other assets           $ 3,630,000                            
Consideration from disposal, equity interest, value received                   $ 5,000,000                    
Consideration from disposal, equity interest percentage received                   2.70%                    
Dispositions | Timberland Properties                                        
Business Combination [Line Items]                                        
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal, Statement of Income or Comprehensive Income [Extensible Enumeration]                                 Gain/(Loss) on divestiture of business and other assets      
Proceeds from the sale of business, net                 $ 70,802,000                      
Area of land | a                 55                      
Disposed assets net book value                           $ 9,857,000     $ 9,857,000      
Gain on the sale of business                                 $ 60,945,000      
Dispositions | Recycling Facility                                        
Business Combination [Line Items]                                        
Gain/(Loss) on divestiture of business and other assets   $ (2,114,000)                                    
Proceeds from the sale of business, net   $ 3,924,000                                    
Dispositions | Tube and Core Operations                                        
Business Combination [Line Items]                                        
Consideration for disposal of business held for sale       $ 145,000                                
Gain/(Loss) on divestiture of business and other assets       (5,390,000)                                
Reclassification of cumulative translation losses       $ 3,792,000                                
Dispositions | Small Construction Tube Operation                                        
Business Combination [Line Items]                                        
Gain/(Loss) on divestiture of business and other assets         $ 1,207,000                              
Proceeds from the sale of business, net         $ 1,513,000                              
Dispositions | China Production Facilities                                        
Business Combination [Line Items]                                        
Consideration for disposal of business held for sale                     $ 302,000                  
Gain/(Loss) on divestiture of business and other assets                     $ 25,607,000                  
Number of production facilities | productionFacility                     2                  
Reclassified cumulative translation losses                     $ 590,000                  
v3.25.4
Acquisitions and divestitures - Additional Ownership Investment (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Jun. 30, 2024
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Mar. 31, 2024
Schedule of Equity Method Investments [Line Items]          
Interest income   $ 20,547 $ 27,570 $ 10,026  
Sustainable Protective Packaging Solutions          
Schedule of Equity Method Investments [Line Items]          
Ownership Interest 39.90% 39.90%     20.50%
Payments to increase investment $ 10,000        
Interest income 145        
Investment in preferred stock   $ 21,212      
Fair value remeasurement, gain in investment 5,867        
Sustainable Protective Packaging Solutions | Preferred Stock          
Schedule of Equity Method Investments [Line Items]          
Increase in investment 18,512        
Increase in investment, fair value remeasurement 5,400        
Reclassification of convertible notes to preferred stock in investment 2,500        
Reclassification of convertible notes to preferred stock, fair value adjustment $ 467        
v3.25.4
Acquisitions and divestitures - Schedule of Acquisition, Integration, and Divestiture-Related Costs (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Business Combination [Line Items]      
Total acquisition, integration, and divestiture-related costs $ 54,131 $ 125,169 $ 24,624
Cost of sales      
Business Combination [Line Items]      
Total acquisition, integration, and divestiture-related costs 17,053 5,806 5,227
Selling, general and administrative expenses      
Business Combination [Line Items]      
Total acquisition, integration, and divestiture-related costs 37,078 85,794 19,397
Interest expense      
Business Combination [Line Items]      
Total acquisition, integration, and divestiture-related costs $ 0 $ 33,569 $ 0
v3.25.4
Restructuring and asset impairment - Schedule of Restructuring and Restructuring-Related Asset Impairment Expenses by Type Incurred and by Reportable Segment (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Restructuring Cost and Reserve [Line Items]      
Restructuring and restructuring-related asset impairment charges, net $ 66,215 $ 65,370 $ 47,909
Other asset impairments 0 0 0
Restructuring/Asset impairment charges, net 66,215 65,370 47,909
Operating segments | Consumer Packaging      
Restructuring Cost and Reserve [Line Items]      
Restructuring and restructuring-related asset impairment charges, net 54,200 19,259 4,111
Operating segments | Industrial Paper Packaging      
Restructuring Cost and Reserve [Line Items]      
Restructuring and restructuring-related asset impairment charges, net 8,307 33,923 38,754
All Other      
Restructuring Cost and Reserve [Line Items]      
Restructuring and restructuring-related asset impairment charges, net 5 1,434 2,547
Corporate      
Restructuring Cost and Reserve [Line Items]      
Restructuring and restructuring-related asset impairment charges, net 3,703 10,754 2,497
Severance and Termination Benefits      
Restructuring Cost and Reserve [Line Items]      
Restructuring and restructuring-related asset impairment charges, net 68,795 37,307 15,543
Restructuring/Asset impairment charges, net 68,795 37,307  
Asset Impairment/Disposal of Assets      
Restructuring Cost and Reserve [Line Items]      
Restructuring and restructuring-related asset impairment charges, net (15,333) 15,719 24,415
Restructuring/Asset impairment charges, net (15,333) 15,719  
Other Costs      
Restructuring Cost and Reserve [Line Items]      
Restructuring and restructuring-related asset impairment charges, net 12,753 12,344 $ 7,951
Restructuring/Asset impairment charges, net $ 12,753 $ 12,344  
v3.25.4
Restructuring and asset impairment - Schedule of Restructuring Accrual Activity (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Restructuring Reserve [Roll Forward]      
Liability, beginning balance $ 24,943 $ 9,136  
2024/2025 charges/(gains) 66,215 65,370 $ 47,909
Cash (payments)/receipts (3,471) (23,583)  
Asset write downs/disposals (30,342) (25,399)  
Foreign currency translation 1,810 (581)  
Liability, ending balance 59,155 24,943 9,136
Severance and Termination Benefits      
Restructuring Reserve [Roll Forward]      
Liability, beginning balance 24,034 8,864  
2024/2025 charges/(gains) 68,795 37,307  
Cash (payments)/receipts (38,367) (21,653)  
Asset write downs/disposals 0 0  
Foreign currency translation 1,166 (484)  
Liability, ending balance 55,628 24,034 8,864
Asset Impairment/Disposal of Assets      
Restructuring Reserve [Roll Forward]      
Liability, beginning balance 0 0  
2024/2025 charges/(gains) (15,333) 15,719  
Cash (payments)/receipts 45,675 9,680  
Asset write downs/disposals (30,342) (25,399)  
Foreign currency translation 0 0  
Liability, ending balance 0 0 0
Other Costs      
Restructuring Reserve [Roll Forward]      
Liability, beginning balance 909 272  
2024/2025 charges/(gains) 12,753 12,344  
Cash (payments)/receipts (10,779) (11,610)  
Asset write downs/disposals 0 0  
Foreign currency translation 644 (97)  
Liability, ending balance $ 3,527 $ 909 $ 272
v3.25.4
Restructuring and asset impairment - Additional Information (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2025
USD ($)
employee
Dec. 31, 2024
facility
employee
Disposal Group, Including Discontinued Operations [Line Items]    
Future additional charges expected to be recognized | $ $ 11,000  
Number of production facilities closures | facility   2
Organizational Effectiveness Efforts    
Disposal Group, Including Discontinued Operations [Line Items]    
Number of eliminated positions | employee 450 300
v3.25.4
Book cash overdrafts and cash pooling (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Cash and Cash Equivalents [Line Items]    
Cash and cash equivalents $ 378,398 $ 431,010
Outstanding A/P check    
Cash and Cash Equivalents [Line Items]    
Outstanding A/P checks 11,996 15,799
Outstanding Payroll Checks    
Cash and Cash Equivalents [Line Items]    
Outstanding A/P checks 260 162
Notional Pooling Arrangement    
Cash and Cash Equivalents [Line Items]    
Cash and cash equivalents $ 2,170 $ 12,915
v3.25.4
Property, plant and equipment - Schedule of Property, Plant and Equipment (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Property, Plant and Equipment [Abstract]    
Land $ 324,635 $ 314,278
Buildings 1,046,723 967,237
Machinery and equipment 4,020,202 3,726,377
Construction in progress 282,948 337,796
Property, plant and equipment, gross 5,674,508 5,345,688
Accumulated depreciation (2,876,708) (2,626,941)
Property, plant and equipment, net $ 2,797,800 $ 2,718,747
v3.25.4
Property, plant and equipment - Additional Information (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Property, Plant and Equipment [Abstract]      
Depreciation and depletion expense $ 324,185 $ 224,595 $ 202,917
v3.25.4
Leases - Additional Information (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2025
USD ($)
option
Nov. 03, 2025
USD ($)
Dec. 31, 2024
USD ($)
Dec. 04, 2024
USD ($)
Apr. 01, 2024
USD ($)
Dec. 31, 2023
Lessee, Lease, Description [Line Items]            
Number of renewal options | option 1          
Operating lease assets $ 307,450   $ 307,688      
Lease liability 317,170          
Finance lease assets 49,059   76,831      
Finance lease obligations $ 53,542   $ 67,628      
Operating leases 9 years 7 months 6 days   10 years 1 month 6 days     10 years
Operating leases 5.09%   4.97%     5.07%
Eviosys            
Lessee, Lease, Description [Line Items]            
Lease liability       $ 42,468    
Operating leases       8 years 1 month 6 days    
Operating leases       4.50%    
Disposal Group, Held-for-Sale or Disposed of by Sale, Not Discontinued Operations | ThermoSafe            
Lessee, Lease, Description [Line Items]            
Operating lease assets   $ 20,825        
Lease liability   21,082        
Finance lease assets   2,743        
Finance lease obligations   $ 2,920        
Disposal Group, Held-for-Sale or Disposed of by Sale, Not Discontinued Operations | Protective Solutions "Protexic"            
Lessee, Lease, Description [Line Items]            
Operating lease assets         $ 21,989  
Lease liability         $ 22,396  
Minimum            
Lessee, Lease, Description [Line Items]            
Lease renewal term 1 year          
Maximum            
Lessee, Lease, Description [Line Items]            
Lease renewal term 5 years          
v3.25.4
Leases - Schedule of Balance Sheet Location and Values of Company's Lease Assets and Lease Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Leases [Abstract]    
Operating lease assets $ 307,450 $ 307,688
Finance lease assets 49,059 76,831
Total lease assets 356,509 384,519
Current operating lease liabilities 53,978 52,648
Current finance lease liabilities 11,617 22,284
Total current lease liabilities 65,595 74,932
Noncurrent operating lease liabilities 263,192 258,735
Noncurrent finance lease liabilities 41,925 45,344
Total noncurrent lease liabilities 305,117 304,079
Total lease liabilities $ 370,712 $ 379,011
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] Other Assets Other Assets
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Accrued expenses and other payables Accrued expenses and other payables
Finance Lease, Liability, Current, Statement of Financial Position [Extensible List] Notes payable and current portion of long-term debt Notes payable and current portion of long-term debt
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] Long-term Debt Long-term Debt
v3.25.4
Leases - Schedule of Components of Company's Total Lease Costs and Other Lease Related Information (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Leases [Abstract]      
Operating lease cost $ 62,687 $ 49,327 $ 43,524
Amortization of lease asset 13,051 12,871 11,789
Interest on lease liabilities 3,100 3,711 3,912
Variable lease cost 48,807 31,404 32,016
Impairment charges 2,526 0 0
Total lease cost $ 130,171 $ 97,313 $ 91,241
v3.25.4
Leases - Schedule of Five-year Maturity of Lease Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Operating Leases    
2026 $ 54,712  
2027 47,158  
2028 42,551  
2029 39,459  
2030 35,978  
Beyond 2030 177,821  
Total lease payments 397,679  
Less: Interest (80,509)  
Lease Liabilities 317,170  
Finance Leases    
2026 11,841  
2027 10,382  
2028 8,750  
2029 6,512  
2030 4,845  
Beyond 2030 20,207  
Total lease payments 62,537  
Less: Interest (8,995)  
Lease Liabilities 53,542 $ 67,628
Total    
2026 66,553  
2027 57,540  
2028 51,301  
2029 45,971  
2030 40,823  
Beyond 2030 198,028  
Total lease payments 460,216  
Less: Interest (89,504)  
Lease Liabilities $ 370,712  
v3.25.4
Leases - Schedule of Weighted Average Remaining Lease Terms, Discounts Rates and Other Lease Information (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Weighted-average remaining lease term (years):      
Operating leases 9 years 7 months 6 days 10 years 1 month 6 days 10 years
Finance leases 8 years 2 months 12 days 6 years 8 months 12 days 7 years 1 month 6 days
Weighted-average discount rate:      
Operating leases 5.09% 4.97% 5.07%
Finance leases 4.65% 5.16% 5.27%
Cash paid for amounts included in the measurement of lease liabilities:      
Operating cash flows used by operating leases $ 59,172 $ 48,380 $ 43,638
Operating cash flows used by finance leases 3,100 3,711 3,912
Financing cash flows used by finance leases 14,997 15,433 14,617
Leased assets obtained in exchange for new operating lease liabilities 42,646 66,585 18,225
Leased assets obtained in exchange for new finance lease liabilities 20,579 11,925 7,755
Modification to leased assets for increase in operating lease liabilities 17,621 37,731 4,431
Modification to leased assets for increase/(decrease) in finance lease liabilities (31,502) 53 18
Termination reclasses to decrease operating lease assets 8,440 5,765 5,702
Termination reclasses to decrease operating lease liabilities 8,544 5,768 6,063
Termination reclasses to decrease finance lease assets 303 270 1,429
Termination reclasses to decrease finance lease liabilities $ 305 $ 271 $ 482
v3.25.4
Goodwill and other intangible assets - Schedule of Changes in Goodwill by Segment (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2025
USD ($)
Goodwill [Roll Forward]  
Balance as of January 1, 2025 $ 2,525,657
Divestitures (175,293)
Measurement period adjustments (27,399)
Foreign currency translation 188,646
Balance as of December 31, 2025 2,511,611
All Other  
Goodwill [Roll Forward]  
Balance as of January 1, 2025 231,050
Divestitures (173,250)
Measurement period adjustments 0
Foreign currency translation (2,556)
Balance as of December 31, 2025 55,244
Consumer Packaging | Operating segments  
Goodwill [Roll Forward]  
Balance as of January 1, 2025 1,807,971
Divestitures 0
Measurement period adjustments (27,399)
Foreign currency translation 167,419
Balance as of December 31, 2025 1,947,991
Industrial Paper Packaging | Operating segments  
Goodwill [Roll Forward]  
Balance as of January 1, 2025 486,636
Divestitures (2,043)
Measurement period adjustments 0
Foreign currency translation 23,783
Balance as of December 31, 2025 $ 508,376
v3.25.4
Goodwill and other intangible assets - Additional Information (Details) - USD ($)
12 Months Ended 13 Months Ended
Nov. 03, 2025
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2025
Sep. 28, 2025
Dec. 04, 2024
Goodwill [Line Items]              
Goodwill, impairment loss   $ 0          
Goodwill   2,511,611,000 $ 2,525,657,000   $ 2,511,611,000    
Intangible assets, gross   3,189,555,000 2,976,211,000   3,189,555,000    
Accumulated amortization   (506,081,000) (389,513,000)   (506,081,000)    
Indefinite-lived intangible assets   0     0    
Aggregate amortization expenses   182,431,000 78,595,000 $ 67,323,000      
Amortization expense on other intangible assets in 2026   182,100,000     182,100,000    
Amortization expense on other intangible assets in 2027   181,900,000     181,900,000    
Amortization expense on other intangible assets in 2028   181,800,000     181,800,000    
Amortization expense on other intangible assets in 2029   180,800,000     180,800,000    
Amortization expense on other intangible assets in 2030   $ 178,500,000     $ 178,500,000    
Minimum              
Goodwill [Line Items]              
Useful lives of intangible asset   3 years     3 years    
Maximum              
Goodwill [Line Items]              
Useful lives of intangible asset   20 years     20 years    
ThermoSafe              
Goodwill [Line Items]              
Wrote off other intangible assets $ 9,405,000            
Intangible assets, gross 89,607,000            
Accumulated amortization (80,202,000)            
Customer lists              
Goodwill [Line Items]              
Intangible assets, gross   $ 2,895,345,000 2,679,372,000   $ 2,895,345,000    
Accumulated amortization   (431,704,000) (332,680,000)   (431,704,000)    
Other              
Goodwill [Line Items]              
Intangible assets, gross   2,054,000 2,339,000   2,054,000    
Accumulated amortization   $ (1,193,000) $ (1,436,000)   $ (1,193,000)    
Other | Minimum              
Goodwill [Line Items]              
Useful lives of intangible asset   3 years     3 years    
Other | Maximum              
Goodwill [Line Items]              
Useful lives of intangible asset   20 years     20 years    
Dispositions | ThermoSafe              
Goodwill [Line Items]              
Goodwill, impairment loss $ 173,250,000            
Dispositions | Customer lists | Recycling Facility              
Goodwill [Line Items]              
Wrote off other intangible assets   $ 1,455,000     $ 1,455,000    
Eviosys              
Goodwill [Line Items]              
Goodwill   1,258,119,000     1,258,119,000   $ 1,285,518,000
Other intangible assets         42,379,000    
Eviosys | Customer lists              
Goodwill [Line Items]              
Other intangible assets   42,379,000          
Metal Packaging EMEA Reporting Unit              
Goodwill [Line Items]              
Excess of fair value of reporting unit over carrying value (percent)           3.10%  
Estimated reduced fair value of reporting unit over carrying value (percent)           3.00%  
Goodwill   1,397,039,000     1,397,039,000    
Global Paper Products APAC Reporting Unit              
Goodwill [Line Items]              
Excess of fair value of reporting unit over carrying value (percent)           9.00%  
Estimated reduced fair value of reporting unit over carrying value (percent)           8.40%  
Goodwill   $ 26,867,000     $ 26,867,000    
Discount Rate | Metal Packaging EMEA Reporting Unit              
Goodwill [Line Items]              
Discount rate (percent)           12.00%  
Change necessary in order for estimated fair value to fall below carrying value (percent)           12.70%  
Discount Rate | Global Paper Products APAC Reporting Unit              
Goodwill [Line Items]              
Discount rate (percent)           13.00%  
Change necessary in order for estimated fair value to fall below carrying value (percent)           15.40%  
v3.25.4
Goodwill and other intangible assets - Schedule of Other Intangible Assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Finite-Lived Intangible Assets [Line Items]    
Total Other Intangible Assets, Gross $ 3,189,555 $ 2,976,211
Total Accumulated Amortization (506,081) (389,513)
Other Intangible Assets, Net 2,683,474 2,586,698
Patents    
Finite-Lived Intangible Assets [Line Items]    
Total Other Intangible Assets, Gross 29,403 28,941
Total Accumulated Amortization (18,706) (15,955)
Customer lists    
Finite-Lived Intangible Assets [Line Items]    
Total Other Intangible Assets, Gross 2,895,345 2,679,372
Total Accumulated Amortization (431,704) (332,680)
Trade names    
Finite-Lived Intangible Assets [Line Items]    
Total Other Intangible Assets, Gross 28,417 38,623
Total Accumulated Amortization (12,488) (13,239)
Proprietary technology    
Finite-Lived Intangible Assets [Line Items]    
Total Other Intangible Assets, Gross 234,336 226,936
Total Accumulated Amortization (41,990) (26,203)
Other    
Finite-Lived Intangible Assets [Line Items]    
Total Other Intangible Assets, Gross 2,054 2,339
Total Accumulated Amortization $ (1,193) $ (1,436)
v3.25.4
Supply chain financing (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Nov. 03, 2025
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Supplier Finance Program, Obligation [Roll Forward]        
Confirmed obligations outstanding at the beginning of the year     $ 28,496 $ 24,779
Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration]   Payable to suppliers Payable to suppliers Payable to suppliers
Invoices confirmed during the year     $ 187,392 $ 96,785
Confirmed invoices paid during the year     (162,766) (93,068)
Confirmed obligations outstanding at the end of the year   $ 28,496 $ 53,122 $ 28,496
Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration]   Payable to suppliers Payable to suppliers Payable to suppliers
Eviosys        
Supplier Finance Program, Obligation [Roll Forward]        
Invoices confirmed during the year   $ 7,547    
ThermoSafe        
Supplier Finance Program, Obligation [Roll Forward]        
Invoices confirmed during the year $ 7,763      
Confirmed invoices paid during the year $ (6,342)      
v3.25.4
Debt - Schedule of Debt (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Debt Instrument [Line Items]    
Finance lease obligations $ 53,542 $ 67,628
Total debt 4,326,925 7,040,021
Less: Notes payable and current portion of long-term debt (537,952) (2,054,525)
Long-term Debt 3,788,973 4,985,496
364-Day term loan due December 2025    
Debt Instrument [Line Items]    
Debt 0 1,493,568
Term loan due December 2026    
Debt Instrument [Line Items]    
Debt 0 698,167
Syndicated term loan due August 2028    
Debt Instrument [Line Items]    
Debt $ 498,320 497,674
1.80% notes due February 2025    
Debt Instrument [Line Items]    
Stated interest rate (percent) 1.80%  
Debt $ 0 399,933
4.45% notes due September 2026    
Debt Instrument [Line Items]    
Stated interest rate (percent) 4.45%  
Debt $ 498,749 496,869
2.25% notes due February 2027    
Debt Instrument [Line Items]    
Stated interest rate (percent) 2.25%  
Debt $ 299,443 298,930
4.60% notes due September 2029    
Debt Instrument [Line Items]    
Stated interest rate (percent) 4.60%  
Debt $ 595,694 594,519
3.125% notes due May 2030    
Debt Instrument [Line Items]    
Stated interest rate (percent) 3.125%  
Debt $ 597,528 596,958
2.85% notes due February 2032    
Debt Instrument [Line Items]    
Stated interest rate (percent) 2.85%  
Debt $ 496,824 496,302
5.00% notes due September 2034    
Debt Instrument [Line Items]    
Stated interest rate (percent) 5.00%  
Debt $ 690,857 689,802
5.75% notes due November 2040    
Debt Instrument [Line Items]    
Stated interest rate (percent) 5.75%  
Debt $ 536,314 $ 536,282
Other foreign denominated debt, average rate of 5.5% in 2025 and 6.0% in 2024    
Debt Instrument [Line Items]    
Weighted average interest rate (percent) 5.50% 6.00%
Debt $ 40,016 $ 155,048
Other debt    
Debt Instrument [Line Items]    
Debt $ 19,638 $ 18,341
v3.25.4
Debt - Additional Information (Details) - USD ($)
12 Months Ended
Nov. 05, 2025
Feb. 03, 2025
Dec. 04, 2024
Sep. 16, 2024
Jun. 22, 2024
May 03, 2024
Sep. 08, 2023
Aug. 07, 2023
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Sep. 19, 2024
Jul. 12, 2024
May 02, 2024
Line of Credit Facility [Line Items]                            
Committed availability under credit facilities                 $ 287,325,000          
Less: Notes payable and current portion of long-term debt                 (537,952,000) $ (2,054,525,000)        
Cash and cash equivalents on hand, including discontinued operations                 378,398,000          
Revolving Credit Facility                            
Line of Credit Facility [Line Items]                            
Maximum borrowing capacity           $ 1,250,000,000               $ 350,000,000
Debt term           5 years                
Committed availability under credit facilities                 $ 1,250,000,000          
Revolving Credit Facility | LIBOR                            
Line of Credit Facility [Line Items]                            
Basis points (percent)                 1.375%          
Unsecured Debt                            
Line of Credit Facility [Line Items]                            
Principal Amount                       $ 1,800,000,000    
Face amount                       1,800,000,000    
Debt                       $ 1,779,910,000    
Eviosys                            
Line of Credit Facility [Line Items]                            
Trade receivables sold and derecognized     $ 73,487,000                      
Eviosys | Bridge Loan | Senior Unsecured Bridge Term Loan Facility                            
Line of Credit Facility [Line Items]                            
Debt issuance costs                   (19,000,000)        
1.80% notes due February 2025                            
Line of Credit Facility [Line Items]                            
Repayments of Debt   $ 400,000,000                        
Stated interest rate (percent)                 1.80%          
Debt                 $ 0 399,933,000        
Term Loan Agreement | Eviosys | Line of Credit                            
Line of Credit Facility [Line Items]                            
Repayments of Debt $ 700,000,000                          
Maximum borrowing capacity                         $ 700,000,000  
Term loan due December 2026                            
Line of Credit Facility [Line Items]                            
Debt                 0 698,167,000        
364-Day Term Credit Agreement | Eviosys                            
Line of Credit Facility [Line Items]                            
Maximum borrowing capacity       $ 1,500,000,000                    
Debt term       364 days 364 days                  
364-Day Term Credit Agreement | Eviosys | Bridge Loan | Senior Unsecured Bridge Term Loan Facility                            
Line of Credit Facility [Line Items]                            
Maximum borrowing capacity         $ 4,000,000,000                  
Other foreign denominated debt, average rate of 5.5% in 2025 and 6.0% in 2024                            
Line of Credit Facility [Line Items]                            
Debt                 40,016,000 155,048,000        
Other foreign denominated debt, average rate of 5.5% in 2025 and 6.0% in 2024 | Eviosys                            
Line of Credit Facility [Line Items]                            
Trade receivables sold and derecognized                   73,487,000        
Syndicated term loan due August 2028                            
Line of Credit Facility [Line Items]                            
Maximum borrowing capacity               $ 900,000,000            
Proceeds from lines of credit             $ 270,000,000 $ 600,000,000            
Repayments of credit facility                   75,000,000 $ 295,000,000      
Debt                 498,320,000 $ 497,674,000        
Syndicated term loan due August 2028 | SOFR                            
Line of Credit Facility [Line Items]                            
Basis points, adjustment (percent)               0.10%            
Basis points (percent)               1.90%            
Commercial paper, average rate of 0.00% in 2025                            
Line of Credit Facility [Line Items]                            
Maximum borrowing capacity           $ 1,250,000,000               $ 750,000,000
Line of credit facility, Increase in commitment           $ 500,000,000                
Debt                 $ 0          
v3.25.4
Debt - Schedule of Debt Instruments (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Sep. 19, 2024
Unsecured Debt      
Line of Credit Facility [Line Items]      
Principal Amount     $ 1,800,000
Issuance Costs and Discounts     (20,090)
Net Proceeds     1,779,910
2026 Notes      
Line of Credit Facility [Line Items]      
Net Proceeds $ 498,749 $ 496,869  
Interest Rate 4.45%    
2026 Notes | Unsecured Debt      
Line of Credit Facility [Line Items]      
Principal Amount     500,000
Issuance Costs and Discounts     (3,697)
Net Proceeds     $ 496,303
Interest Rate     4.45%
2029 Notes      
Line of Credit Facility [Line Items]      
Net Proceeds $ 595,694 594,519  
Interest Rate 4.60%    
2029 Notes | Unsecured Debt      
Line of Credit Facility [Line Items]      
Principal Amount     $ 600,000
Issuance Costs and Discounts     (5,851)
Net Proceeds     $ 594,149
Interest Rate     4.60%
2034 Notes      
Line of Credit Facility [Line Items]      
Net Proceeds $ 690,857 $ 689,802  
Interest Rate 5.00%    
2034 Notes | Unsecured Debt      
Line of Credit Facility [Line Items]      
Principal Amount     $ 700,000
Issuance Costs and Discounts     (10,542)
Net Proceeds     $ 689,458
Interest Rate     5.00%
v3.25.4
Debt - Schedule of Maturities (Details)
$ in Thousands
Dec. 31, 2025
USD ($)
Debt Disclosure [Abstract]  
2026 $ 537,952
2027 316,438
2028 513,555
2029 600,802
2030 $ 602,236
v3.25.4
Financial instruments and derivatives - Schedule of Carrying Amounts and Fair Values of Financial Instruments (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Carrying Amount    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Long-term debt, net of current portion $ 3,788,973 $ 4,985,496
Fair Value    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Long-term debt, net of current portion $ 3,728,480 $ 4,800,455
v3.25.4
Financial instruments and derivatives - Additional Information (Details)
$ in Thousands, MMBTU in Millions
12 Months Ended
Sep. 17, 2024
USD ($)
Apr. 15, 2024
USD ($)
Dec. 31, 2025
USD ($)
MMBTU
t
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Jun. 30, 2025
USD ($)
Aug. 29, 2024
USD ($)
bank
Apr. 30, 2024
USD ($)
Derivative [Line Items]                
Interest expense     $ 233,485 $ 172,620 $ 135,393      
Derivative gain (loss), net of tax     541,722 (136,849) 63,391      
Loss on settlement of derivative $ (11,088)              
Total fair value of other derivatives not designated as hedging instruments     (1,113) (2,694)        
Cash Flow Hedges | Derivatives designated as hedging instruments:                
Derivative [Line Items]                
Price risk cash flow hedge derivative, at fair value, net     1,683 652        
Commodity loss expected to be reclassified to the income statement during the next 12 months     1,508          
Fair value of foreign currency cash flow hedges, gain     49 (1,841)        
Foreign currency gain (loss) expected to be reclassified to the income statement during the next 12 months     $ 103          
Net investment hedge | Derivatives designated as hedging instruments: | Currency Swap                
Derivative [Line Items]                
Received a cash settlement   $ 9,068            
Foreign currency translation gain   $ 3,143            
Natural Gas Swaps | Derivatives not designated as hedging instruments:                
Derivative [Line Items]                
Anticipated usage percentage covered by a swap contract for the next fiscal year (percent)     0.523          
Approximate amount of commodity covered by swap contracts outstanding (btu) | MMBTU     3.0          
Natural Gas Swaps | Cash Flow Hedges | Derivatives designated as hedging instruments:                
Derivative [Line Items]                
Approximate amount of commodity covered by swap contracts outstanding (tonne) | t     6,133          
Aluminum Swaps | Cash Flow Hedges | Derivatives designated as hedging instruments:                
Derivative [Line Items]                
Anticipated usage percentage covered by a swap contract for the next fiscal year (percent)     0.27          
Currency Swap | Net investment hedge                
Derivative [Line Items]                
Purchase position of derivatives       1,500,000 $ 500,000 $ 285,000   $ 500,000
Interest expense     $ 36,480          
Gain (loss) on derivative used in net investment hedge, after tax     (207,203) 11,919        
Derivative gain (loss), net of tax     (154,366) 8,880        
Net investment hedges, tax expense (benefit)     $ (52,837) 3,039        
Currency Swap Maturing September 1, 2026 | Net investment hedge                
Derivative [Line Items]                
Purchase position of derivatives       500,000        
Currency Swap Maturing September 1, 2029 | Net investment hedge                
Derivative [Line Items]                
Purchase position of derivatives       500,000        
Currency Swap Maturing May 1, 2030 | Net investment hedge                
Derivative [Line Items]                
Purchase position of derivatives       $ 500,000        
Treasury Lock                
Derivative [Line Items]                
Purchase position of derivatives             $ 900,000  
Number of banks | bank             11  
v3.25.4
Financial instruments and derivatives - Schedule of Net Positions of Foreign Contracts (Details) - Dec. 31, 2025 - Cash Flow Hedges - Derivatives designated as hedging instruments:
₺ in Thousands, € in Thousands, £ in Thousands, zł in Thousands, kr in Thousands, kr in Thousands, SFr in Thousands, Ft in Thousands, $ in Thousands, $ in Thousands, $ in Thousands, $ in Thousands
COP ($)
MXN ($)
PLN (zł)
DKK (kr)
SEK (kr)
CAD ($)
EUR (€)
TRY (₺)
GBP (£)
USD ($)
HUF (Ft)
CHF (SFr)
USD Contracts                        
Derivative [Line Items]                        
Purchase position of derivatives $ 9,732,940 $ 163,250 zł 87,110 kr 105,120   $ 15,274 € 3,326 ₺ 79,562   $ 9,639    
Sell position of derivatives         kr (1,902)       £ (6,985)      
Euro Contracts                        
Derivative [Line Items]                        
Purchase position of derivatives     zł 3,650       € 4,741   £ 2,850 $ 8,720 Ft 9,026,735 SFr 2,274
v3.25.4
Financial instruments and derivatives - Schedule of Net Positions of Foreign Contracts Non-Designated Derivatives (Details) - Dec. 31, 2025 - Derivatives not designated as hedging instruments:
฿ in Thousands, £ in Thousands, zł in Thousands, Rp in Thousands, Ft in Thousands, $ in Thousands, $ in Thousands, $ in Thousands, $ in Thousands
COP ($)
MXN ($)
PLN (zł)
CAD ($)
GBP (£)
USD ($)
HUF (Ft)
IDR (Rp)
THB (฿)
purchase | USD Contracts                  
Derivative [Line Items]                  
Purchase position of derivatives $ 67,686,355 $ 276,516   $ 4,224       Rp 10,632,390  
purchase | Euro Contracts                  
Derivative [Line Items]                  
Purchase position of derivatives             Ft 356,793    
sell | Euro Contracts                  
Derivative [Line Items]                  
Sell position of derivatives     zł (51,337)   £ (395) $ (2,880)     ฿ (550,013)
v3.25.4
Financial instruments and derivatives - Schedule of Location and Fair Values of Derivative Instruments (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Derivatives designated as hedging instruments: | Commodity Contracts | Prepaid expenses    
Derivatives, Fair Value [Line Items]    
Derivatives assets $ 1,508 $ 671
Derivatives designated as hedging instruments: | Commodity Contracts | Other Assets    
Derivatives, Fair Value [Line Items]    
Derivatives assets 175 0
Derivatives designated as hedging instruments: | Commodity Contracts | Accrued expenses and other payables    
Derivatives, Fair Value [Line Items]    
Derivatives liabilities 0 (19)
Derivatives designated as hedging instruments: | Foreign Exchange Contracts | Prepaid expenses    
Derivatives, Fair Value [Line Items]    
Derivatives assets 1,131 2,068
Derivatives designated as hedging instruments: | Foreign Exchange Contracts | Other Assets    
Derivatives, Fair Value [Line Items]    
Derivatives assets 33 0
Derivatives designated as hedging instruments: | Foreign Exchange Contracts | Accrued expenses and other payables    
Derivatives, Fair Value [Line Items]    
Derivatives liabilities (1,028) (3,909)
Derivatives designated as hedging instruments: | Foreign Exchange Contracts | Other Liabilities    
Derivatives, Fair Value [Line Items]    
Derivatives liabilities (87) 0
Derivatives designated as hedging instruments: | Net investment hedge | Prepaid expenses    
Derivatives, Fair Value [Line Items]    
Derivatives assets 19,358 26,833
Derivatives designated as hedging instruments: | Net investment hedge | Other Assets    
Derivatives, Fair Value [Line Items]    
Derivatives assets 0 1,845
Derivatives designated as hedging instruments: | Net investment hedge | Accrued expenses and other payables    
Derivatives, Fair Value [Line Items]    
Derivatives liabilities (58,594) 0
Derivatives designated as hedging instruments: | Net investment hedge | Other Liabilities    
Derivatives, Fair Value [Line Items]    
Derivatives liabilities (167,967) (16,759)
Derivatives not designated as hedging instruments: | Commodity Contracts | Prepaid expenses    
Derivatives, Fair Value [Line Items]    
Derivatives assets 185 961
Derivatives not designated as hedging instruments: | Commodity Contracts | Accrued expenses and other payables    
Derivatives, Fair Value [Line Items]    
Derivatives liabilities (1,517) (574)
Derivatives not designated as hedging instruments: | Foreign Exchange Contracts | Prepaid expenses    
Derivatives, Fair Value [Line Items]    
Derivatives assets 1,106 (59)
Derivatives not designated as hedging instruments: | Foreign Exchange Contracts | Accrued expenses and other payables    
Derivatives, Fair Value [Line Items]    
Derivatives liabilities $ (887) $ (3,022)
v3.25.4
Financial instruments and derivatives - Schedule of Effect of Derivative Instruments on Financial Performance (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Derivative Instruments, Gain (Loss) [Line Items]      
Gain or (Loss) Recognized $ (1,730) $ 7,225 $ 1,912
Foreign Exchange Contracts      
Derivative Instruments, Gain (Loss) [Line Items]      
Amount of Gain or (Loss) Recognized in OCI on Derivatives 2,879 (4,994)  
Foreign Exchange Contracts | Derivatives not designated as hedging instruments:      
Derivative Instruments, Gain (Loss) [Line Items]      
Gain or (Loss) Recognized 6,683 (8,168)  
Foreign Exchange Contracts | Net sales      
Derivative Instruments, Gain (Loss) [Line Items]      
Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income 3,811 (1,174)  
Foreign Exchange Contracts | Cost of sales      
Derivative Instruments, Gain (Loss) [Line Items]      
Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income (2,557) (253)  
Commodity Contracts      
Derivative Instruments, Gain (Loss) [Line Items]      
Amount of Gain or (Loss) Recognized in OCI on Derivatives 1,478 665  
Commodity Contracts | Derivatives not designated as hedging instruments:      
Derivative Instruments, Gain (Loss) [Line Items]      
Gain or (Loss) Recognized (1,546) (2,976)  
Commodity Contracts | Cost of sales      
Derivative Instruments, Gain (Loss) [Line Items]      
Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income $ 447 $ (28)  
v3.25.4
Financial instruments and derivatives - Schedule of Reclassification of Gains and Losses (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]      
Net sales $ 7,518,753 $ 5,305,365 $ 5,441,426
Cost of sales (5,944,340) (4,166,132) $ (4,238,857)
Reclassification out of Accumulated Other Comprehensive Income | Gains and Losses on Cash Flow Hedges      
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]      
Net sales 3,811 (1,174)  
Cost of sales (2,110) (281)  
Reclassification out of Accumulated Other Comprehensive Income | Gains and Losses on Cash Flow Hedges | Foreign Exchange Contracts      
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]      
Net sales 3,811 (1,174)  
Cost of sales (2,557) (253)  
Reclassification out of Accumulated Other Comprehensive Income | Gains and Losses on Cash Flow Hedges | Commodity Contracts      
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]      
Net sales 0 0  
Cost of sales $ 447 $ (28)  
v3.25.4
Fair value measurements - Schedule of Assets and Liabilities Measured on Recurring Basis (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets $ 320,457 $ 304,000
Common Collective Trust    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 13,139 13,259
Mutual funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 25,885 43,059
Fixed income securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 263,441 235,952
Short-term investments    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 3,184 3,493
Real estate funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 5,019 480
Cash and accrued income    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 9,789 7,757
Assets measured at NAV    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 81,675 76,197
Assets measured at NAV | Common Collective Trust    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 13,139 13,259
Assets measured at NAV | Mutual funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 0 0
Assets measured at NAV | Fixed income securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 63,517 62,458
Assets measured at NAV | Short-term investments    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 0 0
Assets measured at NAV | Real estate funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 5,019 480
Assets measured at NAV | Cash and accrued income    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 0 0
Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 9,789 7,757
Level 1 | Common Collective Trust    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 0 0
Level 1 | Mutual funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 0 0
Level 1 | Fixed income securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 0 0
Level 1 | Short-term investments    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 0 0
Level 1 | Real estate funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 0 0
Level 1 | Cash and accrued income    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 9,789 7,757
Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 228,993 220,046
Level 2 | Common Collective Trust    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 0 0
Level 2 | Mutual funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 25,885 43,059
Level 2 | Fixed income securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 199,924 173,494
Level 2 | Short-term investments    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 3,184 3,493
Level 2 | Real estate funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 0 0
Level 2 | Cash and accrued income    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 0 0
Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 0 0
Level 3 | Common Collective Trust    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 0 0
Level 3 | Mutual funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 0 0
Level 3 | Fixed income securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 0 0
Level 3 | Short-term investments    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 0 0
Level 3 | Real estate funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 0 0
Level 3 | Cash and accrued income    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 0 0
Net investment hedge | Hedge derivatives, net:    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative (207,203) 11,919
Net investment hedge | Assets measured at NAV | Hedge derivatives, net:    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 0 0
Net investment hedge | Level 1 | Hedge derivatives, net:    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 0 0
Net investment hedge | Level 2 | Hedge derivatives, net:    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative (207,203) 11,919
Net investment hedge | Level 3 | Hedge derivatives, net:    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 0 0
Commodity Contracts | Hedge derivatives, net:    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 1,683 652
Commodity Contracts | Non-hedge derivatives, net:    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative (1,332) 387
Commodity Contracts | Assets measured at NAV | Hedge derivatives, net:    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 0 0
Commodity Contracts | Assets measured at NAV | Non-hedge derivatives, net:    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 0 0
Commodity Contracts | Level 1 | Hedge derivatives, net:    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 0 0
Commodity Contracts | Level 1 | Non-hedge derivatives, net:    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 0 0
Commodity Contracts | Level 2 | Hedge derivatives, net:    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 1,683 652
Commodity Contracts | Level 2 | Non-hedge derivatives, net:    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative (1,332) 387
Commodity Contracts | Level 3 | Hedge derivatives, net:    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 0 0
Commodity Contracts | Level 3 | Non-hedge derivatives, net:    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 0 0
Foreign Exchange Contracts | Hedge derivatives, net:    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 49 (1,841)
Foreign Exchange Contracts | Non-hedge derivatives, net:    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 219 (3,081)
Foreign Exchange Contracts | Assets measured at NAV | Hedge derivatives, net:    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 0 0
Foreign Exchange Contracts | Assets measured at NAV | Non-hedge derivatives, net:    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 0 0
Foreign Exchange Contracts | Level 1 | Hedge derivatives, net:    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 0 0
Foreign Exchange Contracts | Level 1 | Non-hedge derivatives, net:    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 0 0
Foreign Exchange Contracts | Level 2 | Hedge derivatives, net:    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 49 (1,841)
Foreign Exchange Contracts | Level 2 | Non-hedge derivatives, net:    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 219 (3,081)
Foreign Exchange Contracts | Level 3 | Hedge derivatives, net:    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 0 0
Foreign Exchange Contracts | Level 3 | Non-hedge derivatives, net:    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative $ 0 $ 0
v3.25.4
Fair value measurements - Additional Information (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2025
USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Percentage of postretirement benefit plan assets comprised of pension plan assets (more than) 96.00%
Level 2  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Investment in preferred stock $ 21,212
Investment, Type [Extensible Enumeration] Preferred Stock
v3.25.4
Share-based compensation plans - Additional Information (Details)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2025
USD ($)
installment
$ / shares
shares
Dec. 31, 2024
USD ($)
$ / shares
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares available for grant (in shares) | shares 1,674,656    
Compensation cost for share-based payment arrangements $ 17,787 $ 26,948 $ 24,738
Related tax benefit recognized in net income 4,475 6,852 6,162
Additional net excess tax benefit realized $ 501 $ 257 $ 978
Restricted Stock Units (RSUs)      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Granted, weighted-average grant date fair value (usd per share) | $ / shares $ 42.75    
Vested units in period (in shares) | shares 0    
Performance Contingent Restricted Stock Units (PCSUs)      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Minimum vesting period 3 years    
Granted, weighted-average grant date fair value (usd per share) | $ / shares $ 40.95 $ 50.54 $ 55.04
Noncash stock-based compensation associated performance contingent restricted stock units $ 2,599 $ 10,176 $ 9,826
Total unrecognized compensation cost related to nonvested awards $ 3,250    
Weighted-average period 15 months    
Performance period 3 years    
Stock return payout percentage 0.20 0.20  
Vested units in period (in shares) | shares 0    
Unit’s earned for total stock return modifier | shares 0    
Performance Contingent Restricted Stock Units (PCSUs) | Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting percentage 25.00%    
Performance Contingent Restricted Stock Units (PCSUs) | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting percentage 75.00%    
Deferred Compensation Plans      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation deferrals in current year $ 1,767 $ 2,024 2,024
Stock Appreciation Rights (SARs)      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation cost for share-based payment arrangements 0 0 0
Total unrecognized compensation cost related to nonvested awards $ 0    
Weighted average remaining contractual life for SAR's, outstanding 3 years 3 months 18 days    
Aggregate intrinsic value of options and SARs exercised $ 0 $ 74 $ 158
Aggregate intrinsic value for SAR's, outstanding $ 79    
Fair market value of the Company’s stock used to calculate intrinsic value (usd per share) | $ / shares $ 43.64    
Executive Officers and Key Management Employees | Restricted Stock Units (RSUs)      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Minimum vesting period 3 years    
Executive Officers and Key Management Employees | Restricted Stock Units (RSUs) | Share-based Compensation Award, Tranche One      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting percentage 33.33%    
Executive Officers and Key Management Employees | Restricted Stock Units (RSUs) | Share-based Compensation Award, Tranche Two      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting percentage 33.33%    
Executive Officers and Key Management Employees | Restricted Stock Units (RSUs) | Share-based Compensation Award, Tranche Three      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting percentage 33.33%    
Executives and Directors | Restricted Stock Units (RSUs)      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Minimum vesting period 5 years    
Granted, weighted-average grant date fair value (usd per share) | $ / shares $ 42.75 $ 52.41 $ 56.87
Fair value of vested units $ 15,348 $ 13,190 $ 10,320
Noncash stock-based compensation associated performance contingent restricted stock units 13,421 $ 14,748 12,888
Total unrecognized compensation cost related to nonvested awards $ 11,264    
Weighted-average period 30 months    
Executives and Directors | Restricted Stock Units (RSUs) | Share-based Compensation Award, Tranche Three      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting percentage 33.33%    
Executives and Directors | Restricted Stock Units (RSUs) | Share-based Compensation Award, Tranche Four      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting percentage 33.33%    
Executives and Directors | Restricted Stock Units (RSUs) | Share-based Compensation Award, Tranche Five      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting percentage 33.33%    
Non-Employee Directors | Deferred Compensation Plans | Share-based Compensation Award, Tranche One      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of annual distribution installments | installment 1    
Non-Employee Directors | Deferred Compensation Plans | Share-based Compensation Award, Tranche Two      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of annual distribution installments | installment 3    
Non-Employee Directors | Deferred Compensation Plans | Share-based Compensation Award, Tranche Three      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of annual distribution installments | installment 5    
2025 PCSU | Performance Contingent Restricted Stock Units (PCSUs)      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Performance period 3 years    
Total performance contingent restricted stock units vested , minimum (in shares) | shares 0    
Total performance contingent restricted stock units, maximum (in shares) | shares 580,331    
2024 PCSU | Performance Contingent Restricted Stock Units (PCSUs)      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Performance period   3 years  
Total performance contingent restricted stock units vested , minimum (in shares) | shares   0  
Total performance contingent restricted stock units, maximum (in shares) | shares   415,611  
2023 PCSU | Performance Contingent Restricted Stock Units (PCSUs)      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Fair value of vested units $ 3,285    
2022 PCSU | Performance Contingent Restricted Stock Units (PCSUs)      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Fair value of vested units   $ 16,164  
Total performance contingent restricted stock units, maximum (in shares) | shares   330,888  
2021 PCSU | Performance Contingent Restricted Stock Units (PCSUs)      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Fair value of vested units     $ 12,600
Vested units in period (in shares) | shares     225,530
v3.25.4
Share-based compensation plans - Activity Related to PCSUs, Restricted Stock Units and Deferred Compensation Plans (Details) - $ / shares
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Restricted Stock Units (RSUs)      
Number of Shares      
Beginning Balance (in shares) 757,196    
Granted (in shares) 451,499    
Vested (in shares) 0    
Converted (in shares) (284,530)    
Cancelled (in shares) (118,243)    
Dividend equivalents (in shares) 6,307    
Ending Balance (in shares) 812,229 757,196  
Average Grant Date Fair Value Per Share      
Beginning Balance, weighted-average grant date fair value (usd per share) $ 53.43    
Granted, weighted-average grant date fair value (usd per share) 42.75    
Converted, weighted-average grant date fair value (usd per share) 54.28    
Cancelled, weighted-average grant date fair value (usd per share) 50.13    
Dividend equivalents, weighted-average grant date fair value (usd per share) 43.90    
Ending Balance, weighted-average grant date fair value (usd per share) $ 47.43 $ 53.43  
Restricted Stock Units (RSUs) | Nonvested      
Number of Shares      
Beginning Balance (in shares) 681,616    
Granted (in shares) 451,499    
Vested (in shares) 327,019    
Converted (in shares) 0    
Cancelled (in shares) (118,243)    
Dividend equivalents (in shares) 517    
Ending Balance (in shares) 688,370 681,616  
Restricted Stock Units (RSUs) | Vested      
Number of Shares      
Beginning Balance (in shares) 75,580    
Granted (in shares) 0    
Vested (in shares) 327,019    
Converted (in shares) (284,530)    
Cancelled (in shares) 0    
Dividend equivalents (in shares) 5,790    
Ending Balance (in shares) 123,859 75,580  
Performance Contingent Restricted Stock Units (PCSUs)      
Number of Shares      
Beginning Balance (in shares) 633,756    
Granted (in shares) 272,478    
Performance adjustments (in shares) (258,333)    
Vested (in shares) 0    
Converted (in shares) (309,397)    
Cancelled (in shares) (46,162)    
Dividend equivalents (in shares) 1,932    
Ending Balance (in shares) 294,274 633,756  
Average Grant Date Fair Value Per Share      
Beginning Balance, weighted-average grant date fair value (usd per share) $ 52.13    
Granted, weighted-average grant date fair value (usd per share) 40.95 $ 50.54 $ 55.04
Performance adjustments, weighted-average grant date fair value (usd per share) 42.17    
Converted, weighted-average grant date fair value (usd per share) 51.94    
Cancelled, weighted-average grant date fair value (usd per share) 48.58    
Dividend equivalents, weighted-average grant date fair value (usd per share) 45.20    
Ending Balance, weighted-average grant date fair value (usd per share) $ 51.25 $ 52.13  
Performance Contingent Restricted Stock Units (PCSUs) | Nonvested      
Number of Shares      
Beginning Balance (in shares) 283,675    
Granted (in shares) 272,478    
Performance adjustments (in shares) (258,333)    
Vested (in shares) 75,263    
Converted (in shares) 0    
Cancelled (in shares) (46,162)    
Dividend equivalents (in shares) 0    
Ending Balance (in shares) 176,395 283,675  
Performance Contingent Restricted Stock Units (PCSUs) | Vested      
Number of Shares      
Beginning Balance (in shares) 350,081    
Granted (in shares) 0    
Performance adjustments (in shares) 0    
Vested (in shares) 75,263    
Converted (in shares) (309,397)    
Cancelled (in shares) 0    
Dividend equivalents (in shares) 1,932    
Ending Balance (in shares) 117,879 350,081  
Deferred Compensation Plans      
Number of Shares      
Beginning Balance (in shares) 361,423    
Deferred (in shares) 42,013    
Converted (in shares) (8,146)    
Dividend equivalents (in shares) 16,857    
Ending Balance (in shares) 412,147 361,423  
v3.25.4
Share-based compensation plans - Company's SARs (Details) - Stock Appreciation Rights (SARs)
12 Months Ended
Dec. 31, 2025
$ / shares
shares
Number of Shares  
Beginning Balance (in shares) 663,404
Vested (in shares) 0
Granted (in shares) 0
Exercised (in shares) (35,972)
Forfeited/Expired (in shares) (111,279)
Ending Balance (in shares) 516,153
Exercisable (in shares) 516,153
Average Grant Date Fair Value Per Share  
Beginning Balance, weighted-average exercise price (usd per share) | $ / shares $ 55.62
Vested, weighted-average exercise price (usd per share) | $ / shares 0
Granted, weighted-average exercise price (usd per share) | $ / shares 0
Exercised, weighted-average exercise price (usd per share) | $ / shares 45.11
Forfeited/Expired, weighted average exercise price (usd per share) | $ / shares 58.22
Ending Balance, weighted average exercise price (usd per share) | $ / shares 55.79
Exercisable, weighted-average exercise price (usd per share) | $ / shares $ 55.79
Nonvested  
Number of Shares  
Beginning Balance (in shares) 0
Vested (in shares) 0
Granted (in shares) 0
Exercised (in shares) 0
Forfeited/Expired (in shares) 0
Ending Balance (in shares) 0
Exercisable (in shares) 0
Vested  
Number of Shares  
Beginning Balance (in shares) 663,404
Vested (in shares) 0
Granted (in shares) 0
Exercised (in shares) (35,972)
Forfeited/Expired (in shares) (111,279)
Ending Balance (in shares) 516,153
Exercisable (in shares) 516,153
v3.25.4
Employee benefit plans - Schedule of Components of Net Periodic Benefit Cost/(Income) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Retirement Plans      
Defined Benefit Plan Disclosure [Line Items]      
Service cost $ 5,497 $ 3,456 $ 2,878
Interest cost 21,588 19,097 18,101
Expected return on plan assets (13,667) (11,133) (9,451)
Amortization of prior service cost 923 864 926
Amortization of net actuarial loss (gain) 3,871 4,472 4,300
Effect of settlement loss 42 530 1,010
Effect of curtailment gain (263) 0 0
Net periodic benefit (income)/cost 17,991 17,286 17,764
Retiree Health and Life Insurance Plans      
Defined Benefit Plan Disclosure [Line Items]      
Service cost 134 178 230
Interest cost 919 919 507
Expected return on plan assets (413) (392) (313)
Amortization of prior service cost 375 385 0
Amortization of net actuarial loss (gain) (1,160) (899) (768)
Net periodic benefit (income)/cost $ (145) $ 191 $ (344)
v3.25.4
Employee benefit plans - Schedule of Plans' Obligation and Assets (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Change in Plan Assets      
Fair value of plan assets at January 1 $ 304,000    
Fair value of plan assets at December 31 320,457 $ 304,000  
Retirement Plans      
Change in Benefit Obligation      
Benefit obligation at January 1 452,275 413,340  
Service cost 5,497 3,456 $ 2,878
Interest cost 21,588 19,097 18,101
Plan participant contributions 306 31  
Plan amendments 675 615  
Actuarial (gain)/loss (6,621) (18,935)  
Benefits paid (27,380) (28,263)  
Impact of foreign exchange rates 23,875 (8,926)  
Effect of settlements (8,576) (2,218)  
Effect of curtailments (408) 0  
Other 1,639 0  
Acquisitions 42 74,078  
Benefit obligation at December 31 462,912 452,275 413,340
Change in Plan Assets      
Fair value of plan assets at January 1 290,825 295,587  
Actual return on plan assets 13,722 (5,203)  
Company contributions 21,490 18,798  
Plan participant contributions 306 77  
Benefits paid (27,380) (28,263)  
Impact of foreign exchange rates 17,588 (7,200)  
Effect of settlements (8,576) (2,218)  
Expenses paid (1,945) (1,976)  
Other (999) 0  
Acquisitions 0 21,223  
Fair value of plan assets at December 31 307,029 290,825 295,587
Funded status of the Plans (155,883) (161,450)  
Retiree Health and Life Insurance Plans      
Change in Benefit Obligation      
Benefit obligation at January 1 19,832 22,571  
Service cost 134 178 230
Interest cost 919 919 507
Plan participant contributions 0 0  
Plan amendments (321) 0  
Actuarial (gain)/loss 1,027 (2,389)  
Benefits paid (1,181) (1,418)  
Impact of foreign exchange rates 16 (29)  
Effect of settlements 0 0  
Effect of curtailments 0 0  
Other 0 0  
Acquisitions 0 0  
Benefit obligation at December 31 20,426 19,832 22,571
Change in Plan Assets      
Fair value of plan assets at January 1 13,175 13,213  
Actual return on plan assets 669 535  
Company contributions 794 835  
Plan participant contributions 0 0  
Benefits paid (1,181) (1,360)  
Impact of foreign exchange rates 0 0  
Effect of settlements 0 0  
Expenses paid (29) (48)  
Other 0 0  
Acquisitions 0 0  
Fair value of plan assets at December 31 13,428 13,175 $ 13,213
Funded status of the Plans $ (6,998) $ (6,657)  
v3.25.4
Employee benefit plans - Schedule of Recognized Amounts in Consolidated Balance Sheets (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Total Recognized Amounts in the Consolidated Balance Sheets    
Noncurrent liabilities $ (177,976) $ (180,827)
Retirement Plans    
Total Recognized Amounts in the Consolidated Balance Sheets    
Noncurrent assets 27,283 24,919
Current liabilities (11,402) (11,382)
Noncurrent liabilities (171,764) (174,987)
Net liability (155,883) (161,450)
Retiree Health and Life Insurance Plans    
Total Recognized Amounts in the Consolidated Balance Sheets    
Noncurrent assets 0 0
Current liabilities (786) (817)
Noncurrent liabilities (6,212) (5,840)
Net liability $ (6,998) $ (6,657)
v3.25.4
Employee benefit plans - Schedule of Component of Net Periodic Pension Cost that are Included in Accumulated Other Comprehensive Loss (Income) (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Defined Benefit Plan Disclosure [Line Items]      
Prior service cost     $ 11,637
Retirement Plans      
Defined Benefit Plan Disclosure [Line Items]      
Net actuarial loss/(gain) $ 100,220 $ 109,718  
Prior service cost 5,683 5,020  
Amount in accumulated other comprehensive loss (income) 105,903 114,738  
Retiree Health and Life Insurance Plans      
Defined Benefit Plan Disclosure [Line Items]      
Net actuarial loss/(gain) (5,747) (7,706)  
Prior service cost 10,555 11,251  
Amount in accumulated other comprehensive loss (income) $ 4,808 $ 3,545  
v3.25.4
Employee benefit plans - Schedule of Amounts Recognized in Other Comprehensive Loss/(Income) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Retirement Plans      
Adjustments arising during the period:      
Net actuarial (gain)/loss $ (4,998) $ (238) $ 10,709
Prior service cost 736 327 430
Net settlement/curtailment gain/(loss) 221 (530) (1,010)
Amortization recognized during the period:      
Net actuarial (loss)/gain (3,871) (4,472) (4,300)
Prior service cost (923) (864) (926)
Total recognized in other comprehensive (income)/loss (8,835) (5,777) 4,903
Total recognized in net periodic benefit cost and other comprehensive loss/(income) 9,156 11,509 22,707
Retiree Health and Life Insurance Plans      
Adjustments arising during the period:      
Net actuarial (gain)/loss 799 (2,485) (451)
Prior service cost (321) 0 11,637
Net settlement/curtailment gain/(loss) 0 0 0
Amortization recognized during the period:      
Net actuarial (loss)/gain 1,160 899 768
Prior service cost (375) (385) 0
Total recognized in other comprehensive (income)/loss 1,263 (1,971) 11,954
Total recognized in net periodic benefit cost and other comprehensive loss/(income) $ 1,118 $ (1,780) $ 11,610
v3.25.4
Employee benefit plans - Additional Information (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 04, 2024
Sep. 08, 2023
Defined Benefit Plan Disclosure [Line Items]          
Defined benefit plans, accumulated benefit obligation $ 469,719 $ 440,126      
Projected benefit obligation (PBO) with accumulated benefit obligations in excess of plan assets 293,402 279,472      
Accumulated benefit obligation (ABO) with accumulated benefit obligations in excess of plan assets 283,773 270,720      
Fair value of plan assets for pension plans with accumulated benefit obligations in excess of plan assets 105,647 94,384      
Total postretirement benefit plan assets $ 320,457 304,000      
Prior service cost     $ 11,637    
Percentage of retiree health liability 98.00%        
Total 92.00%        
Projected contributions to retirement plan $ 23,200        
RTS Packaging          
Defined Benefit Plan Disclosure [Line Items]          
Voting interest acquired         65.00%
Interest held in acquiree before subsequent acquisition (percent)         35.00%
Accumulated other comprehensive loss including define pension plan, before tax         $ 4,756
Accumulated other comprehensive loss including define pension plan, after tax         $ 3,543
Retirement Plans          
Defined Benefit Plan Disclosure [Line Items]          
Defined benefit plan, benefit obligation 462,912 452,275 413,340    
Total postretirement benefit plan assets 307,029 290,825 295,587    
Accumulated other comprehensive loss including define pension plan, before tax (100,220) (109,718)      
Curtailment gains (408) 0      
Prior service cost $ 5,683 $ 5,020      
United States | Retirement Plans          
Defined Benefit Plan Disclosure [Line Items]          
Total 100.00% 100.00%      
United States | Retirement Plans | Equity securities          
Defined Benefit Plan Disclosure [Line Items]          
Total 34.30% 20.90%      
United States | Retirement Plans | Debt securities          
Defined Benefit Plan Disclosure [Line Items]          
Total 63.10% 77.90%      
United States | Retirement Plans | Cash          
Defined Benefit Plan Disclosure [Line Items]          
Total 2.60% 1.20%      
CANADA | Retirement Plans          
Defined Benefit Plan Disclosure [Line Items]          
Non-cash settlement charges $ 42 $ 530 1,010    
Total 100.00% 100.00%      
CANADA | Retirement Plans | Equity securities          
Defined Benefit Plan Disclosure [Line Items]          
Total 31.50% 31.40%      
Current target allocation for investment portfolio 30.00%        
CANADA | Retirement Plans | Debt securities          
Defined Benefit Plan Disclosure [Line Items]          
Total 68.50% 68.60%      
Current target allocation for investment portfolio 70.00%        
CANADA | Retirement Plans | Cash          
Defined Benefit Plan Disclosure [Line Items]          
Total 0.00% 0.00%      
U.K. | Retirement Plans          
Defined Benefit Plan Disclosure [Line Items]          
Total 100.00% 100.00%      
U.K. | Retirement Plans | Equity securities          
Defined Benefit Plan Disclosure [Line Items]          
Total 9.50% 21.00%      
Current target allocation for investment portfolio 10.00%        
U.K. | Retirement Plans | Debt securities          
Defined Benefit Plan Disclosure [Line Items]          
Total 88.40% 77.10%      
Current target allocation for investment portfolio 90.00%        
U.K. | Retirement Plans | Cash          
Defined Benefit Plan Disclosure [Line Items]          
Total 2.10% 1.90%      
Eviosys | Retirement Plans          
Defined Benefit Plan Disclosure [Line Items]          
Total 100.00% 100.00%      
Eviosys | Retirement Plans | Equity securities          
Defined Benefit Plan Disclosure [Line Items]          
Total 0.00% 0.00%      
Current target allocation for investment portfolio 0.00%        
Eviosys | Retirement Plans | Debt securities          
Defined Benefit Plan Disclosure [Line Items]          
Total 79.90% 85.10%      
Current target allocation for investment portfolio 70.00%        
Eviosys | Retirement Plans | Cash          
Defined Benefit Plan Disclosure [Line Items]          
Total 20.10% 14.90%      
Current target allocation for investment portfolio 30.00%        
Eviosys | United States | Retirement Plans          
Defined Benefit Plan Disclosure [Line Items]          
Defined benefit plan, benefit obligation       $ 74,120  
Total postretirement benefit plan assets       21,223  
Defined benefit plan, long-term unfunded pension obligations       51,918  
Defined benefit plan, short-term unfunded pension obligations       $ 979  
Active Plan Investment Portfolio | United States | Retirement Plans | Equity securities          
Defined Benefit Plan Disclosure [Line Items]          
Current target allocation for investment portfolio 35.00%        
Active Plan Investment Portfolio | United States | Retirement Plans | Debt securities          
Defined Benefit Plan Disclosure [Line Items]          
Current target allocation for investment portfolio 65.00%        
Sonoco Savings Plan          
Defined Benefit Plan Disclosure [Line Items]          
Defined contribution plan contribution percentage, minimum 1.00%        
Defined contribution plan contribution percentage, maximum 100.00%        
Defined contribution plan, employer matching contribution (percent) 100.00%        
Employer matching contribution, percent of employees' gross pay (percent) 6.00%        
Companies expense related to the plan $ 33,300 $ 33,700 $ 30,684    
v3.25.4
Employee benefit plans - Schedule of Company's Projected Benefit Payments (Details)
$ in Thousands
Dec. 31, 2025
USD ($)
Retirement Plans  
Defined Benefit Plan Disclosure [Line Items]  
2026 $ 33,035
2027 31,416
2028 33,787
2029 33,314
2030 33,853
2031-2035 178,345,000
Retiree Health and Life Insurance Plans  
Defined Benefit Plan Disclosure [Line Items]  
2026 1,341
2027 1,419
2028 1,483
2029 1,509
2030 1,387
2031-2035 $ 8,723,000
v3.25.4
Employee benefit plans - Schedule of Major Actuarial Assumptions Used in Determining PBO, ABO and Net Periodic Cost (Details)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
United States | Retirement Plans      
Weighted-average assumptions used to determine benefit obligations      
Discount Rate 5.28% 5.52%  
Rate of Compensation Increase 0.00% 0.00%  
Weighted-average assumptions used to determine net periodic benefit cost      
Discount Rate 5.52% 4.84% 5.01%
Expected Long-term Rate of Return 3.89% 3.08% 2.48%
Rate of Compensation Increase 0.00% 0.00% 0.00%
United States | Retiree Health and Life Insurance Plans      
Weighted-average assumptions used to determine benefit obligations      
Discount Rate 5.13% 5.32%  
Rate of Compensation Increase 2.99% 3.02%  
Weighted-average assumptions used to determine net periodic benefit cost      
Discount Rate 5.32% 4.68% 4.92%
Expected Long-term Rate of Return 4.64% 3.05% 2.45%
Rate of Compensation Increase 2.99% 3.03% 2.99%
Foreign Plans      
Weighted-average assumptions used to determine benefit obligations      
Discount Rate 5.02% 6.52%  
Rate of Compensation Increase 2.46% 3.59%  
Weighted-average assumptions used to determine net periodic benefit cost      
Discount Rate 6.52% 4.79% 4.97%
Expected Long-term Rate of Return 5.45% 4.36% 4.70%
Rate of Compensation Increase 2.46% 3.11% 3.29%
v3.25.4
Employee benefit plans - Schedule of Health Care Cost Trend Rates Related to U.S. Plan (Details) - United States
Dec. 31, 2025
Dec. 31, 2024
Pre-age 65    
Defined Benefit Plan Disclosure [Line Items]    
Healthcare Cost Trend Rate 6.20% 6.17%
Ultimate Trend Rate 4.50% 4.50%
Post-age 65    
Defined Benefit Plan Disclosure [Line Items]    
Healthcare Cost Trend Rate 7.00% 7.28%
Ultimate Trend Rate 4.50% 4.50%
v3.25.4
Employee benefit plans - Schedule of Weighted-Average Asset Allocations (Details)
Dec. 31, 2025
Dec. 31, 2024
Defined Benefit Plan Disclosure [Line Items]    
Total 92.00%  
Retirement Plans | Eviosys    
Defined Benefit Plan Disclosure [Line Items]    
Total 100.00% 100.00%
Retirement Plans | Equity securities | Eviosys    
Defined Benefit Plan Disclosure [Line Items]    
Total 0.00% 0.00%
Retirement Plans | Debt securities | Eviosys    
Defined Benefit Plan Disclosure [Line Items]    
Total 79.90% 85.10%
Retirement Plans | Cash and short-term investments | Eviosys    
Defined Benefit Plan Disclosure [Line Items]    
Total 20.10% 14.90%
Retirement Plans | U.S.    
Defined Benefit Plan Disclosure [Line Items]    
Total 100.00% 100.00%
Retirement Plans | U.S. | Equity securities    
Defined Benefit Plan Disclosure [Line Items]    
Total 34.30% 20.90%
Retirement Plans | U.S. | Debt securities    
Defined Benefit Plan Disclosure [Line Items]    
Total 63.10% 77.90%
Retirement Plans | U.S. | Cash and short-term investments    
Defined Benefit Plan Disclosure [Line Items]    
Total 2.60% 1.20%
Retirement Plans | U.K.    
Defined Benefit Plan Disclosure [Line Items]    
Total 100.00% 100.00%
Retirement Plans | U.K. | Equity securities    
Defined Benefit Plan Disclosure [Line Items]    
Total 9.50% 21.00%
Retirement Plans | U.K. | Debt securities    
Defined Benefit Plan Disclosure [Line Items]    
Total 88.40% 77.10%
Retirement Plans | U.K. | Cash and short-term investments    
Defined Benefit Plan Disclosure [Line Items]    
Total 2.10% 1.90%
Retirement Plans | CANADA    
Defined Benefit Plan Disclosure [Line Items]    
Total 100.00% 100.00%
Retirement Plans | CANADA | Equity securities    
Defined Benefit Plan Disclosure [Line Items]    
Total 31.50% 31.40%
Retirement Plans | CANADA | Debt securities    
Defined Benefit Plan Disclosure [Line Items]    
Total 68.50% 68.60%
Retirement Plans | CANADA | Cash and short-term investments    
Defined Benefit Plan Disclosure [Line Items]    
Total 0.00% 0.00%
Retiree Health and Life Insurance Plans    
Defined Benefit Plan Disclosure [Line Items]    
Total 100.00% 100.00%
Retiree Health and Life Insurance Plans | Equity securities    
Defined Benefit Plan Disclosure [Line Items]    
Total 0.00% 0.00%
Retiree Health and Life Insurance Plans | Debt securities    
Defined Benefit Plan Disclosure [Line Items]    
Total 100.00% 100.00%
Retiree Health and Life Insurance Plans | Cash and short-term investments    
Defined Benefit Plan Disclosure [Line Items]    
Total 0.00% 0.00%
v3.25.4
Income taxes - Schedule of Provision for Taxes on Income (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Pretax income      
Domestic $ 529,172 $ (35,733) $ 280,916
Foreign 235,929 99,219 208,111
Income from continuing operations before income taxes 765,101 63,486 489,027
Current      
Federal 59,956 3,693 54,319
State 10,732 1,916 11,282
Foreign 97,293 57,034 63,617
Total current 167,981 62,643 129,218
Deferred      
Federal 30,415 (34,828) (3,307)
State 14,220 (9,837) (1,646)
Foreign (29,030) (12,469) (4,535)
Total deferred 15,605 (57,134) (9,488)
Total taxes $ 183,586 $ 5,509 $ 119,730
v3.25.4
Income taxes - Schedule of Deferred tax (Liabilities)/Assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Income Tax Disclosure [Abstract]    
Property, plant and equipment $ (235,929) $ (266,278)
Intangibles (488,519) (545,330)
Leases (109,707) (76,225)
Outside basis in Metal Packaging (63,105) (68,649)
Other (192) 0
Gross deferred tax liabilities (897,452) (956,482)
Retiree health benefits 4 245
Foreign loss carryforwards 110,055 79,314
U.S. Federal loss and credit carryforwards 31,980 34,082
Capital loss carryforwards 3,983 3,755
U.S. State loss and credit carryforwards 23,413 26,181
Capitalized research and development costs 67,894 103,043
Net investment hedge 50,524 0
Employee benefits 54,258 56,192
Leases 116,184 82,031
Accrued liabilities and other assets 44,023 71,370
Gross deferred tax assets 502,318 456,213
Valuation allowance on deferred tax assets (107,451) (81,496)
Total deferred taxes, net $ (502,585) (581,765)
Deferred taxes, net, discontinued operations   (15,666)
Deferred tax assets, valuation allowance, discontinued operations   $ (4,628)
v3.25.4
Income Taxes - Schedule of Reconciliation of the U.S. Federal Statutory Tax Rate (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Effective Income Tax Rate Reconciliation, Amount [Abstract]      
U.S. Federal statutory tax rate $ 160,671 $ 13,332 $ 102,696
State and local income taxes, net of Federal income tax effect 16,129 (883) 12,263
Changes in valuation allowances   7,763 4,486
Other foreign jurisdictions   12,271 13,108
Effect of changes in tax laws or rates enacted in the current period 0 (1,552) 387
Effect of cross-border tax laws      
Global intangible low-taxed income (GILTI), net of foreign tax credit (FTC) 9,525 (5,604) 4,853
Tax on undistributed earnings of subsidiaries 11,756    
Foreign branch inclusion 10,479    
Other 4,380    
Tax credits (9,627) (11,834) (18,848)
Nontaxable or nondeductible items      
Benefit for purchased credits (14,875)    
Other 5,927    
Changes in unrecognized tax benefits 2,622    
Other adjustments      
Disposition of business (29,994) (2,954) 464
Other 1,497 (3,103) (3,870)
Total taxes $ 183,586 $ 5,509 $ 119,730
Effective Income Tax Rate Reconciliation, Percent [Abstract]      
U.S. Federal statutory tax rate 21.00% 21.00% 21.00%
State and local income taxes, net of Federal income tax effect 2.10% (1.40%) 2.50%
Changes in valuation allowances   12.20% 0.90%
Other foreign jurisdictions   19.30% 2.70%
Effect of changes in tax laws or rates enacted in the current period 0.00% (2.40%) 0.10%
Effect of cross-border tax laws      
Global intangible low-taxed income (GILTI), net of foreign tax credit (FTC) 1.20% (8.80%) 1.00%
Tax on undistributed earnings of subsidiaries 1.50%    
Foreign branch inclusion 1.40%    
Other 0.60%    
Tax credits (1.30%) (18.60%) (3.90%)
Nontaxable or nondeductible items      
Benefit for purchased credits (0.019)    
Other 0.80%    
Changes in unrecognized tax benefits 0.30%    
Other adjustments      
Disposition of business (3.90%) (4.70%) 0.10%
Other 0.20% (4.90%) (0.80%)
Provision for income taxes 24.00% 8.70% 24.50%
Luxembourg      
Effective Income Tax Rate Reconciliation, Amount [Abstract]      
Changes in valuation allowances $ 10,826    
Other $ (5,572)    
Effective Income Tax Rate Reconciliation, Percent [Abstract]      
Changes in valuation allowances 1.40%    
Other (0.70%)    
Finland      
Effective Income Tax Rate Reconciliation, Amount [Abstract]      
Other $ (479)    
Nontaxable income $ (8,115)    
Effective Income Tax Rate Reconciliation, Percent [Abstract]      
Other (0.10%)    
Nontaxable income (1.10%)    
Other foreign jurisdictions      
Effective Income Tax Rate Reconciliation, Amount [Abstract]      
Other foreign jurisdictions $ 18,402    
Effective Income Tax Rate Reconciliation, Percent [Abstract]      
Other foreign jurisdictions 2.40%    
United States      
Effective Income Tax Rate Reconciliation, Amount [Abstract]      
Changes in valuation allowances $ 34    
Effective Income Tax Rate Reconciliation, Percent [Abstract]      
Changes in valuation allowances 0.00%    
v3.25.4
Income taxes - Additional Information (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Taxes [Line Items]      
Tax credit carryforwards, foreign $ 25,601    
Capital loss carryforwards 3,983 $ 3,755  
Increase (decrease) in reserve for uncertain tax positions   (8,613) $ 1,819
Tax credits 9,627 11,834 18,848
Tax cuts and jobs act, global intangible low-tax income, net tax expense (benefit) amount 3,008    
Global intangible low-taxed income (GILTI) 9,525    
Divestiture of business (29,994) (2,954) 464
Unrecognized tax benefits 11,102 9,857  
Accrued for interest 2,817 1,667  
Income taxes, net interest expense $ 1,150    
Income Tax, Interest Recognition, Classification [Extensible Enumeration] Total taxes    
Interest benefit $ 384    
Interest expense 1,534    
Next five years      
Income Taxes [Line Items]      
Tax credit carryforwards, foreign 22,474    
Tax years, 2030 - 2044      
Income Taxes [Line Items]      
Tax credit carryforwards, foreign 3,127    
U.S. Federal      
Income Taxes [Line Items]      
Loss carryforwards 31,556    
Foreign tax effects      
Income Taxes [Line Items]      
Loss carryforwards 532,745    
Loss carryforwards not subject to expiration 309,722    
Capital loss carryforwards 16,108    
Foreign tax effects | Next five years      
Income Taxes [Line Items]      
Operating loss carryforwards subject to expiration 193,878    
Foreign tax effects | Tax years, 2030 - 2044      
Income Taxes [Line Items]      
Operating loss carryforwards subject to expiration 29,145    
State      
Income Taxes [Line Items]      
Loss carryforwards 9,242    
State credit carry forwards 20,395    
Uncertain Items Arising During Year      
Income Taxes [Line Items]      
Increase (decrease) in reserve for uncertain tax positions 1,732 3,405 2,710
Uncertain Items Arising During Prior Years      
Income Taxes [Line Items]      
Increase (decrease) in reserve for uncertain tax positions $ (899) $ (13,229) $ (891)
v3.25.4
Income Taxes - Schedule of Income Taxes Paid (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Effective Income Tax Rate Reconciliation [Line Items]      
Federal taxes paid $ 125,868    
State taxes paid 30,926    
Foreign taxes paid 108,107    
Total 264,901 $ 92,427 $ 189,773
Spain      
Effective Income Tax Rate Reconciliation [Line Items]      
Foreign taxes paid 20,109    
BRAZIL      
Effective Income Tax Rate Reconciliation [Line Items]      
Foreign taxes paid 17,688    
Other      
Effective Income Tax Rate Reconciliation [Line Items]      
Foreign taxes paid $ 70,310    
v3.25.4
Income taxes - Schedule of Reconciliation of U.S. Federal Statutory Tax Rate to Actual Consolidated Tax Expense (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Effective Income Tax Rate Reconciliation, Amount [Abstract]      
U.S. Federal statutory tax rate $ 160,671 $ 13,332 $ 102,696
State income taxes, net of federal tax benefit 16,129 (883) 12,263
Valuation allowance   7,763 4,486
Tax examinations including change in reserve for uncertain tax positions   (8,613) 1,819
Adjustments to prior year deferred taxes   (9,129) (2,489)
Foreign earnings taxed at other than U.S. rates   12,271 13,108
Divestiture of business (29,994) (2,954) 464
Effect of tax rate changes 0 (1,552) 387
Foreign withholding taxes   5,344 4,591
Tax credits (9,627) (11,834) (18,848)
Global intangible low-taxed income (GILTI) 9,525 (5,604) 4,853
Foreign-derived intangible income   (858) (1,106)
Foreign currency gain/(loss) on distributions of previously taxed income   642 (2,614)
IRC Subpart F Income   916 119
Executive compensation limitation   2,569 3,767
Capitalized acquisition costs   7,202 104
Other, net 1,497 (3,103) (3,870)
Total taxes $ 183,586 $ 5,509 $ 119,730
Effective Income Tax Rate Reconciliation, Percent [Abstract]      
U.S. Federal statutory tax rate 21.00% 21.00% 21.00%
State income taxes, net of federal tax benefit 2.10% (1.40%) 2.50%
Valuation allowance   12.20% 0.90%
Tax examinations including change in reserve for uncertain tax positions   (13.60%) 0.40%
Adjustments to prior year deferred taxes   (14.40%) (0.50%)
Foreign earnings taxed at other than U.S. rates   19.30% 2.70%
Divestiture of business (3.90%) (4.70%) 0.10%
Effect of tax rate changes 0.00% (2.40%) 0.10%
Foreign withholding taxes   8.40% 0.90%
Tax credits (1.30%) (18.60%) (3.90%)
Global intangible low-taxed income (GILTI) 1.20% (8.80%) 1.00%
Foreign-derived intangible income   (1.40%) (0.20%)
Foreign currency gain/(loss) on distributions of previously taxed income   1.00% (0.50%)
IRC Subpart F Income   1.40% 0.00%
Executive compensation limitation   4.00% 0.80%
Capitalized acquisition costs   11.30% 0.00%
Other, net 0.20% (4.90%) (0.80%)
Provision for income taxes 24.00% 8.70% 24.50%
v3.25.4
Income taxes - Schedule of Reconciliation of Gross Amounts of Unrecognized Tax Benefits (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Unrecognized Tax Benefits [Roll Forward]      
Gross Unrecognized Tax Benefits at January 1 $ 12,138 $ 21,677 $ 18,621
Increases in prior years’ unrecognized tax benefits 2,743 627 378
Decreases in prior years’ unrecognized tax benefits (1,404) (1,915) (572)
Increases in current year unrecognized tax benefits 688 4,325 4,395
Decreases in unrecognized tax benefits from the lapse of statutes of limitations (235) (12,100) (1,094)
Settlements (748) (476) (51)
Gross Unrecognized Tax Benefits at December 31 $ 13,182 $ 12,138 $ 21,677
v3.25.4
Revenue recognition - Schedule of Disaggregated Revenues (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Disaggregation of Revenue [Line Items]      
Total $ 7,518,753 $ 5,305,365 $ 5,441,426
United States      
Disaggregation of Revenue [Line Items]      
Total 3,614,921 3,569,806 3,700,872
EMEA      
Disaggregation of Revenue [Line Items]      
Total 3,207,438 955,520 885,386
CANADA      
Disaggregation of Revenue [Line Items]      
Total 104,414 113,349 116,171
APAC      
Disaggregation of Revenue [Line Items]      
Total 249,559 311,052 329,394
Other      
Disaggregation of Revenue [Line Items]      
Total 342,421 355,638 409,603
Operating segments | Consumer Packaging      
Disaggregation of Revenue [Line Items]      
Total 4,874,291 2,531,852 2,471,048
Operating segments | Industrial Paper Packaging      
Disaggregation of Revenue [Line Items]      
Total 2,299,233 2,349,488 2,374,113
Operating segments | United States | Consumer Packaging      
Disaggregation of Revenue [Line Items]      
Total 1,864,861 1,785,857 1,817,268
Operating segments | United States | Industrial Paper Packaging      
Disaggregation of Revenue [Line Items]      
Total 1,464,574 1,431,232 1,389,492
Operating segments | EMEA | Consumer Packaging      
Disaggregation of Revenue [Line Items]      
Total 2,789,400 524,699 431,189
Operating segments | EMEA | Industrial Paper Packaging      
Disaggregation of Revenue [Line Items]      
Total 361,878 371,896 389,261
Operating segments | CANADA | Consumer Packaging      
Disaggregation of Revenue [Line Items]      
Total 18,539 17,486 16,076
Operating segments | CANADA | Industrial Paper Packaging      
Disaggregation of Revenue [Line Items]      
Total 85,875 95,863 100,095
Operating segments | APAC | Consumer Packaging      
Disaggregation of Revenue [Line Items]      
Total 100,482 96,154 94,136
Operating segments | APAC | Industrial Paper Packaging      
Disaggregation of Revenue [Line Items]      
Total 148,012 213,127 233,446
Operating segments | Other | Consumer Packaging      
Disaggregation of Revenue [Line Items]      
Total 101,009 107,656 112,379
Operating segments | Other | Industrial Paper Packaging      
Disaggregation of Revenue [Line Items]      
Total 238,894 237,370 261,819
All Other      
Disaggregation of Revenue [Line Items]      
Total 345,229 424,025 596,265
All Other | United States      
Disaggregation of Revenue [Line Items]      
Total 285,486 352,717 494,112
All Other | EMEA      
Disaggregation of Revenue [Line Items]      
Total 56,160 58,925 64,936
All Other | CANADA      
Disaggregation of Revenue [Line Items]      
Total 0 0 0
All Other | APAC      
Disaggregation of Revenue [Line Items]      
Total 1,065 1,771 1,812
All Other | Other      
Disaggregation of Revenue [Line Items]      
Total $ 2,518 $ 10,612 $ 35,405
v3.25.4
Revenue recognition - Schedule of Contract Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Revenue from Contract with Customer [Abstract]      
Contract Assets $ 77,978 $ 67,062 $ 14,754
Contract Liabilities $ (58,784) $ (60,024) $ (15,252)
v3.25.4
Revenue recognition - Schedule of Significant Changes in Contract Assets and Liabilities (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Contract Assets    
Beginning balance $ 67,062 $ 14,754
Acquired/ sold as part of a business combination/ divestiture (53) 62,439
Increases due to rights to consideration for customer specific goods produced, but not billed during the period 77,978 67,062
Transferred to receivables from contract assets recognized at the beginning of the period and acquired as part of business combination (67,009) (77,193)
Ending balance 77,978 67,062
Contract Liabilities    
Beginning balance (60,024) (15,252)
Acquired/ sold as part of a business combination/ divestiture (324) (47,478)
Revenue deferred or rebates accrued (94,947) (25,736)
Recognized as revenue 1,183 2,341
Rebates paid to customers 95,328 26,101
Ending balance $ (58,784) $ (60,024)
v3.25.4
Commitments and contingencies (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Site Contingency [Line Items]    
Total future payments $ 71,200  
Payments in 2025 23,700  
Payments in 2026 24,500  
Payments in 2027 23,000  
Payments in 2028 0  
Payments in 2029 - 2033 0  
Purchase commitments 93,900  
Multiple Sites    
Site Contingency [Line Items]    
Environmental accrual $ 1,779 $ 1,933
Tegrant Holding Corporation | Spartanburg, South Carolina Site    
Site Contingency [Line Items]    
Environmental accrual   $ 5,096
v3.25.4
Shareholders’ equity and earnings per share - Additional Information (Details)
$ in Thousands
1 Months Ended 12 Months Ended
Apr. 01, 2025
USD ($)
Mar. 02, 2025
USD ($)
Nov. 30, 2024
productionFacility
Dec. 31, 2025
USD ($)
shares
Dec. 31, 2024
USD ($)
shares
Dec. 31, 2023
USD ($)
shares
Dec. 04, 2024
Apr. 20, 2021
USD ($)
Equity [Line Items]                
Number of shares authorized for repurchase               $ 350,000
Number of shares repurchased (in shares) | shares       0 0      
Number of shares available for repurchase (in shares)       $ 137,972 $ 137,972      
Divestiture of non-controlling interest       910 2,043      
Non-controlling interest from acquisition       $ 2,346 $ 9,533      
Ivory Coast | Eviosys                
Equity [Line Items]                
Ownership percentage by parent             85.20%  
Morocco | Eviosys                
Equity [Line Items]                
Ownership percentage by parent             99.34%  
Dispositions | Timberland Properties                
Equity [Line Items]                
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal, Statement of Income or Comprehensive Income [Extensible Enumeration]           Gain/(Loss) on divestiture of business and other assets    
Dispositions | China Production Facilities                
Equity [Line Items]                
Number of production facilities | productionFacility     2          
Tax Withholding Obligations                
Equity [Line Items]                
Number of shares repurchased (in shares) | shares       227,560 164,402 175,665    
Cost of shares repurchased       $ 10,930 $ 9,246 $ 10,617    
Non- controlling Interests                
Equity [Line Items]                
Divestiture of non-controlling interest       910 2,043      
Non-controlling interest from acquisition       2,346 9,533      
Non- controlling Interests | Eviosys                
Equity [Line Items]                
Non-controlling interest from acquisition       $ 2,346        
Non- controlling Interests | TFP                
Equity [Line Items]                
Divestiture of non-controlling interest $ 600              
Non- controlling Interests | Tube and Core Operations                
Equity [Line Items]                
Divestiture of non-controlling interest   $ 310            
Non- controlling Interests | China Production Facilities                
Equity [Line Items]                
Divestiture of non-controlling interest         $ 2,043      
v3.25.4
Shareholders’ equity and earnings per share - Schedule of Earnings /(Loss) Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Numerator:      
Net income from continuing operations $ 591,038 $ 67,565 $ 379,644
Net (income)/loss from continuing operations attributable to noncontrolling interests (375) 180 (768)
Net income from continuing operations attributable to Sonoco 590,663 67,745 378,876
Net income attributable to Sonoco $ 1,003,011 $ 163,949 $ 474,959
Denominator:      
Basic (in shares) 99,124 98,637 98,294
Dilutive effect of stock-based compensation (in shares) 447 653 596
Diluted (in shares) 99,571 99,290 98,890
Basic earnings per common share:      
Net income from continuing operations (usd per share) $ 5.96 $ 0.69 $ 3.85
Net income attributable to Sonoco (usd per share) 10.12 1.66 4.83
Diluted earnings per common share:      
Net income from continuing operations (usd per share) 5.93 0.68 3.83
Net income attributable to Sonoco (usd per share) 10.07 1.65 4.80
Cash dividends (usd per share) $ 2.11 $ 2.07 $ 2.02
v3.25.4
Shareholders’ equity and earnings per share - Schedule of Shares Not Included in Computations of Diluted Income Per Share (Details) - shares
shares in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Equity [Abstract]      
Anti-dilutive stock appreciation rights (in shares) 513 408 352
v3.25.4
Segment reporting - Additional Information (Details)
12 Months Ended
Dec. 31, 2025
segment
Segment Reporting [Abstract]  
Number of reportable segments 2
v3.25.4
Segment reporting - Schedule of Financial Segment Information (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Segment Reporting Information [Line Items]      
Sales from reportable segments $ 7,317,224 $ 5,001,044 $ 4,952,154
Other sales 349,888 431,107 604,442
Total consolidated sales 7,518,753 5,305,365 5,441,426
Cost of sales (5,944,340) (4,166,132) (4,238,857)
Segment operating profit 1,017,735 326,578 589,049
Other segment disclosures:      
Equity in earnings of affiliates, net of tax 9,523 9,588 10,347
Depreciation and amortization 519,356 374,859 340,988
Consumer Packaging      
Segment Reporting Information [Line Items]      
Sales from reportable segments 4,896,838 2,539,874 2,476,219
Industrial Paper Packaging      
Segment Reporting Information [Line Items]      
Sales from reportable segments 2,420,386 2,461,170 2,475,935
Operating segments      
Segment Reporting Information [Line Items]      
Sales from reportable segments 7,173,524 4,881,340 4,845,161
Segment operating profit 939,374 566,486 603,679
Other segment disclosures:      
Equity in earnings of affiliates, net of tax 9,523 9,588 10,347
Operating segments | Consumer Packaging      
Segment Reporting Information [Line Items]      
Sales from reportable segments 4,874,291 2,531,852 2,471,048
Total consolidated sales 4,874,291 2,531,852 2,471,048
Cost of sales (3,950,750) (2,041,078) (1,999,514)
Other segment items (319,168) (203,964) (190,943)
Segment operating profit 626,920 294,832 285,762
Other segment disclosures:      
Equity in earnings of affiliates, net of tax 226 365 564
Depreciation and amortization 209,618 109,355 95,340
Operating segments | Industrial Paper Packaging      
Segment Reporting Information [Line Items]      
Sales from reportable segments 2,299,233 2,349,488 2,374,113
Total consolidated sales 2,299,233 2,349,488 2,374,113
Cost of sales (1,726,225) (1,818,324) (1,809,803)
Other segment items (381,707) (371,192) (348,215)
Segment operating profit 312,454 271,654 317,917
Other segment disclosures:      
Equity in earnings of affiliates, net of tax 9,297 9,223 9,783
Depreciation and amortization 118,889 116,149 104,723
Intersegment sales      
Segment Reporting Information [Line Items]      
Sales from reportable segments 143,700 119,704 106,993
Total consolidated sales (148,359) (126,786) (115,170)
Intersegment sales | Consumer Packaging      
Segment Reporting Information [Line Items]      
Sales from reportable segments 22,547 8,022 5,171
Intersegment sales | Industrial Paper Packaging      
Segment Reporting Information [Line Items]      
Sales from reportable segments $ 121,153 $ 111,682 $ 101,822
v3.25.4
Segment reporting - Schedule of Reconciliation of Segment Operating Profit to Income Before Income Taxes (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Segment Reporting Information [Line Items]      
Segment operating profit $ 1,017,735 $ 326,578 $ 589,049
Restructuring/Asset impairment charges, net (66,215) (65,370) (47,909)
Amortization of acquisition intangibles (182,431) (78,595) (67,323)
Gain/(Loss) on divestiture of business 371,717 (23,452) 78,929
Acquisition, integration and divestiture-related costs (54,158) (91,600) (24,624)
Changes in LIFO inventory reserves (58) 6,263 11,817
Derivative (losses)/gains $ (1,730) $ 7,225 $ 1,912
Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag Derivative (losses)/gains Derivative (losses)/gains Derivative (losses)/gains
Other corporate costs, net $ (35,242) $ (46,675) $ (42,254)
Other operating (charges)/income, net (4,335) (982) (10,326)
Other (expense)/income, net (27,481) (104,200) 39,657
Non-operating pension costs (12,215) (13,842) (14,312)
Interest expense (233,485) (172,620) (135,393)
Interest income 20,547 27,570 10,026
Income from continuing operations before income taxes 765,101 63,486 489,027
Operating segments      
Segment Reporting Information [Line Items]      
Segment operating profit 939,374 566,486 603,679
Other operating profits      
Segment Reporting Information [Line Items]      
Segment operating profit $ 50,813 $ 53,278 $ 85,148
v3.25.4
Segment reporting - Schedule of Reconciliation of Other Segment to Consolidated Totals (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Segment Reporting Information [Line Items]      
Equity in earnings of affiliates, net of tax $ 9,523 $ 9,588 $ 10,347
Continuing Operations      
Segment Reporting Information [Line Items]      
Equity in earnings of affiliates, net of tax 9,523 9,588 10,347
Depreciation and amortization 519,667 316,061 282,029
Operating segments      
Segment Reporting Information [Line Items]      
Equity in earnings of affiliates, net of tax 9,523 9,588 10,347
Depreciation and amortization 328,507 225,504 200,063
Operating segments | Consumer Packaging      
Segment Reporting Information [Line Items]      
Equity in earnings of affiliates, net of tax 226 365 564
Depreciation and amortization 209,618 109,355 95,340
Operating segments | Industrial Paper Packaging      
Segment Reporting Information [Line Items]      
Equity in earnings of affiliates, net of tax 9,297 9,223 9,783
Depreciation and amortization 118,889 116,149 104,723
Other      
Segment Reporting Information [Line Items]      
Equity in earnings of affiliates, net of tax 0 0 0
Depreciation and amortization $ 191,160 $ 90,557 $ 81,966
v3.25.4
Segment reporting - Schedule of Sales to Unaffiliated Customers and Long-Lived Assets by Geographic Region (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Sales to Unaffiliated Customers      
Total sales $ 7,518,753 $ 5,305,365 $ 5,441,426
Long-lived Assets      
Long-lived Assets 8,042,530 7,898,903 3,743,734
United States      
Sales to Unaffiliated Customers      
Total sales 3,614,921 3,569,806 3,700,872
Long-lived Assets      
Long-lived Assets 2,462,090 2,695,885 2,779,178
EMEA      
Sales to Unaffiliated Customers      
Total sales 3,207,438 955,520 885,386
Long-lived Assets      
Long-lived Assets 4,893,882 4,690,098 617,949
CANADA      
Sales to Unaffiliated Customers      
Total sales 104,414 113,349 116,171
Long-lived Assets      
Long-lived Assets 27,214 35,750 39,842
APAC      
Sales to Unaffiliated Customers      
Total sales 249,559 311,052 329,394
Long-lived Assets      
Long-lived Assets 180,882 176,547 157,235
All other      
Sales to Unaffiliated Customers      
Total sales 342,421 355,638 409,603
Long-lived Assets      
Long-lived Assets $ 478,462 $ 300,623 $ 149,530
v3.25.4
Accumulated other comprehensive loss - Schedule of Components of Accumulated Other Comprehensive Income/(Loss) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]      
Beginning balance $ 2,286,213 $ 2,431,835 $ 2,072,797
Other comprehensive income/(loss) 541,722 (136,849) 63,391
Ending balance 3,631,832 2,286,213 2,431,835
Foreign Currency Items      
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]      
Beginning balance (410,931) (267,578)  
Other comprehensive (loss)/income before reclassifications 484,608 (146,856)  
Amounts reclassified from accumulated other comprehensive loss to net income 50,550 3,503  
Other comprehensive income/(loss) 535,158 (143,353)  
Ending balance 124,227 (410,931) (267,578)
Defined Benefit Pension Items      
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]      
Beginning balance (90,613) (99,627)  
Other comprehensive (loss)/income before reclassifications 1,159 4,636  
Amounts reclassified from accumulated other comprehensive loss to net income 1,496 4,378  
Other comprehensive income/(loss) 2,655 9,014  
Ending balance (87,958) (90,613) (99,627)
Gains and Losses on Cash Flow Hedges      
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]      
Beginning balance (1,190) 943  
Other comprehensive (loss)/income before reclassifications 3,486 (3,213)  
Amounts reclassified from accumulated other comprehensive loss to net income (1,361) 1,080  
Other comprehensive income/(loss) 2,125 (2,133)  
Ending balance 935 (1,190) 943
Accumulated Other Comprehensive Loss      
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]      
Beginning balance (502,734) (366,262)  
Other comprehensive (loss)/income before reclassifications 489,253 (145,433)  
Amounts reclassified from accumulated other comprehensive loss to net income 50,685 8,961  
Other comprehensive income/(loss) 539,938 (136,472)  
Ending balance $ 37,204 $ (502,734) $ (366,262)
v3.25.4
Accumulated other comprehensive loss - Schedule of Effects on Net Income of Significant Amounts Reclassified from Accumulated Other Comprehensive Income/(Loss) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Net income from discontinued operations $ 412,348 $ 96,375 $ 96,257
Loss on divestiture of business 978,350 (23,452) 57,104
Net income 1,003,386 163,940 475,901
Income from continuing operations before income taxes 765,101 63,486 489,027
Provision for income taxes (183,586) (5,509) (119,730)
Net sales 7,518,753 5,305,365 5,441,426
Cost of sales (5,944,340) (4,166,132) $ (4,238,857)
Reclassification out of Accumulated Other Comprehensive Income      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Net income (50,685) (8,961)  
Reclassification out of Accumulated Other Comprehensive Income | Foreign Currency Items      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Net income (50,550) (3,503)  
Reclassification out of Accumulated Other Comprehensive Income | Foreign Currency Items | TFP      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Net income from discontinued operations (47,955) 0  
Reclassification out of Accumulated Other Comprehensive Income | Foreign Currency Items | Tube and Core Operations      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Loss on divestiture of business (3,792) 0  
Reclassification out of Accumulated Other Comprehensive Income | Foreign Currency Items | ThermoSafe      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Loss on divestiture of business 1,197 0  
Reclassification out of Accumulated Other Comprehensive Income | Foreign Currency Items | Black Diamond Capital Management LLC      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Loss on divestiture of business 0 (3,503)  
Reclassification out of Accumulated Other Comprehensive Income | Effect of settlement loss      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Non-operating pension costs (42) (530)  
Reclassification out of Accumulated Other Comprehensive Income | Effect of curtailment gain      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Non-operating pension costs 263 0  
Reclassification out of Accumulated Other Comprehensive Income | Defined Benefit Pension Items      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Net income (1,496) (4,378)  
Income from continuing operations before income taxes (3,788) (5,352)  
Provision for income taxes 2,292 974  
Reclassification out of Accumulated Other Comprehensive Income | Amortization of defined benefit pension items      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Non-operating pension costs (4,009) (4,822)  
Reclassification out of Accumulated Other Comprehensive Income | Gains and Losses on Cash Flow Hedges      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Net income 1,361 (1,080)  
Income from continuing operations before income taxes 1,701 (1,455)  
Provision for income taxes (340) 375  
Reclassification out of Accumulated Other Comprehensive Income | Gains and Losses on Cash Flow Hedges | Foreign exchange contracts      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Net sales 3,811 (1,174)  
Cost of sales (2,557) (253)  
Reclassification out of Accumulated Other Comprehensive Income | Gains and Losses on Cash Flow Hedges | Commodity Contracts      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Cost of sales $ 447 $ (28)  
v3.25.4
Accumulated other comprehensive loss - Schedule of Before and After Tax Amounts for Comprehensive Income (Loss) Components (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Foreign Currency Items    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Other comprehensive income/(loss) before reclassifications before tax $ 428,732 $ (140,210)
Other comprehensive income/(loss) before reclassifications, tax 55,876 (6,646)
Other comprehensive income/(loss) before reclassifications, net of tax 484,608 (146,856)
Amounts reclassified from accumulated other comprehensive income/(loss) before tax 50,550 3,503
Amounts reclassified from accumulated other comprehensive income/(loss) loss, tax 0 0
Amounts reclassified from accumulated other comprehensive income/(loss) net of tax 50,550 3,503
Other comprehensive income/(loss) before tax 479,282 (136,707)
Other comprehensive income/(loss), tax 55,876 (6,646)
Other comprehensive income/(loss) 535,158 (143,353)
Defined Benefit Pension Items    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Other comprehensive income/(loss) before reclassifications before tax 3,784 2,395
Other comprehensive income/(loss) before reclassifications, tax (2,625) 2,241
Other comprehensive income/(loss) before reclassifications, net of tax 1,159 4,636
Amounts reclassified from accumulated other comprehensive income/(loss) before tax 3,788 5,352
Amounts reclassified from accumulated other comprehensive income/(loss) loss, tax (2,292) (974)
Amounts reclassified from accumulated other comprehensive income/(loss) net of tax 1,496 4,378
Other comprehensive income/(loss) before tax 7,572 7,747
Other comprehensive income/(loss), tax (4,917) 1,267
Other comprehensive income/(loss) 2,655 9,014
Cash flow hedges:    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Other comprehensive income/(loss) before reclassifications before tax 4,357 (4,329)
Other comprehensive income/(loss) before reclassifications, tax (871) 1,116
Other comprehensive income/(loss) before reclassifications, net of tax 3,486 (3,213)
Amounts reclassified from accumulated other comprehensive income/(loss) before tax (1,701) 1,455
Amounts reclassified from accumulated other comprehensive income/(loss) loss, tax 340 (375)
Amounts reclassified from accumulated other comprehensive income/(loss) net of tax (1,361) 1,080
Other comprehensive income/(loss) before tax 2,656 (2,874)
Other comprehensive income/(loss), tax (531) 741
Other comprehensive income/(loss) 2,125 (2,133)
Other comprehensive income/(loss)    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Other comprehensive income/(loss) before tax 489,510 (131,834)
Other comprehensive income/(loss), tax 50,428 (4,638)
Other comprehensive income/(loss) $ 539,938 $ (136,472)
v3.25.4
Schedule II - Valuation and Qualifying Accounts (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Allowance for Doubtful Accounts      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Year $ 10,989 $ 18,868 $ 14,280
Charged to Costs and Expenses 1,783 3,457 6,479
Charged to Other 1,124 (199) 160
Deductions 1,384 11,137 2,051
Balance at End of Year 12,512 10,989 18,868
LIFO Reserve      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Year 33,265 39,528 51,342
Charged to Costs and Expenses 58 (6,263) (11,814)
Charged to Other 0 0 0
Deductions 0 0 0
Balance at End of Year 33,323 33,265 39,528
Valuation Allowance on Deferred Tax Assets      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Year 76,868 66,266 79,427
Charged to Costs and Expenses 36,862 7,921 4,432
Charged to Other (6,279) 2,681 (17,593)
Deductions 0 0 0
Balance at End of Year $ 107,451 $ 76,868 $ 66,266